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Abstract
y-amino-butyric acid type A (GABAa) receptors are the major sites of fast synaptic 
transmission in the central nervous system and can be assembled from 7 subunit 
classes: a l-6 ,  (31-3, y l-3, 5, e, 7t, and 0. Although expression o f receptor a  and (3 
subunits can produce functional GABA-gated chloride channels the presence o f the 
y2 subunit within the GABAa receptor complex has been shown to play a key role 
in clustering and synaptic targeting. The regulation o f GABAa receptor cell surface 
stability by endocytosis has been previously shown to be a crucial determinant of 
inhibitory synaptic strength. The main focus o f this thesis is to further understand 
the molecular mechanisms by which the number of GABAa receptors clustered in 
synapses can be regulated.
Microscopy and biochemical experiments showed that the y2 subunit o f GABAa 
receptors confers an enhancement in the targeting o f GABAa receptors to a 
degradative pathway after internalization from the plasma membrane. Furthermore, 
blocking lysosomal degradation with the lysosomal inhibitor leupeptin results in 
increased GABAergic currents in cells expressing GABAa receptors containing a l ,  
(33 and y2 subunits but not those expressing a  1(33 receptors alone. In order to 
characterise the molecular signals determining this degradative pathway, p3-y2 
chimeras were created and expressed in both HEK293 cells and hippocampal 
neurons. Quantitative confocal microscoscopy studies on these chimeras revealed a 
20 amino acid region to be responsible for the late endosomal/lysosomal targeting 
o f y2 subunit containing GABAa receptors.
Further analysis into this 20 amino acid region identified a lysine stretch that when 
mutated resulted in decreased levels o f internalised GABAa receptors in late 
endosomes. Within this region the mutation o f serine 327, a known 
phosphorylation site o f GABAa receptors, also caused a reduction in the targeting 
o f internalised GABAa receptors to lysosomes. Interestingly GABAergic currents 
formed by the expression of oclp3 and y2L (lysine or serine mutant) were
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unaffected by the lysosomal inhibitor leupeptin. Biochemical studies found these 
lysines to be modified by the small poly-peptide ubiquitin, a known molecular 
signal for the degradation o f proteins in the proteasome and the endocytic pathway. 
Moreover, mutation o f serine 327 was sufficient to inhibit the ubiquitination o f this 
lysine stretch in the intracellular loop o f the y2L subunit.
The results presented in this thesis suggest that the endocytic sorting fate of 
synaptic GABAa receptors plays an important role in determining the strength of 
inhibitory synapses and provide a mechanism by which serine 327 acts as a 
molecular switch to regulate the ubiquitination dependent degradation o f GABAa 
receptors in the lysosome.
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1. INTRODUCTION
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Neuronal communication
Synaptic transmission describes the ability to receive, integrate and deliver signals 
between neuronal cells. The sites o f communication between two cells are termed 
synapses o f which two types exist: electrical and chemical. The majority of 
synaptic connections within the central nervous system use chemical transmission. 
Chemical synapses have a large (20-40nm) synaptic cleft into which a chemical 
neurotransmitter is released from the presynaptic terminal in response to an action 
potential (Fig. 1.1). Released neurotransmitter is able to diffuse across the synaptic 
cleft and bind specialized receptors on the postsynaptic membrane, which can 
respond to alter the probability o f action potential firing. The manner o f the 
response achieved by neurotransmitter binding to a post-synaptic receptor is 
determined by a number o f factors including the amount and identity of 
neurotransmitter as well as the type and number o f post-synaptic receptors. There 
are two major types o f chemical synapses in the central nervous system (CNS): at 
excitatory synapses release o f the neurotransmitter glutamate activates glutamate 
receptors resulting in a depolarization o f the cell, increasing its chances o f firing an 
action potential; whereas activation o f GABA receptors at inhibitory synapses 
causes hyperpolarization moving the membrane potential away from the spike 
threshold for action potentials (Fig. 1.1).
GABA is the major inhibitory neurotransmitter in the 
brain
The majority o f fast inhibitory neurotransmission in the adult central nervous 
system is mediated by the amino acid neurotransmitter y  amino butyric acid 
(GABA) acting on GABA type A (GABAa) receptors. GABA is synthesized from 
glutamate in a reaction catalysed by glutamic acid decarboxylase (GAD). GABA 
was identified in large quantities in mammalian brain in 1950 (Roberts and 
Frankel, 1950; Udenfriend, 1950). The inhibitory neurotransmitter properties of 
GABA were beginning to be characterised in crustaceans throughout the mid 50s 
(Bazemore et al., 1956; Boistel and Fatt, 1958), although it w asn’t until 1963 that
16
\
Excitatory synapse
Ca2+ Na+ 
Depolarisation
Inhibitory synapse # 
• • • • • •* • • _
C l C l  Cl-
Hyperpolarisation
Figure 1.1: Neurotransmitter release at chemical synapses. Propagation of the 
action potential along the axon activates voltage-gated calcium channels (VDCC) 
which allow influx of calcium ions into the presynaptic terminal. An increase in 
calcium stimulates vesicle fusion with the  plasma membrane allowing 
neurotransmitter release into the  synaptic cleft and subsequent binding to 
receptors on the  postsynaptic membrane. There are two main types of synapses: 
excitatory and inhibitory. Central excitatory synapses release the neurotransmitter 
glutamate, which binds to  glutamate receptors allowing the influx of cations 
resulting in membrane depolarisation. In contrast activation of GABAa receptors at 
central inhibitory synapses results in hyperpolarisation due to an influx of chloride
was established GABA as an inhibitory neurotransmitter. Kuffler and colleagues 
carried out a set o f experiments which demonstrated that GABA was found in 
peripheral inhibitory but not excitatory axons, was released from inhibitory motor 
axons and was the most active inhibitory substance in the central nervous system 
(Dudel et al., 1963; Kravitz et al., 1963a; Kravitz et al., 1963b). However, it wasn’t 
until the late 60s that GABA was shown to mimic the action o f an endogenous 
neurotransmitter in mammalian brain (Kmjevic and Schwartz, 1966; Kmjevic and 
Schwartz, 1967). Furthermore, using electron microscopic autoradiography and [3H1 
GABA, Bloom and Iversen were able to demonstrate that at least one third o f 
synapses in the mammalian brain are GABAergic (Bloom and Iversen, 1971).
The GABA receptor
Pharmacological characterization o f GABA action provided evidence for the 
existence o f a receptor. Three classes of GABA receptors have been identified 
based on their pharmacological and electrophysiological response to GABA. The 
first GABA receptor known, the G A B A a receptor, is activated by muscimol and 
inhibited by bicuculline and its activation leads to opening o f an integral chloride 
channel resulting in a rapid hyperpolarisation o f the membrane potential (Moss and 
Smart, 2001). In the early 80s, a second GABA receptor was discovered. The 
G A B A b receptor is insensitive to bicuculline and muscimol, but in turn is activated 
by baclofen, inhibited by 2-hydroxysaclofen and produces a slower inhibitory 
response (Bowery et al., 1981; Hill and Bowery, 1981). In addition to G A B A a and 
G A B A b receptors, a third receptor (GABAc), homologous in structure to the 
G A B A a receptor but insensitive to both bicuculline and baclofen and sensitive to 
the GABA analogue cis-4-aminocrotonic acid and picrotoxin has also been 
identified (Drew et al., 1984; Shimada et al., 1992; Quian and Dowling, 1993).
Pharmacology of the GABAa receptor
GABAa receptor function can be allosterically modulated by a range o f therapeutic 
agents including benzodiazepines, barbiturate, steroids and anaesthetics 
(Macdonald and Olsen, 1994; Rabow et al., 1995; Fig. 1.2). Benzodiazepines such
18
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Figure 1.2: Site of action of pharmacological agents on GABAa receptors. The
neurotransmitter GABA binds GABAa receptors on a site formed by the  N-terminus 
of a  and p subunits. GABAa receptors can be potentiated by binding of 
benzodiazepines to a site created at the interface of the  a  and ysubunit. In addition, 
GABAa receptors can also be modulated by barbiturates, ethanol and picrotoxin. 
The site of action for these drugs is believed to be inside the chloride permeable 
channel.
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as valium and diazepam potentiate GABA responses by increasing the frequency o f 
channel opening without altering channel open time or conductance (Study and 
Barker, 1981). In contrast, barbiturates enhance GABA responses by increasing 
average channel open time without affecting channel conductance or opening 
frequency as well as being able to directly activate GABAa receptors at high 
concentrations (Bormann, 1988). Steroids, including progesterone, corticosterone, 
testosterone and steroid anaesthetics are thought to potentiate GABA responses by 
increasing both the frequency and open time of channel opening (Twyman and 
Macdonald, 1992). General anaesthetics such as isoflurane and halothane increase 
GABA induced currents by potentiating the action o f GABA or by directly 
activating the channel. Ethanol has also been shown to have a potentiating effect on 
GABAa receptors (Dietrich et al., 1989) with sites on receptor transmembrane 
domains believed to be required for receptor modulation (Mihic et al., 1997).
GABAa receptors are also inhibited by a number o f other pharmacological agents. 
Picrotoxin, a plant convulsant, is a non competitive GABAa receptor inhibitor that 
is thought to act by binding to a site within the channel (Zhang et al., 1994) leading 
to stabilization o f receptors in an agonist bound desensitised state (Newland and 
Cull-Candy, 1992). In addition, GABAa receptors lacking the y subunit (and 
therefore extrasynaptic - see below) have been shown to be inhibited by zinc 
(Smart, 1992, Smart et al., 2004).
GABAa receptor structure
The GABAa receptor was initially purified using GABA/benzodiazepine affinity 
chromatography. SDS-PAGE analysis revealed two receptor subunits, a  and p, with 
molecular weights o f 53 kDa and 58 kDa respectively (Sigel, 1983; Sigel and 
Barnard, 1984). Oligonucleotides, designed based on peptide microsequencing 
results, were used for screening bovine cDNA libraries and allowed for the cloning 
o f both a  and p subunits. Analysis o f the amino acid sequences o f a  and p subunits 
revealed that these receptors showed significant homology with each other and 
with the nicotinic acetylcholine receptor (nAChR).
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GABAa receptors and nAChRs are members o f the ligand gated ion channel 
superfamily, which are homologous in structure and include glycine receptors and 
serotonin (5HT3) receptors (Schofield et al., 1987; Unwin, 1993). Members o f this 
family share a common subunit structure encompassing a large extracellular amino 
terminus, four transmembrane (TM) domains and a large intracellular loop between 
TM3 and TM4 (Fig. 1.3). In addition, based on biochemical and electron 
microscopy analysis members o f this family have been shown to be pentameric in 
structure where subunits are arranged around a central aqueous pore (Unwin, 
2003).
GABAa subunit diversity
Following the cloning o f the a l  and (31 GABAa receptor subunits, a total o f 16 
genes encoding GABAa receptor subunits have been identified in the mammalian 
nervous system. Based on amino acid sequence homology five additional a  
subunits were identified (Levitan et al., 1988, Ymer et al., 1989; Khrestchatisky et 
al., 1989; Malherbe et al., 1990; Kato, 1990; Luddens et al., 1990) as well as 
another two p subunits (Ymer et al., 1989). Co-expression o f a  and p subunits in 
heterologous systems, however, formed receptors that lacked benzodiazepine 
sensitivity, a pharmacological trait observed in neuronal GABAa receptors. A novel 
GABAa receptor subunit that when co-expressed with a  and p subunits inferred 
benzodiazepine sensitivity on the assembled receptors was then identified (Pritchett 
et al., 1989). This subunit, termed 72, shows 42% and 35% identity to the a l  and 
p l subunits respectively. Three y subunits have been identified in total (Pritchett et 
al., 1989; Ymer et al., 1990; Wilson-Shaw et al., 1991). In addition to a , P and y 
subunits other receptor subunits have been identified: 8 (Shivers et al., 1989), e 
(Davies et al., 1997; Whiting et al., 1997), n  (Hedblom and Kirkness, 1997) and 0 
(Bonnert et al., 1999). In addition many of these genes undergo alternative splicing 
the most predominant o f these being the y2 subunit, which exists in a short (y2S) 
and long (y2L) form (Whiting et al., 1990; Kofuji et al., 1991).
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Synaptic Extrasynaptic
Figure 1.3: GABAa receptor structure. A. Transmembrane topology of the  GABAa 
receptor. Receptor subunits consist of four hydrophobic transmembrane domains 
(TM 1-4) where TM2 is believed to line the  pore of the  channel. The large 
extracellular N-terminus is the  site for ligand binding as well as the  site of action of 
various drugs. Each receptor subunit also contains a large intracellular domain 
between TM3 and TM4, which is the  site for various protein interactions as well as 
the  site for post-translational modifications. B. Five subunits from seven subunit 
families assemble to form a heteropentameric channel. Despite the  extensive 
heterogeneity of GABAa receptors, most synaptic receptors are thought to consist 
of 2a, 2(3 and 1 y subunit. Extrasynaptic receptors mainly consist of 2a, 2(3 and 15 
subunit. C. GABAa receptor subunits assemble to line a central chloride selective 
pore.
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GABAa receptor subunit composition and assembly
The large diversity o f GABAa receptor subunits generates the potential for a 
bewildering heterogeneity o f receptor structure. However, a number o f functional, 
biochemical and immunocytochemical studies have revealed that only a limited 
number o f receptor subunit combinations are likely to exist on the neuronal cell 
surface (Sieghart et al., 1999).
Expression o f (31 and (33 subunits alone results in the formation of chloride 
permeable channels that are, like native GABA receptors, sensitive to picrotoxin 
and barbiturates. However these channels are insensitive to application o f GABA. 
Further studies have revealed that individual expression o f any GABAa receptor 
subunit does not result in the formation o f GABA gated channels. Co-expression of 
a  and (3 subunits does result in the production o f functional GABA gated chloride 
channels sensitive to picrotoxin, bicuculline, barbiturates and zinc (Schofield et a l, 
1987; Levitan et al., 1988, Draguuhn et al., 1990). Furthermore it has now been 
shown that the binding site o f GABA lies in the interface o f a  and (3 subunits 
(Boileau et al., 1999). Unlike most native receptors, the expression o f a  and (3 
subunits does not form channels that are sensitive to benzodiazepine modulation. 
Only when the a , (3 and y subunits are expressed GABA gated, benzodiazepine 
sensitive channels are formed (Pritchett et al., 1989; Ymer et al., 1990). 
Interestingly these channels are insensitive to zinc modulation (Smart et al., 2004).
The above results together with biochemical experiments suggest that the most 
prevalent GABAa receptor subunit composition in the brain consists o f a , (3 and y 
subunits. In addition the 5, 8 and 0 subunits can substitute for the y subunit to form 
benzodiazepine insensitive GABA gated channels (Quirk et al., 1994; Davies et al., 
1997; Neelands and Macdonald, 1999; Shivers et al., 1989; Bonnert et al., 1999). 
Immunoprecipitation studies show that more than one a  or p subunit isoform can 
coexist within the same receptor (McKeman et al., 1991; Mertens et al., 1993; 
Pollard et al., 1993; Khan et al., 1996) whereas most GABAa receptors are thought
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to contain a single y subunit (Mossier et al., 1994; Quirk et al., 1994). Furthermore, 
a number o f studies suggest that the stoichiometry o f these channels is of 2a , 2P 
and ly  subunit (Chang et al., 1996; Farrar et al., 1999; Knight et al., 2000; Tretter et 
al., 1997).
Immunocytochemical analysis has revealed that only certain subunit combinations 
can access the cell surface whereas other combinations result in the subunits being 
retained in the endoplasmic reticulum (ER; Moss and Smart, 2001). These result 
suggest that there are molecular mechanisms in place that govern receptor 
assembly. GABAa receptor assembly appears to be a complex process where 
several factor are involved. Although this process is not yet completely understood 
a number o f studies in the past decade have allowed us to further understand the 
rules that govern receptor assembly.
With exception o f the p i ,  P3 and y2S subunits, individual GABAa receptor 
subunits are retained in the ER. Moreover, pulse chase experiments demonstrated 
that a l  and P2 subunits are rapidly degraded when expressed alone (Gorrie et al., 
1997) suggesting that these proteins are targeted for degradation from the ER. 
Importantly, GABAa receptor subunits have been shown to associate with BiP and 
Calnexin (Connolly et al., 1996; Gorrie et al., 1997), two chaperone molecules 
which assist in protein quality control in the ER (Kleizen and Braakman, 2004).
Initial chimeric studies suggested that assembly was dependent on the N-terminus 
o f receptor subunits (Hackam et al., 1997). Using a chimeric approach, four amino 
acids in the N-terminal domain o f the p3 subunit have been identified to mediate 
functional cell surface expression o f this subunit compared to p2 (Taylor et al., 
1999). Introduction o f these four amino acids into the N-terminus o f the p2 subunit 
is sufficient to enable P2 homomerization and ER exit. These four amino acids are 
also important for the oligomerization o f p subunits with y subunits but not with a  
subunits. Interestingly, mutation o f these four amino acids within the P3 subunit 
abolished its ability to form homomers but not its ability to oligomerize with y2L
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suggesting that at least one alternative signal for the assembly o f p and y subunits 
must exist (Taylor et al., 1999). A conserved domain in the N-terminus o f a  
subunits has also been identified to play a role in the oligomerization o f a  with P 
but not y subunits (Taylor et al., 2000; Bollan et al., 2003). Furthermore, conserved 
glutamine and arginine residues have been shown to independently play a key role 
in determining the assembly o f a  with p subunits (Taylor et al., 2000; Bollan et al., 
2003), whereas a conserved arginine in a , p and y subunits has been shown to be 
essential for subunit oligomerisation (Hales et al., 2005). Finally, two regions 
within the N-terminus of the y2 subunit have been shown to mediate assembly of 
this subunit with a  and p subunits (Klausberger et al., 2000, 2001).
Together the results from the above studies suggest that a number o f combined 
factors play a role in restricting the subunit composition o f GABAa receptors 
expressed in the brain.
GABAa receptor localization within the brain
In addition to molecular determination o f GABAa receptor assembly, subunit 
composition is in part restricted to regional and temporal expression o f receptor 
subunits.
Regional distribution o f GABAa receptors
GABAa receptors are ubiquitously expressed throughout the brain forming one 
third o f synapses. In situ  hybridisation and immunohistochemical studies are all in 
agreement that a l ,  p2/3, and y2 are the most abundant GABAa receptor subunits in 
the brain (Laurie et al., 1992; Wisden et al., 1992; Pirker et al., 2000). The a l  
subunit is found to be present in most brain regions whereas the a4  subunit is 
restricted to the thalamus, the striatum and the molecular layer o f the dentate gyrus 
and is the least abundant a  subunit (Wisden et al., 1992; Pirker et al., 2000). In 
contrast, a5  is found enriched in the CA1 region of the hippocampus whereas a6  is 
found almost exclusively in the granular layer o f the cerebellum (Laurie et al.,
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1992a; Pirker et al., 2000). The a2  and a3  subunits, like a l ,  are found in most 
brain regions although at lower levels. Furthermore, an in depth study o f o f 
developmental expression revealed that these two subunits are highly expressed 
neonataly and this expression is reduced in adult brain (Laurie et al., 1992b).
Despite a wide distribution o f all three (3 subunits, pi is expressed at much lower 
levels compared to p2 and P3 subunits (Pirker et al., 2000). Interestingly, higher 
expression o f one p subunit in certain brain regions comes at the expense o f 
another. For example, p2 subunits are highly expressed in the thalamus in 
comparison to pi and p3 subunits (Wisden et al., 1992; Pirker et al., 2000) whereas 
the p3 subunit is found to be expressed at high levels in the striatum where very 
low levels o f the P2 subunit are found (Pirker et al., 2000). In addition, pi and P3 
subunits are found at higher concentrations than the P2 subunit in the hippocampus 
(Wisden et al., 1992) and, in this region, are mainly found in principal neurons 
whereas p2 subunits are expressed mainly in intemeurons (Pirker et al., 2000).
O f the y subunit isoforms, the y2 subunit is, by far, the most abundant. However, all 
three y subunits are found widely distributed with the yl subunit expressed at 
higher concentrations in the pallidum and substantia nigra whereas the y3 subunit is 
slightly more concentrated in the cerebral cortex (Laurie et al., 1992b; Wisden et 
al., 1992; Pirker et al., 2000). Despite being widely expressed yl and y3 are unable 
to fully substitute for the y2 subunit in y2 knockout mice, which show a lethal 
phenotype (Essrich et al., 1998).
In contrast to the y subunits, the 8 subunit o f GABAa receptors is specifically 
concentrated in the granular layer o f the cerebellum and in the thalamus where it is 
thought to be assembled only in receptors that contain a 6  and a4  subunits, 
respectively (Laurie et al., 1992a; Wisden et al., 1992; Pirker et al., 2000).
£, n  and 0 are the least abundant GABAa receptor subunits expressed in the CNS.
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The 8 subunit has been observed in the hypothalamus, amygdala and brainstem 
(Davies et al., 1997; W hiting et al., 1997; Moragues et al., 2002). Interestingly, the 
0 subunit has also been observed in all these regions as well as the substantia nigra 
and hippocampus (Bonnert et al., 1999, Moragues et al., 2002). The n  subunit 
appears to be expressed mainly in the uterus, although low expression levels have 
been observed in the hippocampus (Hedblom et al., 1997).
GABAa receptor subcellular localization
Immunocytochemical and immunogold electron microscopy studies have revealed 
that G A B A a receptor subunit combinations can be targeted to different subcellular 
domains. Although the a  1-3 and a5  subunits are all found to be expressed in 
hippocampal and cerebellar cells, studies showed that the a2  subunit is found 
concentrated in the axon initial segment (AIS) o f the majority o f cells where it 
colocalizes with the inhibitory synaptic marker gephyrin (Nusser et al., 1996; 
Brunig et al., 2002). In contrast, the a l  subunit is expressed throughout the cell and 
shows both diffuse and clustered staining suggesting both a synaptic and 
extrasynaptic localisation (Brunig et al., 2002). Interestingly, the a l  subunit cannot 
be found in the AIS on its own, but only colocalised with the a2  subunit indicating 
that subunit composition o f G A B A a receptors in the AIS consists o f one copy of 
a l  and one o f a 2  (Brunig et al., 2002).
a3  containing receptors appear to be differentially targeted depending on the cell 
type where they are expressed. In pyramidal cells, the a3  subunit is found in 
clusters at postsynaptic sites, whereas in a subset o f hippocampal cells, 
characterised by a round cell body and numerous short dendrites, a3  containing 
receptors show a diffuse expression pattern across the membrane and are not found 
at synaptic sites (Brunig et al., 2002). The a5  subunit, on the other hand, is found 
to be diffuse in all hippocampal cells and never colocalised with gephyrin clusters 
suggesting that a5  containing receptors are exclusively extrasynaptic (Brunig et al., 
2002).
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In addition to the a  subunit, subcellular localization has also been shown to be 
determined by the y and 5 subunits. In the cerebellum, immunocytochemical 
studies on electron microscopic sections demonstrated that synaptic and 
extrasynaptic GABAa receptors differed in their subunit composition. Synapses in 
cerebellar granule neurons were found to be positive for the GABAa receptor y2 
subunit, whereas the 5 subunit was found exclusively in extrasynaptic membranes 
(Nusser et al., 1998).
Experiments in polarized epithelial cells have suggested a role for the p subunit in 
subcellular targeting. Heterologous expression o f a l p l  complexes resulted in a 
non-polarized distribution, whereas a ip 2  and a ip 3  subunit combinations were 
targeted to the basolateral domain (Connolly et al., 1996). However, to date, there 
is no evidence for the role of the p subunits in subcellular targeting in vivo.
Functional relevance of heterogeneity
Pharmacological studies are beginning to provide us with a better understanding of 
the functional consequences o f GABAa receptor composition (reviewed in Farrant 
and Nusser, 2005). There is evidence to suggest that the sensitivity o f the receptor 
to GABA as well as its deactivation rate is defined by the type of a  subunit 
expressed (Lavoie et al., 1997; Bohme et al., 2004; Farrant and Nusser 2005). In 
addition, the y2 and 8 subunits are important in determining channel opening times 
as well as being involved in modulating receptor sensitivity to GABA and receptor 
deactivation (Fisher and Macdonald., 1997; Haas and Macdonald, 1999; Brown et 
al., 2002; Farrant and Nusser, 2005). Interestingly, in the cerebellum phasic and 
tonic GABAa receptor mediated inhibition has been observed and this has been 
attributed to synaptic and extrasynaptic GABAa receptors respectively (Brickley et 
al., 1996, Brickley et al., 1999). Furthermore, in addition to immunocytochemical 
studies that show y2 and 8 subunits being respectively targeted to synaptic and 
extrasynaptic sites, electrophysiological studies have confirmed that the y2 subunit 
mediates phasic inhibition whereas the 8 subunit plays a role in mediating tonic
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inhibition (Brickley et al., 1999; Brickley et al., 2001; Stell et al., 2003)
GABAa receptor associated proteins
Given the selective subcellular distribution o f GABAa receptors it is clear that the 
trafficking, targeting and clustering o f these receptors is a tightly controlled and 
regulated process. Although the exact molecular mechanisms that govern the 
subcellular targeting o f GABAa receptors are not yet fully understood, a number o f 
GABAa receptor associated proteins have been recently implicated in these 
processes (Table 1).
As outlined above, the GABAa receptor y2 subunit is not required for the 
formation o f GABA gated chloride channels. However, evidence from neuronal 
cultures from mice deficient in y2 subunit expression revealed that this subunit is 
essential for the synaptic localization, clustering and function o f GABAa receptors. 
A recent study using oc2/y2 chimeras has suggested a role for the TM4 o f the y2 
subunit to play an important role in the synaptic targeting and clustering o f GABAa 
receptors although the exact mechanisms on how this is achieved are not yet 
understood (Alldred et al., 2005). In addition, a yeast two hybrid screen using the 
y2 subunit as the bait, identified a 17 kDa GABAa receptor associated protein 
(GABARAP), which is thought to play a role in the trafficking of GABAa 
receptors (Wang et al., 1999). GABARAP binds y subunits both in vitro and in vivo 
and although it is not found at inhibitory synapses it appears to colocalize with 
GABAa receptors in intracellular compartments resembling the Golgi and sub- 
synaptic cistemae (Wang et al., 1999; Kittler et al., 2001). GABARAP shows 
amino acid sequence similarity to the small microtubule binding proteins GATE-16 
and the light chain-3 (LC3) subunit o f MAP-1A and IB and is able to bind 
micro tubules as well as N-ethylmaleimide sensitive factor (NSF) supporting a role 
for GABARAP in GABAa receptor intracellular transport (Wang and Olsen, 2000; 
Kittler et al., 2001). Recent immunochemical and electrophysiological studies have 
provided evidence to support a functional role for GABARAP in the trafficking o f 
GABAa receptors to the plasma membrane. Coexpression o f GABARAP and
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PROTEIN CELLULAR
LOCALISATION
INTERACTION
GABAAR
PUTATIVE
FUNCTION
REFERENCES
GEPHYRIN Synapses No C lustering/
Scaffold
Craig e t al., 1996; 
Essrich e t  al., 1998; 
Levi e ta l. ,2 0 0 4
DYSTROPHIN Syn apses No Stabilization K nuesel e ta l., 1999
GABARAP Golgi y2 subunit Trafficking W ang e t  al., 1999; 
Kittler e ta l., 2001; Leil 
e t  al., 2004; Chen et 
al.,2005
PRIP-1 Syn apses (33 subuit R egulation o f  
p h osp horylation  s ta te /  
trafficking
K anem atsu e t al 2002  
Terunum a e t al., 2004
PLIC-1 Intracellular
com p a rtm en ts
a  & |3 subunits Surface num ber  
regulation
Bedford e t a 1., 2001
AP2 Clathrin co a ted  pits P & y su b u n its E ndocytosis Kittler e ta l., 2000a
HAP1A E n d osom es P subunits Endocytic Sorting Kittler e t  al., 2004b
BIG-2 Intracellular
co m p a rtm en ts
P subunits Trafficking Charych e t a l.,2004
GODZ Golgi ysu b u n its Palm itoylation Keller e ta l., 2004
GRIF-1 Intracellular
co m p a rtm en ts
P2 subunit U nknow n B eck et a l.,2002
gC lqR Intracellular
co m p a rtm en ts
P subunits Unknow n Schaerer e ta l., 2001
T a b le  1: G A B A a r e c e p t o r  a s s o c ia t e d  p r o t e in s .  A n u m b e r  o f  p ro te in s  
a s so c ia te d  w ith  GABAa re c e p to r  func tion  is d e sc r ib e d  to g e th e r  w ith  the ir  
cellu lar localisation a n d  p u ta t iv e  role in th e  reg u la tio n  o f  GABAa re ce p to r  
fu n c tio n .  A d a p te d  from  A rancib ia-C arcam o a n d  Moss, 2006.
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GABAa receptors in COS-7 cells results in an increase in the levels o f GABAa 
receptors expressed at the cell surface (Leil et al., 2004) as well as an increase of 
GABA mediated currents in oocytes (Chen et al., 2005).
Although GABARAP is not found at synapses, a yeast two hybrid screen and in 
vitro binding studies have identified the synaptic protein GRIP-1 as a binding 
partner for GABARAP (Kittler et al., 2004a). GRIP-1 (Glutamate Receptor 
Interacting Protein 1), is a 7 PDZ domain protein that has been shown to play an 
essential role in AMPA receptor clustering (Dong et al., 1997). GRIP-1 and the 4- 
PDZ domain splice form GRIP-lc (PDZ 4-7) have also been observed at inhibitory 
synapses in cultured neurons and in brain slices where it colocalizes with the y2 
subunit o f GABAa receptors (Burette et al., 1999; Dong et al., 1999; Wyszynski et 
al., 1999; Charych et al., 2004a; Li et al., 2005). The role o f  GRIP-1 at inhibitory 
synapses remains unknown, although its ability to interact with GABARAP suggest 
that it may be involved in the synaptogenesis of inhibitory synapses or in the 
regulation o f GABAa receptor function (Kittler et al., 2004a).
GABARAP has also been shown to associate with the Phospholipase-C related 
inactive protein type 1 (PRIP-1) (Kanematsu et al., 2002). Although PRIP-1 does 
not associate with the y2 subunit o f GABAa receptors it appears to compete with 
this for GABARAP binding (Kanematsu et al., 2002). Interestingly PRIP-1 
knockout mice showed an impairment in GABAa receptor modulation by y2 
selective pharmacological agents suggesting that PRIP-1 might play a role in the 
regulation of GABAa receptor trafficking by GABARAP ensuring that only mature 
a p y  receptors are delivered to the plasma membrane (Kanematsu et al., 2002).
Another protein that has been shown to interact with GABAa receptors is the 
ubiquitin related protein Plic-1. Plic-1 is a 67 kDa protein with a ubiquitin like N- 
terminus and a carboxy-terminal ubiquitin associated domain (UBA) (Wu et al., 
1999; Kleijnen et al., 2000). Plic proteins are thought to regulate ubiquitin 
dependent protein degradation in the proteasome by their ability to bind the 
proteasome and ubiquitin ligases (Kleijnen et al., 2000). Yeast two hybrid screens
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and GST affinity purification assays have revealed an interaction between Plic-1 
and all a  (1-6) and p (1-3) subunits o f GABAa receptors indicating that Plic-1 
function may be relevant for the majority o f GABAa receptor subtypes expressed 
in the brain (Bedford et al., 2001). Immunocytochemical studies found Plic-1 to be 
mainly expressed intracellularly in the cell body and dendritic axonal processes 
(Kleijnen et al., 2000; Bedford et al., 2001) although a significant number of 
GABAa receptors were found to colocalize with Plic-1 immunostaining beneath 
the plasma membrane and synaptic sites (Bedford et al., 2001). Interestingly 
binding to the intracellular loops o f a  and p subunits is mediated by the UBA 
domain o f Plic-1 and functional studies in HEK293 cells and hippocampal slices 
revealed that blockade o f this interaction results in reduced cell surface expression 
o f GABAa receptors (Bedford et al., 2001). Consistent with these results, 
overexpression o f P lic-1 in recombinant systems results in an increase in GABAa 
receptors expressed at the cell surface without affecting internalization rates 
(Bedford et al., 2001). The above results suggest that Plic-1 modulates GABAa 
receptor cell surface numbers by inhibiting their degradation by the proteasome.
The brefeldin A-inhibited GDP/GTP exchange factor 2 (BIG2) has also been 
identified in a yeast two-hybrid screen as a GABAa receptor p subunit interacting 
protein (Charych et al., 2004b). BIG2 is mainly found concentrated in the trans 
Golgi network although a small proportion is found in vesicle-like structures along 
dendrites and near post-synaptic sites (Charych et al., 2004b). BIG2 has previously 
been implicated in vesicular transport by its ability to catalyse the GDP-GTP 
exchange on ARF GTPases. Interestingly, coexpression o f BIG2 with the GABAa 
receptor p3 subunit results in an increase in p3 exit from the ER (Charych et al., 
2004b) suggesting that BIG2 is involved in the post-Golgi vesicular trafficking of 
GABAa receptors.
Other GABAa receptor interacting proteins have been identified including GRIF-1 
(Beck et al., 2002) and gC lqR  (Schaerer et al., 2001). These proteins however are 
not enriched at synapses and their functional significance remains to be established.
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GABAa receptor clustering
The clustering o f GABAa receptors at postsynaptic sites is thought to be dependent 
on the presence o f the y2 subunit and the 93 kDa protein gephyrin. Gephyrin has 
been previously shown to be involved in mediating glycine receptor clustering via 
a direct interaction with the intracellular domain o f the (3 subunit o f these receptors 
(Pfeiffer et al., 1982; Meyer et al., 1995; Kneussel et al., 1999a). 
Immunocytochemistry experiments show gephyrin specifically localised at 
glycinergic synapses in spinal cord, retina and hippocampal neurons. Depletion of 
gephyrin expression using antisense oligonucleotides inhibits the clustering o f 
glycine receptors (Kirsch et al., 1993) and neuronal cultures from gephyrin 
knockout mice show diffuse staining o f glycine receptors confirming the 
importance o f gephyrin in glycine receptor clustering (Feng et al., 1998).
Interestingly, gephyrin is found clustered at postsynaptic sites in both hippocampal 
and cortical neurons where glycine receptor expression is relatively low (Craig et 
al., 1996; Essrich et al., 1998). In these cells, gephyrin colocalises with GABAa 
receptors suggesting that gephyrin is a universal inhibitory synaptic marker (Craig 
et al., 1996; Essrich et al., 1998). Furthermore in cultures from y2 knockout mice 
there are no GABAa receptors accumulated at postsynaptic sites and this loss is 
parallel to a loss in gephyrin clusters (Essrich et al., 1998). In addition hippocampal 
neurons treated with gephyrin antisense oligonucleotides, and hippocampal cultures 
and spinal cord sections from gephyrin knockout mice show a loss o f GABAa 
receptor a2  and y2 subunit clusters (Essrich et al., 1998; Kneussel et al., 1999). 
However, despite these observations it has not so far been possible to show a direct 
interaction between gephyrin and GABAa receptors.
Recent observations suggest that the role o f gephyrin at gabaergic synapses is to act 
as a scaffold rather than as a protein required for GABAa receptor clusterting. The 
structure o f gephyrin together with its ability to bind tubulin suggest that gephyrin 
can assemble as a lattice and act as a scaffold (Ramming et al., 2000; Schwartz et 
al., 2001). Gephryin clusters colocalize with all GABAa receptors independent of
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subunit composition however, in hippocampal cultures from gephyrin knockout 
mice the levels o f a2  containing receptors at the cell surface were reduced by 65%, 
cell surface y2 containing receptors were reduced by 43% and a l  subunit 
containing synaptic aggregates were unaffected (Levi et al., 2004). Furthermore, 
these cultures only showed a 23% reduction in the amplitude o f GABA currents 
compared to wild type neurons (Levi et al., 2004). These results were consistent 
with previous observations in immature neurons where GABAa receptor clusters 
form before gephyrin can be detected at postsynaptic sites (Dumoulin et al., 2000; 
Danglot et al., 2003). Together these results implicate a role for gephyrin in the 
clustering o f only a subset o f GABAa receptors and suggest a different function at 
GABAergic synapses. A recent study looked at the role o f gephyrin in modulating 
the cell surface dynamics o f GABAa receptors (Jacob et al., 2005). Using FRAP 
(Fluorescence Recovery After Photobleaching) and RNAi, they observed that 
clustered GABAa receptors were 3 times more motile in cells where gephyrin 
expression had been impaired compared to control neurons. These results inplicate 
gephyrin in enhancing the confinement o f GABAa receptors at synaptic sites 
suggesting that gephyrin, much like PSD-95 at excitatory synapses, acts as a 
scaffold and aids in the stabilization of previously clustered GABAa receptors 
(Jacob et al., 2005).
Another protein found highly concentrated at inhibitory synapses is dystrophin 
(Knuesel et al., 1999). In brain slices of 2-3 month old rats, dystrophin colocalizes 
with a 2  and y2 GABAa receptor subunit clusters found in the soma and dendrites 
o f pyramidal cells as well as a l  and y2 clusters in the soma and proximal dendrites 
o f Purkinje cells (Knuesel et al., 1999). Interestingly, not all GABAa receptor 
clusters are found colocalized with dystrophin indicating that dystrophin is found at 
a subset o f inhibitory synapses (Knuesel et al., 1999). In brain sections from mdx 
mutant mice, which lack dystrophin, GABAa receptor clusters in pyramidal and 
Purkinje cells are reduced in size and number whereas gephyrin clusters appear 
unaltered (Knuesel et al., 1999). Dystrophin is found associated with a -  
dystroglycan and (3-dystroglycan to form the dystrophin associated glycoprotein
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complex (DGC). Analysis o f both a -  and (3-dystroglycan localization in cultured 
hippocampal neurons revealed that, like dystrophin, dystroglycan is found at a 
subset o f GABAergic terminals, although this colocalization was only evident in 
late stages o f development (Levi et al., 2002). In cultured hippocampal neurons 
from dystroglycan conditional knockout mice, there was no evidence o f dystophin 
accumulation yet GABAa receptor and gephyrin synaptic accumulation was 
unaltered (Levi et al., 2002). Together these results indicate that the DGC is not 
required for GABAa receptor clustering, but might play a stabilizing role for the 
receptor at inhibitory synapses.
Modulation of GABAa receptor function by post- 
translational modifications
Phosphorylation
Modulation o f GABAa receptor function is thought to be, in part, achieved by the 
phosphorylation o f GABAa receptor subunits (reviewed in Brandon et al., 2002; 
Kittler et al., 2003; Song and Messing 2005). Diverse studies on GABAa receptor 
phosphorylation have implicated this process in altering channel kinetics, channel 
open time, rate o f desensitization, sensitivity to pharmacological agents as well as 
channel receptor stability (see below). It has proven difficult to study 
phosphorylation o f GABAa receptors in their native state which is why the most 
compelling evidence o f direct phosphorylation on GABAa receptor function comes 
from the study on recombinant receptors. However, the effects o f phosphorylation 
on GABAa receptor function are complex and contradictory.
The large intracellular domains of GABAa receptor (3 subunits contain a conserved 
serine residue (S409 in (31, S410 in (32, S408/409 in (33) that can be phosphorylated 
by a number o f kinases in vitro including PKA, PKC, PKG and Ca2+/calmodulin 
dependent protein kinase II (CamKII). The functional effects o f GABAa receptor 
phosphorylation have been mainly addressed in heterologous expression systems 
and results appear to be varied and complex. The modulation of channel function
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by phosphorylation is dependent on the identity o f the p subunit. For example 
phosphorylation o f the p i subunit by PKA results in a time dependent decrease of 
GABAergic currents (Moss et al., 1992). In contrast phosphorylation of Ser408 and 
409 in the p3 subunit by the same kinase results in an enhanced GABA response 
whereas the p2 subunit is not a substrate for PKA phosphorylation in expression 
systems (McDonald et al., 1998).
The effects o f PKC phosphorylation on GABAa receptor function have also been 
examined in heterologous expression systems. Activation o f PKC activity using 
phorbol esters results in a downregulation o f GABAa receptor function in a manner 
that is dependent on the phosphorylation o f S409 in the p i subunit, S410 in the p2 
subunit. However, the use o f PKM, a constitutively active catalytic domain of 
PKC, produced contradicting results to those obtained with phorbol esters. PKM 
enhances the the response to GABA in transfected mouse fibroblasts in a manner 
that is dependent on S409 in the p i subunit (Lin et al., 1996). The reason for this 
discrepancy remains unsolved although it has been speculated that different PKC 
isoforms may produce different responses (Song and Messing, 2005).
In addition, BDNF induced PKC mediated phosphorylation o f the P3 subunit 
results in a transient enhancement o f GABAa receptor function followed by a 
lasting depression o f miniature inhibitory post-synaptic currents (mIPSCs) in both 
cultured hippocampal and cortical neurons (Jovanovic et al., 2004). This 
modulation was concurrent with with PKC mediated phosphorylation followed by 
phosphatase 2A mediated dephosphorylation suggesting that in vivo 
phosphorylation o f GABAa receptor (33 subunits can enhance GABAa receptor 
function (Jovanovic et al., 2004).
The y2 subunit is also a substrate for PKC phosphorylation. In vitro studies using 
GST fusion proteins have shown the y2 subunit to be phosphorylated by multiple 
kinases at S327 as well as S343 in y2L. Interestingly, the results observed above 
with PKM or PKC activation by phorbol esters have also been shown to be
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dependent on the phosphorylation o f S327 and S343 in the y2L subunit. In addition 
to the enhancement (using PKM) and downregulation (using phorbol esters) of 
GABAergic function by phosphorylation o f the y2 subunit, the dephosphorylation 
o f the y2 subunit at S327 in hippocampal neurons by calcineurin has been shown to 
result in a downregulation o f GABAa receptor function (Wang et al., 2003).
In addition, the y2 subunit can be phosphorylated by Src kinase on tyrosine 
residues Y365 and Y367 (Moss et al., 1995). Coexpression o f Src kinase with 
GABAa receptors in mammalian cells results in increased GABAa receptor 
function, an effect that is dependent on tyrosine residues 365/367 in the y2 subunit 
(Moss et al., 1995). This effect was also observed in cultured cortical neurons, 
although only in the presence o f tyrosine phosphatase inhbitors suggesting that the 
y2 subunit is found basally phosphorylated at these residues (Moss et al., 1995).
Interestingly phosphorylation o f GABAa receptors has also been shown to play a 
key role in determining the modulation o f receptor function by pharmacological 
agents such as ethanol, barbiturates and benzodiazepines. In oocytes expressing 
a l|3 ly 2 L  subunits activation o f PKC by PMA (a potent phorbol ester) inhibited 
GABA gated chloride currents (Leidenheimer et al., 1993). However, PMA 
treatment o f  xenopous oocytes expressing a l |3l 72L GABA receptors showed a 
two-fold increase on diazepam potentiation o f GABAergic function (Leidenheimer 
et al., 1993). Similarly, PMA treatment also resulted in an enhancement o f 
pentobarbital modulation o f GABA response (Leidenheimer et al., 1993). Studies 
on specific PKC isoenzyme knockout mice have provided further evidence for the 
role o f PKC in the allosteric modulation of GABAa receptor function. In constrast 
to the effects o f PMA activation of PKC in oocytes expressing GABAa receptors, 
PKCe knockout mice have increased sensitivity to both pentobarbital and diazepam 
(Hodge et al., 1999). However, PKCy knockout mice show no changes in the 
sensitivity to pentobarbital or diazepam (Harris et al., 1995). The effects on the 
modulation o f GABAa receptors by ethanol has also been studied in these mice. 
Ethanol has been shown to enhance GABAa receptor function in a number of
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neuronal preparations including hippocampal, cortical and spinal cord neurons 
(Mehta and Ticku, 1988; Soldo et al., 1994; Weiner et al., 1994). Interestingly, this 
effect is abolished in the presence o f PKC inhibitors suggesting that 
phosphorylation by PKC may play a role in the ethanol modulation o f GABAa 
receptors. Supporting this evidence, PKCy knockout mice show reduced sensitivity 
to ethanol modulation o f GABAa receptors (Bowers et al., 1999). However, PKCe 
knockout mice show increased sensitivity to ethanol (Olive et al., 2000).
The above data highlights the complexity of GABAa receptor modulation by 
phosphorylation. However, studies in knockout mice demonstrate how specific 
kinase isoforms may play an important role in determining the effects of 
phosphorylation on GABAa receptor function.
Palmitoylation
Palmitoylation is a post-translational modification that involves the attachment of 
the fatty acid palmitate to cysteine residues and has been shown to be involved in 
the membrane targeting and subcellular trafficking o f various proteins including 
AMPA receptors (Hayashi et al., 2005) and the neuronal scaffold proteins PSD-95 
and GRIP (DeSouza et al., 2002; El-Husseini Ael and Bredt, 2002; El-Husseini Ael 
et al., 2002; Smotrys and Linder, 2004). The intracellular loop o f the GABAa 
receptor y2 subunit has been recently identified as a substrate for palmitoylation 
(Keller et al., 2004; Rathenberg et al., 2004). Using a SOS-recruitment yeast two- 
hybrid assay, a 14-amino acid cysteine rich domain conserved in the intracellular 
loops o f all three GABAa receptor y subunits was found to interact with the 
palmitoyl transferase GODZ (Golgi-specific DHHC zinc finger domain protein). 
However, this interaction was not observed in pull down assays, suggesting that 
any interaction between GODZ and the y2 subunit is transient (Keller et al., 2004). 
Similarly GODZ was found to be localized in the Golgi where there was partial 
overlap with the y2 subunit in HEK293 cells but not in neurons (Keller et al.,
2004). Interestingly, mutating the cysteine residues within the intracellular loop of 
the y2 subunit resulted in a loss of GABAa receptor clusters at the cell surface as
38
did treatment with the palmitoylation inhibitor 2-BrP (Rathenberg et al., 2004). 
From these studies it is evident that GABAa receptor palmitoylation plays a critical 
role in the trafficking and clustering o f GABAa receptors, although the exact 
mechanisms by which this is achieved remain unknown.
Ubiquitination
The regulation o f GABAa receptor trafficking by the ubiquitin like protein Plic 
suggests that GABAa receptors may also be a direct target for modification by the 
polypeptide ubiquitin. A recent abstract presented at the Society for Neuroscience 
annual meeting provided evidence to show that the intracellular loop of the 
GABAa receptor [33 subunit contains a number o f lysine residues that are 
substrates for ubiquitination. Mutation o f all 12 lysines within the intracellular loop 
o f the (33 subunit resulted in decreased levels o f (33 subunit ubiquitination without 
compromising its ability to form benzodiazepine sensitive heteromeric receptors. 
Expression o f this mutant ((33K12R) in cultured cortical neurons showed increased 
cell surface expression o f GABAa receptors than those containing wild type (33 
subunits, although the cell surface half life or endocytosis rates o f the receptors 
were not affected. In addition, the rate of insertion at the cell surface o f the (33K12R 
subunit was greater than that o f the wild type subunit. This study, is the first to 
show ubiquitination o f GABAa receptors and suggests that ubiquitination o f the [33 
subunit acts specifically within the secretory pathway to regulate GABAa receptor 
insertion at the cell surface (Saliba et al., 2005).
Receptor stability
Altering the number o f GABAa receptors found at synaptic sites is an important 
mechanism for regulating the strength o f synaptic inhibition (Kittler et al., 2000a; 
Kittler and Moss, 2003; Nusser et al., 1997; Nusser et al., 1998). Therefore a 
significant amount o f research has focused on detailing the mechanisms that 
control the stability o f cell surface receptor populations and their accumulation at 
inhibitory synapses.
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Studies on the lateral mobility of both glycine and AMPA receptors using single 
particle tracking have revealed that there are significant rates o f exchange between 
synaptic and extrasynaptic pools o f these ion channels. Interestingly, synaptic 
receptors exhibit reduced rates o f lateral mobility compared to their extrasynaptic 
counterparts (Choquet and Triller, 2003; Dahan et al., 2003; Tardin et al., 2003). 
More recently the lateral movement of GABAa receptors has been studied in 
cultured hippocampal neurons. Thomas and colleagues used a novel 
electrophysiological tagging method to demonstrate that in common with glycine 
and AMPA receptors, GABAa receptors are dynamic along the plasma membrane 
and can readily diffuse in and out o f synaptic sites providing a molecular 
mechanism to regulate the efficacy o f synaptic inhibition (Thomas et al., 2005). 
The ability o f GABAa receptors to diffuse along the plasma membrane was also 
observed in a different study using FRAP (fluorescence recovery after 
photobleaching) and pHluorin labeled GABAa receptors (Jacob et al., 2005). 
Furthermore, this study showed that extrasynaptic receptors are more mobile than 
their synaptic counterparts and that this difference in motility is dependent on the 
postsynaptic protein gephyrin (Jacob et al., 2005). Importantly GABAa receptors 
have been recently reported to be inserted and removed from the plasma membrane 
exclusively at extrasynaptic sites highlighting the importance of lateral diffusion 
(Bogdanov et al., 2006).
In addition to the ability to undergo lateral diffusion along the plasma membrane, 
GABAa receptors have been shown to undergo extensive constitutive endocytosis 
in both heterologous and neuronal systems. Furthermore, a number o f associated 
proteins have been identified to play a key role in regulating GABAa receptor 
internalization and endocytic sorting.
GABAa receptors can be found localized in clathrin coated pits suggesting that 
these receptors undergo classical clathrin mediated endocytosis (Connolly et al., 
1999a). In addition, GABAa receptor endocytosis is impaired by conditions that 
block clathrin mediated endocytosis. In both heterologous recombinant systems 
and in cultured hippocampal neurons, GABAa receptor endocytosis is blocked by
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hypertonic sucrose (Kittler et al., 2000a), conditions which have been shown to 
impair clathrin function (Heuser and Anderson, 1989). In addition, blocking 
dynamin function by overexpression of the catalytically inactive dynamin K44A 
mutant also results in a reduction o f GABAa receptor internalization (Herring et 
al., 2003; Kittler et al., 2000a; van Rijnsoever et al., 2005). Interestingly, the 
infusion o f neurons with a peptide that disrupts the association between dynamin 
and amphiphysin (p4 peptide), and therefore dynamin function, results in an 
increase in amplitude o f inhibitory postsynaptic currents (IPSCs) highlighting the 
physiological significance o f receptor internalization (Kittler et al., 2000). 
Moreover both (3 and y subunits have been shown to bind the clathrin adaptor 
protein complex AP2, an integral member o f the clathrin endocytosis machinery 
(Kittler et al., 2000a). In addition, GABAa receptor endocytosis has also been 
reported to undergo a form of clathrin independent internalization in HEK293 cells 
although there is not yet any evidence that this mechanism also occurs in neurons 
(Cinar and Barnes, 2001).
The molecular determinants o f GABAa receptor endocytosis are beginning to be 
understood. A study using recombinant receptors in HEK293 cells revealed the 
importance o f a dileucine m otif present in the (32 subunit, and conserved in the (31 
and (33 subunits, o f GABAa receptors for efficient internalization (Herring et al., 
2003). In addition, a novel AP2 binding motif, which includes the major sites o f 
serine phosphorylation, has recently been identified in all p subunits o f the GABAa 
receptor (Kittler et al., 2005). In vitro binding studies, revealed that AP2 was able 
to bind the p3 subunit in its dephosphorylated state but not when phosphorylated 
by PKC or PKA. Interestingly, activation o f dopamine D3 receptors in the nucleus 
accumbens has been reported to cause a downmodulation o f GABAergic currents 
(Chen et al., 2006). This downregulation of GABAergic currents is inhibited by the 
p4 peptide or a peptide o f the AP2 binding site o f the p3 subunit. Furthermore, 
PKA activation also blocked the dopamine dependent downregulation of 
GABAergic IPSCs (Chen et al., 2006). Together these results provide direct 
evidence for the importance of phosphorylation in regulating receptor stability at
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th e  c e l l  s u r fa c e .
Quantitative measurements of GABAa receptor endocytosis have revealed that 
approximately 25% of the total cell surface population o f (33 subunit containing 
receptors are internalized within 30min (Kittler et al., 2004b). Given this high rate 
o f internalization the endocytic fate of internalized receptors is likely to play a 
critical role in regulating receptor cell surface expression levels. It is emerging that 
internalized GABAa receptors can be sorted for two endocytic fates. The majority 
o f internalized receptors constitutively recycle back to the plasma membrane over 
short time frames (tens o f minutes) but over longer time periods (6h) 25% of 
surface receptors are degraded upon internalization (Kittler et al., 2004b). 
Furthermore internalized receptors have been shown to localize to a subsynaptic 
pool associated with postsynaptic proteins such as gephyrin (van Rijnsoever et al., 
2005), suggesting high levels o f receptor recycling in neurons. Recently huntingtin 
associated protein-1 (HAP1) has been identified as a GABAa receptor associated 
protein (Kittler et al., 2004b). HAP1 binds the intracellular loop of (3 subunits in 
vitro and in vivo. Overexpression of HAP 1 in cortical neurons results in a decrease 
o f GABAa receptor degradation and consequently an increase in GABAa receptor 
recycling (Kittler et al., 2004b). Interestingly, HAP1 knockout mice have reduced 
GABAa receptor (3 subunit expression in the hypothalamus (Sheng et al., 2006). 
Furthermore, insulin has been shown to downregulate HAP1 expression resulting 
in a reduction o f mIPSCs and muscimol binding sites (Sheng et al., 2006). 
Together, these results identify HAP1 as a regulator o f GABAa receptor endocytic 
sorting although the exact molecular mechanisms by which this is achieved remain 
unknown.
Alterations in GABAa receptor trafficking in 
neurological disorders
It is evident that there are a number o f mechanisms in place to dynamically regulate 
the cell surface expression of GABAa receptors and hence synaptic inhibition. 
Changes in the functional properties of GABAa receptors are relevant in a number
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o f neurological disease, however recent evidence has implicated receptor 
trafficking to play a major role in certain pathologies associated with GABAa 
receptors.
Alterations in the GABAergic system have been reported in schizophrenic patients 
(Blum and Mann, 2002; Benes and Berretta, 2001; Fritschy and Brunig, 2003). A 
number o f studies have reported an increase in muscimol binding sites in the 
anterior cingulate cortex (Benes et al., 1992), hippocampus (Benes et al., 1996) and 
prefrontal cortex (Hanada et al., 1997; Benes et al., 1996; Dean et al., 1999). A 
recent study demonstrated an upregulation o f a2  subunit containing GABAa 
receptors in the AIS o f pyramidal cells (Volk et al., 2002). Interestingly this 
upregulation o f GABAa receptor expression occurred in parallel to a 
downregulation o f the GABA transporter GAT-1 in the axon terminals o f chandelier 
cells in the prefrontal cortex (Woo et al., 1998).
GABAa receptor dysfunction has long been implicated in the development of 
epilepsy and status epilepticus (Jones-Davis and Macdonald, 2003). Genetic studies 
have provided evidence for mutations in GABAa receptor subunits in a number of 
idiopathic epilepsies (reviewed in Macdonald et al., 2003, 2004). However other 
forms o f epilepsy are characterised by profound changes in the subunit composition 
and expression o f GABAa receptors. Studies in models o f temporal lobe epilepsy 
(induced by the administration o f pilocarpine or kainic acid) reported decreased 
expression o f most subunit subtypes (a2, a3 , a5 , p i, p3, y2 and 6) in the molecular 
layer o f the dentate gyrus and the pyramidal cell layer o f CA1 and CA3 during 
acute seizures. However, chronically there appears to be an upregulation of most 
GABAa receptor subunit subtypes ( a l ,  a2 , a4 , p i, p3 and y2) in the molecular 
layer o f the dentate gyrus whereas the pyramidal cell layer of CA1 and CA3 
remains with decreased subunit expression (Sperk et al., 1997; Schwarzer et al., 
1997; Tsunashima et al., 1997, Bouilleret et al., 2000). Interestingly, the dentate 
granule cell layer shows a decrease in a l  subunit expression that is accompanied 
by an increase in a4 , p3 and 8 subunit expression (Brooks-Kayal et al., 1998;
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Schwarzer et al., 1997; Fritschy et a l ,  1999). Similarly, analysis of GABAa 
receptor subunit expression in human hippocampal tissue from patients with 
temporal lope epilepsy also revealed increased subunit expression and changes in 
the subcellular distribution o f some subunit subtypes (Loup et al., 2000).
Status epilepticus is characterised by acute loss o f responsiveness to 
benzodiazepines suggesting rapid changes in GABAa receptor function. A recent 
study by Wasterlain and colleagues has provided evidence to a possible mechanism 
for the inhibitory loss and pharmacoresistance to benzodiazepines in status 
epilepticus (Naylor et al., 2005). Following status epilepticus Wasterlain and 
colleagues observed a decrease in mIPSCs and a relocation o f both (3 and y2 
subunits from synapses to the cell interior suggesting that GABAa receptor 
endocytosis is upregulated, or there is a reduction in GABAa receptor recylcing, 
during status epilepticus (Naylor et al., 2005). In contrast, extrasynaptic GABAa 
receptor tonic currents were enhanced following status epilepticus, however 
changes in the expression o f the GABAa receptor 5 subunit have not yet been 
identified.
Altered GABAa receptor subunit expression has also been reported in different 
brain regions in models o f Huntington’s disease (HD). Following quinolinic acid 
induced lesions o f the striatum there is a fast (within 2hr) and long lasting (>15 
months) upregulation o f GABAa receptors in the substantia nigra (Brickell et al., 
1999). This upregulation also observed in the globus pallidus o f HD patients and is 
accompanied by a profound reduction in GABAa receptor expression in the 
caudate nucleus and putamen (Faull et al., 1993; Kunig et al., 2000). The recently 
identified role o f HAP 1 in regulating GABAa receptor endocytic trafficking may 
provide new insights to the molecular mechanisms o f altered receptor trafficking in 
HD (Kittler et al., 2004).
Lack o f blood flow to the brain (cerebral ischemia) results in neuronal cell death 
(Lipton, 1999). Recently, ischemia induced neuronal death has been linked to 
changes in GABAergic transmission (Schwartz-Bloom and Sah, 2001). Following
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ischemia, a rapid (within 30min) and long-lasting (several months) reduction in 
GABA neurotransmission has been observed in in vivo and in vitro models. In 
addition, these changes have been associated with a significant loss o f GABAa 
receptor surface expression within 30min o f oxygen deprivation (Alicke and 
Schwartz-Bloom, 1995). Furthermore, this downregulation o f GABAa receptor 
expression is coupled with long term changes in the mRNA expression o f a  and 
subunits in hippocampal areas (Li et al., 1993). Interestingly, modulators of 
GABAa receptor function (eg. benzodiazepines) and trafficking (eg. insulin) have 
been shown to exert neuroprotection following ischemia, highlighting the 
important role played by GABAa receptors in ischemia induced neuronal death 
(Schwartz et al., 1995; Schwartz-Bloom and Sah, 2001; Mielke and Wang, 2005).
There is a growing list o f CNS pathologies that display altered GABAa receptor 
expression, highlighting the significance o f further understanding GABAa receptor 
trafficking.
The endocytic pathway
Cells have the ability to internalise membrane proteins, lipids, extracellular ligands 
and soluble molecules by a process known as endocytosis. Although a variety of 
endocytic pathw ays have been identified, including phagocytosis, 
macropinocytosis and caveolae/raft mediated uptake, the most well characterised 
method o f internalisation is clathrin mediated endocytosis (reviewed in (Le Roy 
and Wrana, 2005; Nichols and Lippincott-Schwartz, 2001)).
Clathrin Mediated Endocytosis
Clathrin mediated endocytosis allows for surface proteins to be transported to 
specific organelles in coated vesicles (Fig. 1.4). Soluble clathrin consists of both a 
heavy (190 kDa) and a light (25 kDa) chain (for reviews on clathrin structure and 
clathrin mediated endocytosis see (Le Roy and Wrana, 2005; Marsh, 2000; Marsh 
and McMahon, 1999; Takei and Haucke, 2001)). The heavy and light chain 
complex can form a clathrin triskelion that can in turn assemble into a polygonal 
lattice, which aids to deform the plasma membrane into a bud or clathrin-coated pit
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and subsequently a clathrin coated vesicle (CCV). Recruitment o f clathrin to the 
plasma membrane is achieved by the interaction o f clathrin with the adaptor protein 
(AP) complex AP2. There are four distinct adaptor protein complexes (A PI-4), all 
o f which have been involved in protein trafficking. However, AP2 is the only one 
that has been shown to play a key role in the formation o f CCVs at the plasma 
membrane (Owen et al., 2004; Robinson, 1987). In contrast, API is associated with 
golgi-derived CCVs whereas AP3 and AP4 have not yet been fully characterized. 
AP2 is hetero-tetrameric complex consisting o f two large subunits ( a  and (32) of 
approximately 100-130 kDa, a medium subunit termed \\2 (50 kDa) and a small 20 
kDa subunit termed <32. The (3 subunit o f AP2 has been shown to directly interact 
with clathrin heavy chains whereas the p2 subunit (and potentially the p2 subunit) 
is able to interact with specific amino acid sequences within the cytoplasmic 
domains o f membrane protein cargo (Collins et al., 2002). In addition to 
recognition o f the signal sequence in protein cargo, AP2 is recruited to the plasma 
membrane in a manner that is dependent on the binding o f the a  and p2 subunit to 
plasma membrane phosphatidylinositol 4,5 bisphosphate (PIP2) (Jost et al., 1998; 
Honing et al., 2005).
The a  subunit o f AP2 has also been shown to interact with a number o f accessory 
proteins which form essential components o f the clathrin mediated endocytic 
machinery. These include API 80/CALM, epsin/epsl5, amphiphysin and auxilin 
(Wakenham et al., 2000). Interestingly all o f these proteins have been shown to 
bind AP2 at the same site as well as clathrin suggesting that these proteins may act 
at different steps during the life cycle of CCVs (Jarousse and Kelly, 2000).
The conversion o f the invaginated clathrin coated pit into a fully formed and 
detached CCV is achieved by action o f the large GTPase dynamin (Jarousse and 
Kelly, 2000; Praefcke and McMahon, 2004; Sweitzer and Hinshaw, 1998; Takei et 
al., 1998). Dynamin is recruited to the nascent clathrin coated pit by an interaction 
between its poly-proline rich domain and SH3 domain in amphiphysin. Upon 
formation o f the CCV hsc70 and auxilin participate in the removal o f the clathrin
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Figure 1.4: The clathrin mediated endocytic pathway. Recruitment of AP-2 and 
clathrin to the  cell membrane, via specific amino acid signals in the  intracellular 
domains of cargo, results in a deformation and invagination of the  membrane. 
Action of the  large GTPase dynamin causes the clathrin coated pit to "pinch off" 
releasing a clathrin coated vesicle (CCV). Upon shedding the  clathrin coat,the cargo 
containing vesicle fuses with the sorting endosom e by action of Rab5 and other 
endosomal proteins such as EEA1. Cargo can then be recycled back to the  plasma 
membrane via the  recycling endosome (R.E.) in a manner dependent of Rab4 or 
Rab11, or can be transported to late endosomes with the aid of Hrs and the ESCRT 
complexes. From late endosomes most cargo are targeted for degradtion in the 
lysosome. Adapted from Arancibia-Carcamo et al.,2006.
coat. A number o f proteins on the membrane o f the early endosome, including rab 
5, rabenosyn 5 and early endosomal antigen 1 (EEA1) control vesicle docking and 
fusion to allow entry of protein cargo into the endosomal system.
The Endosomal System
Endosomes comprise a system of heterogeneous compartements characterised as 
early or late endosomes depending on the kinetics with which the compartments are 
loaded with endocytosed material. Also known as sorting endomes, early 
endosomes are the first reached by internalised protein cargo. Here, receptor cargo 
is sorted into specific transport pathways depending, in part, on targeting 
information contained in their amino acid sequences.
Within the early endosome it is possible to distinguish 3 distinct microdomains 
characterised by the presence o f different rab GTPases (Sonnichsen et al., 2000). 
Rab GTPases are members o f the ras superfamily o f small GTPases and have been 
shown to exert a key regulatory function in membrane trafficking (reviewed in 
(Pfeffer, 2003; Zerial and McBride, 2001)). They act as molecular switches, which 
regulate a number o f cellular events including cellular budding, interaction between 
motile vesicles and target organelles and organelle architecture (Deneka et al., 
2003; Pfeffer, 2003; Zerial and McBride, 2001). Subdomains within the early 
endosome, containing rab 4 or rab 4 and 11 mature to form recycling endosomes 
which then are able to deliver protein cargo back to the plasma membrane. A 
different subdomain o f the early endosome, enriched in rab 5, matures to form late 
endosomes, a process which is characterised by a reduction in the levels o f rab 5 
and increasing levels o f Rab7 (Rink et al., 2005).
Late endosomes eventually mature into lysosomes where their cargo is degraded by 
lysosomal proteases. In addition to Rab7, several components o f the protein 
machinery thought to be involved in sorting receptor cargo towards the degradative 
pathway have recently been identified including Hrs/STAM, TGS101, and the 
ESCRT complexes.
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Signals for endocytosis and sorting
A number o f sequences for the endocytosis o f cell surface receptors and other 
membrane proteins have been identified (reviewed in (Bonifacino and Traub,
2003)). Most o f the signals so far identified have been classified into tyrosine- 
based signals, dileucine based signals, and motifs that are targets for post- 
translational modifications.
Classical signals
The sequence m otif NPXY was one o f the first signals for internalisation to be 
identified. It was originally identified in the LDL receptor, but later studies found 
this m otif in various cell surface proteins including integrins, and the (3-amyloid 
precursor protein. In addition to the NPXY m otif another important family of 
tyrosine-based signal are the Y X X 0 signals, where 0  represents any bulky 
hydrophobic amino-acid (Bonifacino and Traub, 2003). These tyrosine based 
internalisation signals have been shown to be important for the internalisation of a 
variety o f membrane proteins and receptors including the transferrin receptor.
Tyrosine type sorting signals have not only been implicated in internalisation but 
have also been found to be important in other sorting events such as lysosomal 
targeting from endosomes and the trans-golgi network (TGN; (Bonifacino and 
Traub, 2003; Marks et al., 1995; Williams and Fukuda, 1990). Analysis of the 
cytosolic domain o f the CD3 receptor in T-cells led to the discovery o f dileucine- 
based signals (Letoumeur and Klausner, 1992). The [DE]XXXL[LI] m otif is found 
to be highly conserved, and as with the Y X X 0 m otif its function is not restricted to 
internalization but can also mediate other membrane trafficking events such as 
lysosomal targeting (Bonifacino and Traub, 2003).
Tyrosine and di-leucine type endocytosis signals have also been implicated in the 
internalisation of several neurotransmitter receptors including GABAa receptors 
and NMDA receptors. Studies using chimeras o f Tac and the cytoplasmic tail o f the 
NR2B subunit revealed that the NR2B subunit contained a Y X X 0 m otif that was 
responsible for internalization (Roche et al., 2001). Furthermore, internalization of
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the Tac-NR2B chimera was prevented using dynamin K44A mutant that abolishes 
the activity o f the GTPase dynamin indicating that the internalization o f Tac-NR2B 
is dynamin dependent. NR2A also contains a Y X X 0 m otif within its intracellular 
tail. However, Lavezzari et al. recently showed in a chimeric study that this m otif 
was not involved in the internalization of NR2A, instead mutation of a di-leucine 
type m otif (L I319 and L I320) resulted in a significant reduction o f NR2A 
endocytosis (Lavezzari et al., 2004). In this same study they found that both NR2A 
and NR2B are able to bind to the \x2 subunit o f AP2 although NR2B binds with 
much higher affinity. Di-leucine type signals have also been implicated in 
internalisation o f GABAa receptors from the cell surface o f HEK293 cells. Herring 
and colleagues reported that a dileucine m otif within the GABAa receptor p2 
subunit is critical for endocytosis and that internalization o f GABAa receptors 
lacking this m otif is dramatically inhibited (Herring et al., 2003).
Atypical signals
In addition, several atypical endocytosis and AP2 adaptor binding motifs have been 
identified in neurotransmitter receptor intracellular domains. These include basic 
amino acid rich atypical AP2 binding motifs in both GABAa receptor (Kittler et al.,
2005) and AMPA receptor (Lee et al., 2002) intracellular domains conserved with a 
previously identified atypical m otif in synaptotagmin 1 (Haucke et al., 2000). 
AMPA receptors also contain other atypical amino acid motifs important for their 
internalization (Ahmadian et al., 2004; Lin et al., 2000). In addition Scott et al were 
able to show using tagged NMDA receptor subunits and chimeric constructs that 
the NR1 subunit also contains a number o f endocytosis signals in the membrane 
proximal domain o f its C-terminal tail which defined a novel set o f internalization 
motifs, and which contribute in an additive manner to NMDA receptor endocytosis 
when expressed with NR2B subunits (Scott et al., 2004).
In addition to non-classical endocytosis motifs, another recently defined atypical 
signal for internalisation is the covalent modification o f lysine residues with the 
polypeptide ubiquitin, which has also been suggested to act as a membrane sorting
50
signal. The presence o f several endogenous lysines in ubiquitin allows for it to self- 
ubiquitinate generating poly-ubiquitin chains. Evidence suggests that mono- 
ubiquitination or small ubiquitin chains act as signals for endocytosis (Hicke, 1999; 
Pickart, 2001). Evidence o f ubiquitin functioning as an internalization signal 
initially came from studies in yeast where a number o f  plasma membrane proteins 
are internalised and targeted for vacuolar degradation by a ubiquitin dependent 
mechanism (Hicke, 1999). More recently it has also been demonstrated that 
ubiquitin acts as a signal for endocytosis for a number o f mammalian receptors 
including the EGF receptor (Joazeiro et al., 1999; Levkowitz et al., 1999; 
Waterman et al., 2002), the epithelial sodium channel (Rotin et al., 2000), E- 
cadherin (Fujita et al., 2002) and potentially glycine receptors (Buttner et al.,
2001). The exact mechanims by which ubiquitination serves as a signal for 
endocytosis are however still incompletely understood (DiAntonio and Hicke,
2004). Similarly to tyrosine and di-leucine type signals, ubiquitin modification of 
membrane proteins is also implicated in further trafficking events down the 
endosomal system through interaction with proteins such as Hrs and the ESCRT 
complexes, including targeting to multivesicular bodies and late endosomes 
suggesting that ubiquitination plays an important role in the late stages o f the 
endocytic pathway (Dupre et al., 2001; Rocca et al., 2001).
The role of ubiquitin in the synapse
Ubiquitination has been recently observed as a key process for regulating synaptic 
function and development. Ubiquitination has been implicated to play key roles in 
the degradation of proteins at both the level of the lysosome and proteasome. 
Studies on ubiquitin in neuronal systems have highlighted this process as an 
important mechanism to control protein stability, activity and localisation at 
synapses.
Ubiquitin is a highly conserved polypeptide that can be conjugated to lysine chains 
via its carboxyl-terminal glycine. Ubiquitylation of proteins occurs in three steps: 
firstly the ubiquitin is activated through the formation o f a thiol ester with a 
cysteine residue of E l ubiquitin activating enzyme; the ubiquitin polypeptide is
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Figure 1.5: Multiple steps in the ubiquitin pathway. (A) Ubiquitin is activated 
by E1 and ATP hydrolysis. (B) Ubiquitin is then passed on to E2 (ubiquitin carrier 
enzymes) which is recognised by an E3 ligase bound to the  target substrate (C). 
(D) E3 ligase facilitates the ligation of ubiquitin onto a lysine residue within the 
target substrate. (E) This process can be repeated to create a polyubiquitin chain 
by the  addition of ubiquitin to  lysine residues within the ubiquitin peptide itself. (F) 
Finally the ubiquitin chain may be removed and the ubiquitin recycled by action of 
deubiquitinating enzymes (DUBs).
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then transferred to a cysteine residue of E2 ubiquitin conjugating enzyme; finally, 
the ligation of ubiquitin to its target lysine is catalysed by a ubiquitin E3 ligase 
(Fig. 1.5). E3 ligases are the key regulatory determinants in the ubiquitination 
reaction as they specify the timing and substrate selection o f ubiquitination 
reactions. Deubiquitinating enzymes are responsible for the removal and 
regeneration o f ubiquitin.
Interestingly the role o f ubiquitin may be determined on the length of the ubiquitin 
chain as well as the lysine residues within ubiqutin that are found ubiquitinated. 
For example, monoubiquitination, or small ubiquitin chains, has been shown to 
play a role in endocytosis, histone regulation and the budding o f retroviruses from 
the plasma membrane. Polyubiqutin chains that contain four or more ubiquitin 
molecules and in which the ubiquitin is linked to Lys48 o f the preceding ubiquitin 
results in the targeting o f substrates for degradation in the 26S proteasome.
The majority o f studies on ubiquitin in the nervous system have focused on the role 
o f the ubiquitin proteasome system (UPS) in regulating synaptic function and 
development. The UPS has been implicated in many developmental processes 
including axon guidance and outgrowth and synapse development as well as long 
term potentiation (LTP). Interestingly, many neurodegenerative disorders are 
characterised by aberrant UPS function including Alzheimer’s Disease (Van 
Leeuwen et al., 1998; Keck et al., 2003; Angelman’s syndrome (Kishino et al., 
1997; Matsuura et al., 1997), Parkinson’s Disease (Kitada et al., 1998; Leroy et al., 
1998; Shimura et al., 2001), Huntington’s Disease (Bence et al., 2001), Ataxia 
(Wilson et al., 2002; Anderson et al., 2005) and Schizophrenia (Middleton et al.,
2002).
Genetic studies in Drosophila and C. elegans have provided some of the best 
evidence in support o f UPS function in synapse development. The E3 ubiquitin 
ligase highwire and the deubiquitinating enzyme fat facets in Drosophila have been 
implicated in regulating synaptic growth and function. Mutation o f highwire leads 
to enlarged synaptic boutons that display abnormal physiology characterised by
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reduced mEJPs (miniature junctional potentials) and evoked release despite their 
normal structural appearance. Similarly, overexpression o f fat facets results in 
similar results suggesting that a balance between ubiquitination and 
deubiquitination is o f crucial importance during synapse development. The 
highwire C. elegans homolog RPM-1 has also been shown to play a role in 
controlling synaptic growth by acting on both DLK-1 , the C. elegans MAPKKK 
(Nakata et al., 2005), and the receptor tyrosine kinase ALK (anaplastic lymphoma 
kinase, Liao et al., 2004).
Another E3 ligase that has been recently implicated in neuronal development and 
synaptic function is the anaphase promoting complex (APC). The APC is a large, 
multisubunit E3 ligase with critical function in the cell cycle (Harper et al., 2002; 
Peters et al., 2002). Interestingly, this ligase is highly expressed in neurons in many 
parts o f the CNS including the cerebral cortex, hippocampus and cerebellum 
suggesting a new role for the APC in the brain (Gieffers et al., 1999). More 
recently, genetic and RNAi studies in rodents, Drosophila and C. elegans have 
identified a role for the APC in regulating axon growth, morphological 
differentiation o f neuronal processes, and synapse size and number (reviewed in 
Stegmuller and Bonni, 2005).
Neuronal activity causes changes in structure and composition o f the PSD in a 
manner that is inhibited by proteasome inhibition (Ehlers, 2003). Moreover, 
increases in neuronal activity are mirrored by an enhancement in the ubiquitination 
o f a number o f post synaptic proteins including Shank, GKAP, AKAP79/150 and 
PSD-95 (Colledge et al., 2003; Ehlers, 2003). Interestingly, the ubiquitin dependent 
degradation of PSD-95 has been shown to play a role in regulating AMPA receptor 
stability at the plasma membrane (Patrick et al., 2003).
Research into the direct ubiquitination o f post synaptic receptors is an active 
research area. The a l  subunit o f glycine receptors has been shown to be 
ubiquitinated at the plasma membrane, facilitating its internalization and 
subsequent degradation (Buttner et al., 2001). In addition, GABAa receptors have
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been recently shown to be a target for ubiquitination on their (33 subunit and that 
this ubiquitination plays a role in determining cell surface expression by regulating 
insertion rate (Saliba et al., 2005). A recent study by Burbea and colleagues found 
that the GluRl subunit o f AMPA receptors can be ubiquitinated generating a signal 
for internalization in C. elegans (Burbea et al., 2002). However, the direct 
ubiquitination o f mammalian AMPA receptors has not yet been demonstrated.
Given the importance o f receptor trafficking in regulating synaptic strength. This 
thesis focuses on further undestanding the molecular determinants for regulating 
the GABAa receptor endocytic pathway. Furthermore it investigates a possible role 
for ubiquitin in this pathway and looks at the functional consequences of altering 
GABAa receptor endocytic sorting.
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2. MATERIALS AND METHODS
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Antibodies
9E10 anti-myc antibody was obtained from 9E10 hybridoma cells and used directly 
as supernatant. Rabbit anti-GABAA receptor (33 was raised against GST-(33 amino 
acids 345-408 and purified on an MBP-(33 345-408 column.
Antibody production
Monoclonal 9E10 (anti-myc) and 12CA5 (anti-HA) antibody
12CA5 and 9E10 hybridoma cells were grown in Integra CL350 flasks. Cells were 
maintained in the cell compartment in DMEM supplemented with 20% FBS. The 
nutrient compartment contained serum free DMEM. After cells had reached 
confluency (no more than 2x l06/mL) cells were harvested every 3 days. Harvesting 
involved the removal of 50% of cells and replacement with new media. In addition 
nutrition media had to be changed with every harvest. Cells removed from each 
harvest were centrifuged for 2min at lOOOrpm. Supernatant containing high 
concentrations (estimated at 0.5mg/mL) of antibody was filtered through a 0.45 pm 
filter and stored at -20°C.
Purification of 12CA5 anti-HA antibody
Monoclonal anti-HA antibody was purified from supernatant on a protein G 
column. Briefly, protein G sepharose beads were swollen in 20mM NaP04 buffer 
pH 7 and stacked in a disposable column. Supernatant, harvested from 12CA5 
hybridoma cells, was loaded twice through the column. After washing with 10 
volumes of 20mM N aP04, bound antibody was eluted with 0.1M Glycine pH 2.5. 
Eluates were immediately neutralised with 1M Tris pH 8.0. Fractions containing 
antibody present (determined by optical density (OD) at 280nm) were dialysed at 
4°C overnight in PBS pH 7.4. Antibody concentration was calculated by OD 
reading at 280nm using the following extinction coefficient:
OD280 1.4 = lmg/mL IgG
The purified antibody was stored at 4°C at a concentration of 0.6mg/ml.
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Rabbit Anti-GABAA receptor (33 subunit antibody
Production of Antisera
Rabbit anti-GABAA (33 subunit antibody was raised against MBP-(33 345-408. 
Production of antisera was carried out at Cocalico Biologicals (PA, USA). The 
procedure consisted of an initial inoculation with 300pg of antigen mixed with 
complete Freund’s adjuvant on day 0. This was followed by a booster injection 
with lOOpg of antigen mixed with incomplete Freund’s adjuvant on day 14 and 2 
more boosters with 50pg of antigen on days 21 and 49. 10 days after the final boost 
rabbits were exsanguinated.
Preparation of Affinity Chromatography Coloumn
Rabbit anti GABAa p3 subunit antibody was purified on a GST-p3 345-408 
coupled Affigel (Biorad) column. 4mL of Affigel resin were washed in lOmM 
NaHP04 buffer at 4°C. Coupling of GST-p3 to the Affigel resin took place 
overnight at 4°C on a rotating wheel. The resin was then blocked with 1M 
ethanolamine pH 8.0 for 30min at 4°C. The column was then washed 5 x 15min at 
4°C in different solutions as follows:
Wash 1: 50mL lOmM Tris-HCl pH 7.5
Wash 2: 30mL lOOmM Glycine pH 2.5
Wash 3: 50mL lOmM Tris-HCl pH 7.5
Wash 4: 30mL lOOmM Triethylamine (TEA) pH 11.5
Wash 5: 50mL lOmM Tris-HCl pH 7.5
The resin was then packed into a lOmL glass column (BioRad).
Antibody purification
Rabbit anti GABAa p3 subunit antibody was purified from 5mL of serum. Serum 
was filtered through a 0.45pm  filter, diluted 1:5 in dH2Q with protease inhibitors
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(lOOpM PMSF, 20pg/mL leupeptin, 20pg/mL antipain, 5pg/mL pepstatin). Prior to 
loading the serum the column was washed with lOmL Tris-HCl pH 7.5, lOmL 
lOOmM Glycine pH 2.5, lOmL Tris-HCl pH 7.5, lOmL lOOmM TEA pH 11.5 and 
lOmL Tris-HCl pH 7.5. Serum was loaded onto the column with aid of a peristaltic 
pump (flow rate approx. 2mL/min) for 4hrs at 4°C. The column was then washed 
with lOmL Tris-HCl pH 7.5 followed by 30mL Tris-HCl pH 7.5 including 0.5M 
NaCl. Bound antibody was eluted with lOOmM Glycine pH 2.5 in 20 x lm L 
fractions. After a wash with 30mL Tris-HCl pH 7.5 a second elution with lOOmM 
TEA pH 11.5 was collected. Protein levels in each fraction were determined by OD 
reading at 280nm as described above.
Those fractions containing higher concentrations of IgG were pooled and 
concentrated using an Amicon Ultra centrifugal filter (Millipore). Using this same 
filter, a buffer exchange was carried out by resuspending the antibody in 2 x 50mL 
of PBS. The purified antibody was stored at 4°C at a final concentration of 0.5mg/ 
mL.
Molecular Biology
Constructs
GABAa receptor cDNA constructs encoding a l ,  (33 y2S and y2L subunits in the 
expression vector pRK5 have been previously described (McDonald et al., 1998). 
The subunits were tagged with a 9E10 epitope (EQKLISEEDL) between amino 
acids 4 and 5 as described previously (Connolly et al., 1996). Chimeric p3/y2 
constructs were made by MJ Lumb as described below. GFP-2FYVE, GFP-Rab 7 
and HA-Ub were kind gifts from H Stenmark, F Maxfield, and Y. Fujita, 
respectively.
Chimeras
The 9E10|33 N-terminus-TM3 and the y2 intracellular loop and TM4 fragments were 
obtained by PCR using the oligonucleotides described below. The fragments were 
then cloned into BamHI/Hindlll digested pRK5 in a three-way ligation as shown in 
Figure 2.1.
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A AGATCT 
TCTAGA
ACCGGT B9 HI wGATCT
TGGCCA Agel A
A
TGGCC
B ACCGGT '■■■ AAGCTT Agel . CCGGT ' -  A
TGGCCA — —  TTGCAA HindN| *  A ■ —  TTGCA
G ag ctt  —
A ■ ■ H BCCTAG
D
Figure 2.1: Schematic diagram of a 3 way ligation to create p3/y2 chimeras. 
PCR products of the  p3 (A) and y2 (B) subunit containing inserted restriction sites 
are digested using the appropriate enzymes to  create 5' and 3' overhangs. (C) 
pRK5 is digested using BamHI andHindlll (sites present in the  multiple cloning site 
(MCS) of the plasmid). All digestion products are incubated at 4°C overnight with 
T4 ligase allowing for the  creation of a p3/y2 chimera in pRK5 (D).
T4 DNA ligase 
4°C Overnight
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O lig o n u cleo tid es  u sed  fo r  P C R
/33-Mvc common forward primer
CATCATAGATCTACCATGTGGGGCTTTGCGGGAG
v2 common reverse primer
CATCATAAGCTTTTACAGATAAAGATAGGAG
C h im e ra  1
(33 reverse primer
CATCATACCGGTGACAAAGGCATACTCCAG 
y2 forward primer
CATCATACCGGTCATTATTTTGTCAGCAACCGG 
C h im e ra  2 (C D
f33 reverse primer
CATCATACCGGTAGAACGATCATTCTTGGC 
y2 forward primer
CATCATACCGGTGCCCCTACCATTGATATTC 
C h im e ra  3 (C 3)
j63 reverse primer
CATCATACCGGTATCCATCGGTGCTAATAG 
y2 forward primer
CATCATACCGGTCACCTTCAAGAGAGGGATG
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Chimera 4 (C4)
j33 reverse primer
CATCATACCGGTTGCTGAATTCCTGGTGTCAC 
v2 forward primer
CATCATACCGGTGCCAGTTTCTTCTGCTGTTTTG 
Chimera 5 (C5)
/33 reverse primer
CATCATACCGGTCCGCCCATGCCCTTCCTTG 
y2 forward primer
CATCATACCGGTCGCATTGCCAAAATGGACTC 
Growth Media and agar plates
Bacteria were grown in Luria-Bertani (LB) medium at 37°C. Plasmids encoding 
Ampicilin resistance were grown in lOOpg/ml Ampicilin. Plasmids encoding 
Kanamycin resistance were grown in 30pg/ml Kanamycin.
Transformation o f  bacteria with plasmid DNA
Plasmid DNA was transformed into One Shot® chemically competent E.coli 
(Invitrogen) following manufacturer’s guidelines. Briefly, one vial of One Shot® 
chemically competent E.coli was used per transformation. Plasmid DNA was 
incubated for 5-10min with E.coli cells on ice. Cells were then heat-shocked for 
30s at 42°C and immediately returned to ice. Following this bacteria were 
resuspended in 200pl SOC medium and incubated at 37°C for lh r prior to plating 
on LB agar plates. Bacterial colonies were grown on LB agar plates overnight at 
37°C.
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Maxi-preparation o f  plasmid DNA
Plasmid DNA was purified from bacterial cultures using Perfectprep® Plasmid 
Isolation Maxi Kit (Eppendorf). In brief, cells from a 500mL overnight bacterial 
culture were resuspended in 15mL of Solution 1 and incubated at room temperature 
for lOmin followed by a 5min incubation on ice. Alkaline lysis was carried out on 
ice for 5min and cells were then neutralized in Solution 3 for lOmin on ice. 
Plasmid DNA was bound to a silica matrix under high chaotropic salt conditions 
and washed with an alcohol buffer containing low salt. After elution in TE the 
DNA was concentrated by ethanol precipitation and finally resuspended in 
molecular biology grade water.
Cell Culture
HEK293 and COS cells
Human Embryonic Kidney (HEK293) or COS cells were grown in NUNC 10cm 
dishes in lOmL of Dubelco’s Modified Eagles Medium (DMEM) supplemented 
with 10% heat inactivated fetal bovine serum (FBS). Cells were grown at 37°C in a 
humidified 5% CO2 enviroment.
Transient transfection o f  HEK293 cells
Transient transfections o f HEK293 cells were carried using Nucleofector (Amaxa 
biosystems) technology. Briefly cells seeded 48hrs prior to transfection and at 
60-70% confluence were trypsinised for 2 min at 37°C. The trypsin enzymatic 
reaction was blocked by washing the cells in FBS supplemented DMEM. After 
centrifugation at lOOOrpm for 2 min excess DMEM was removed and the cell pellet 
was resuspended in lOOpl of Nucleofector Solution V per transfection. Cells were 
transfected with a maximum of 6|Jg of DNA using Nucleofector program Q-01. 
Cells were then plated onto poly-L-lysine (lOpg/ml) and fibronectin (lpg/m l) 
coated coverslips at a density of 35000 cells/cm2 and analysed 24-48 hrs after 
transfection.
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Transient transfection o f  COS cells
For biochemical experiments, where a large number of cells were needed, transient 
transfections of COS cells were carried out by electroporation. Two 10cm dishes of 
cells split the previous day and growing at 50-60% confluency were used per 
transfection. Cells were trypsinised from the dish and washed once in DMEM. 
After centrifugation at 1000 rpm for 2min, the cells were washed once in 20ml of 
Optimem. Cells were centrifuged once more and pellets were resuspended in 0.5ml 
Optimem per transfection. Cells were transfected by electroporation (0.400V, 
infinity resistance, 125pF) using a Bio-Rad Gene Electropulser II with a total of 
15pg of DNA. Cells were used 40-48hrs after transfection.
Hippocampal Neurons
Embryonic (E l8) hippocampal neurons were isolated as previously described 
(Banker and Goslin, 1998). Briefly, hippocampi were dissected from E l 8 Sprague- 
Dawley rats in HEPES buffered Hanks Balanced Salt Solution (HBSS). Cells were 
dissociated in 0.25% trypsin for 15min at 37°C. Cells were cleared from further 
trypsin enzymatic activity by three washes in HBSS. Cells were then gently 
triturated in HBSS using a fire polished glass pasteur pipette followed by trituration 
in a second fire polished pipette with a diameter 40% smaller than that of the first. 
Cells were counted using a Neubauer Haemocytometer and cell viability was 
assessed by erythrosin B exclusion. Dissociated neurons were then plated onto 
poly-L-lysine (500|Jg/ml) coated glass coverslips at a density of 14000 cells/cm2. 
Neurons were allowed to attach in Minimum Essential Medium (MEM) 
supplemented with 10% Horse Serum and sodium pyruvate. 2-4 hours after plating 
the media was replaced with Neurobasal supplemented with 2% B27, 1% 
glutamine and 33mM glucose.
Cortical neurons
Embryonic (E l8) cortical neurons were isolated as previously described (Brandon 
et al 1999). Briefly, cortices were dissected from E l 8 Sprague-Dawley rats in 
HEPES buffered Hanks Balanced Salt Solution (HBSS). Cells were dissociated in 
0.25% trypsin for 15min at 37°C. Cells were cleared from further trypsin enzymatic
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activity by three washes in HBSS. Cells were then gently triturated in HBSS using 
a glass lOmL pipette. Cells were counted using a Neubauer Haemocytometer and 
cell viability was assessed by erythrosin B exclusion. Dissociated neurons were 
then plated onto poly-L-lysine (50pg/ml) coated 10cm dishes at a density of 40000 
cells/cm2. Neurons were allowed to attach in Minimum Essential Medium (MEM) 
supplemented with 10% Horse Serum and sodium pyruvate. 2-4 hours after plating 
the media was replaced with Neurobasal supplemented with 2% B27, 1% 
glutamine and 33mM glucose.
Transfection o f  hippocampal cells
Transfections of hippocampal cells were carried using Nucleofector (Amaxa 
biosystems) technology. Briefly after dissociation of hippocampal cells lx l0 6cells 
were resuspended in lOOpl of Rat Neuron Nucleofector Solution per transfection. 
Cells were transfected with a maximum of 6pg of DNA using Nucleofector 
program 0-03. Cells were then plated onto poly-L-lysine (500|Jg/ml) coated 
coverslips at a density of 30000 cells/cm2.
Imaging
In transfected HEK293 cells 
Receptor Cell Surface Labelling
In order to visualise the surface expression of transfected myc-tagged constructs 
cells were washed in PBS and fixed in 4% paraformaldehyde for lOmin at room 
temperature. Cells were then blocked in PBS containing 0.5% BSA and 10% horse 
serum. Cells were incubated for 1 hour at room temperature with monoclonal anti- 
myc antibody diluted in blocking solution, followed by a 1 hr incubation with FITC 
conjugated anti-mouse. Cells were washed in PBS, mounted with Prolong® Gold 
Antifade mounting media (Molecular Probes, Invitrogen) and visualised using 
confocal microscopy.
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Receptor Internalisation Assay
Receptor internalization assays were carried out using an antibody feeding protocol 
as described in Figure 2.2. Live transfected cells were incubated for 30min on ice 
in HEPES buffer (25mM HEPES, 140mM NaCl, 5.4mM KC1, 1.8mM CaCl, 
15mM glucose, pH 7.4) containing 9E10 anti-myc antibody. Unbound excess 
antibody was removed by washing in ice-cold PBS and the cells were returned to 
conditioned media for a 30min incubation at 37°C. Surface antibody was stripped 
away using 0.2M acetic acid, 0.5M glycine in PBS prior to fixation as previously 
described (Carroll et al., 1999). Cells were then fixed in 4% paraformaldehyde for 
lOmin at room temperature and permeabilised in block buffer containing 0.1% 
Triton. To identify internalised receptors cells were then incubated for lh r with 
Texas-Red conjugated goat anti-mouse. Cells were washed in PBS, mounted with 
Prolong® Gold Antifade mounting media (Molecular Probes, Invitrogen) and 
visualised using confocal microscopy.
In Cultured Hippocampal Neurons
In order to visualise the surface expression of GABAa receptors, cultured 
hippocampal neurons were were washed in PBS and fixed in 4% 
paraformaldehyde/ 4% sucrose for lOmin at room temperature. Cells were then 
blocked in PBS containing 0.5% BSA and 10% horse serum. Cells were incubated 
for 1 hour at room temperature with guinea pig anti-y2 subunit antibody diluted 
(1:200) in blocking solution. Cells were then washed in PBS and permeabilised for 
15min at room temperature in block buffer containing 0.1% Triton. Cells were then 
incubated for lh r with anti-VIAAT (to label inhibitory presynaptic terminals) and 
anti-MAP2 (to visualise dendrites). After washing in PBS cells were incubated for 
lh r incubation with Alexa-Fluor 594 conjugated anti-guinea pig, Alexa-Fluor 488 
conjugated anti-rabbit and Cy5 conjugated anti-mouse. Cells were washed in PBS, 
mounted with Prolong® Gold Antifade mounting media (Molecular Probes, 
Invitrogen) and visualised using confocal microscopy.
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Figure 2.2: Schematic diagram of the antibody feeding technique. (A) Diagram 
showing th e  steps involved in the  labeling of surface and internalised receptors. 
Primary antibody to  an extracellular epitope is allowed to bind the receptor under 
conditions tha t block internalisation. Cells are then returned to  conditioned media 
where receptors are are allowed to internalise. After fixation, addition of a 
fluorophore conjugated secondary antibody (green) labels all remaining surface 
receptors. Cells are then permeabilised and incubated with a different fluorophore 
conjugated secondary antibody (red) to  label the  pool of internalised receptors. (B) 
Schematic diagram showing the use of antbody feeding to exclusively label 
internalised receptors. Binding and internalisation of receptor-antibody complexes 
are carried out as above. Before fixation, cells are washed in PBS pH 4 to  remove any 
remainnig surface bound primary antibody. Cells are then permeabilised and 
incubated with a fluorophore conjugated secondary antibody (red) to  identify 
internalised receptors. Adapted from Arancibia-Carcamo et al., 2006
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Confocal Microscopy
Cells were viewed using a Zeiss LSM 510 META confocal microscope. All images 
were digitally captured with LSM software with excitation at 488nm for GFP, FITC 
and Alexa-Fluor 488, 568nm for Texas-Red and Alexa-Fluor 594 and 647nm for 
Cy5 conjugated secondary antibodies. Pinholes were set to 1 Airy unit creating an
optical slice of 0.8pm. Images were scanned at a speed of 25.60ps/pixel with a 
Kalman factor of 8 or at 12ps/pixel with a Kalman factor of 16.
Image processing and quantitation
Captured confocal images were analysed using Metamorph software (Universal 
Imaging Corporation). Acquired images were noise subtracted using a series of 
low-pass filters (detailed below).
For colocalisation studies, a user-defined threshold was then set for each channel 
on the resulting image. Colocalization was measured as the integration of the 
intensities in the regions of overlap. Results are expressed as percent colocalisation 
over total internalised receptor. In addition, a pixel by pixel intensity analysis was 
carried out on both channels and the correlation calculated using Metamorph’s 
correlation plot function. The correlation factor ranges from -1, indicating that as 
pixels brighten in one channel, they become dim in the other channel; to + 1 
indicating a linear increase in intensity on both channels.
For cluster identification, images were scaled using a pseudocolor look up table 
(LUT) on Metamorph. Clusters were defined as an increase in intensity around a 
central point. Regions were drawn around each cluster and Metamorph software 
was used to record the size (in pm2) of each cluster.
Low-pass filter
In order to reduce excessive background noise and to correct shading whilst 
preserving high frequency detail images were subjected to two distinct low pass 
filters. After an initial shading correction, the image was subjected to a low pass 
filter with a 3 x 3 kernel. Separately, the image was also filtered using a 7 x 7 low 
pass filter and the resulting pixel intensities were halved. The final image is a result
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from the 7 x 7 filtered image being subtracted from the 3 x 3 filtered image. This 
process results in an image with enhanced high-frequency spatial detail and low 
noise levels.
Biochemistry
Biotinylation o f  cell surface proteins
Cortical cells were washed twice in ice-cold PBS Ca2+/Mg2+ (PBS containing ImM 
CaCh and 0.5mM M gCk) and incubated for 12min on ice with biotin solution 
(0.5mg/mL Sulfo-NHS-biotin (PIERCE) in PBS Ca2+/Mg2+). Cells were then 
washed in PBS Ca2+/Mg2+ and quenched for 5min with 50mM glyicne, lmg/mL 
BSA in PBS Ca2+/Mg2+. Cells were washed twice in quenching buffer and after a 
final wash in PBS Ca2+/M g2+ they were scraped in ice-cold RIPA (50mM Tris pH 
7.4, ImM  EDTA, 2mM EGTA, 150mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS) 
containing protease inhibitors and solubilised by rotating lh r at 4°C. Nuclear and 
cellular debris was removed by centrifugation at 13000 rpm for lOmin at 4°C. 15% 
of the lysate supernatant was kept for total protein comparison and the rest was 
precipitated with 50pl of a 50% Ultralink Neutravidin slurry for 2hrs at 4°C. Beads 
were washed twice in high salt RIPA buffer (containing 500mM NaCl) and once in 
normal RIPA. Beads were resuspended in 50pi of 3X SDS sample buffer and 
resolved by SDS-PAGE. Biotinylated surface receptors were then detected by 
immunoblot analysis using anti-P3 (0.5pg/ml). Results were quantified on a 
phosphorimager.
Ubiquitin immunoprecipitations
COS cells, transfected with HA-tagged ubiquitin and different chimeras, were 
washed in ice cold PBS and scraped in lysis buffer (50mM Tris pH 7.4, 150mM 
NaCl, ImM  EDTA, 2mM EGTA, 1% Triton, 0.1% SDS) containing protease 
inhibitors. Cells were allowed to solubilse for lh r at 4°C. Nuclear and cellular 
debris was removed by centrifugation at 13000 rpm for lOmin at 4°C. Chimeras
were immunoprecipitated from lysate supernatant using lp g  rabbit anti-myc and 
40pl Protein A beads (50% slurry) for lhr at 4°C. Beads were washed twice in high
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salt lysis buffer (lysis buffer containing 500mM NaCl) and once in normal lysis 
buffer. Beads were resuspended in 50|Jl of 3X SDS sample buffer and resolved by 
SDS-PAGE. Immunoprecipitated chimeras were detected by immunoblot analysis 
using anti-9E10 antibody and ubiquitin levels were detected using anti-HA 
antibody. Results were detected using ECL chemiluminescence and quantified by 
densitometry.
SDS-PAGE
3X or 5X SDS PAGE sample buffer was added to all samples prior to loading to a 
final concentration of IX  SDS PAGE sample buffer (50mM Tris-HCl pH 8.0, 2% 
SDS, 0.1M DTT, 10% Glycerol and 0.1% Bromophenol Blue). Samples were then 
loaded in a 1.5mm thick polyacrilamide gel consisting of a low pH (pH 6.8) 
stacking gel and a higher pH (pH 8.8) resolving gel.
Stacking gels were made as follows (per lOmL):
Protogel (30% acrylamide, National Diagnostics) 1.70mL 
dH20  6.80mL
1M Tris-HCl pH 6.8 1.25mL
10% SDS lOOMl
10 Ammonium persulfate 100pi
TEMED lOpl
Resolving gels were as follows (per 40mL):
dH20  + Protogel (to required percentage) 29.2mL
1.5M Tris-HCl pH 8.8 lO.OmL
10% SDS 400pi
10 Ammonium persulfate 400pi
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TEMED 16pl
Gels were run in IX PAGE buffer (25mM Tris, 250mM glycine, 0.1% SDS). 
Transfer o f  PAGE gels
Resolved proteins were transferred from SDS-PAGE gels onto a Hybond 
nitrocellulose membrane (Amersham). Briefly, the gel was placed against a pre­
wetted nitrocellulose membrane and this was sandwiched between three pieces of 
3mm filter paper (Whatman) and a fiber pad on each side. This was then placed in a 
BioRad transfer apparatus cassette and fitted in a BioRad transfer tank. Transfer 
was carried out in IX transfer buffer (25mM Tris, 192mM glycine, 0.037% SDS, 
and 20% methanol) at 350mA for 3hrs. After transfer the membrane was stained 
with Ponceau S solution (0.1% Ponceau S, 5% acetic acid) and the positions for the 
molecular weight markers were indicated in pencil.
Western Blotting
Following transfer the membrane was blocked with 4% milk (Marvel) in PBS-T 
(PBS containing 0.1% Tween-20) for lhr. Antibodies were diluted in block buffer 
to the appropriate concentrations and applied to the membrane in a sealed plastic 
bag. Antibodies were allowed to bind their epitopes overnight at 4°C on a rotating 
platform. Excess antibody was washed off with three lOmin washes in block buffer. 
Horseradish Peroxidase (HRP) conjugated secondary antibodies (Jackson 
Immunoreasearch) diluted in block buffer were incubated with the membrane at 
room temperature for lhr. Excess antibody was washed of with three lOmin washes 
in block buffer. The membrane was then rinsed twice in PBS and proteins were 
detected by application of Super Signal Chemiluminescent substrate (Pierce).
GST-Fusion protein production
BL21 bacteria were transformed with pGEX constructs and grown on LB Agar 
plates containing Ampicilin. A single colony was grown overnight in lOmL LB 
containing 50|jg/m L Ampicilin and 30pg/mL Chloramphenicol (LB Amp-Chl) at 
37°C. This was then grown further in 1L of LB Amp-Chl for 2-3hrs until the 
culture reached an OD600 of 0.5-0.6. Protein expression was then induced by
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addition of isopropylthio-p-D-galactoside (IPTG) to a final concentration of 0.3mM 
and vigorous shaking at room temperature for 3hrs. Bacterial cultures were 
centrifuged at 4200rpm for 15min. The bacterial pellet was washed in lOmL of 
buffer A (50mM Tris-HCl pH 8.0, 25% sucrose, lOmM EDTA), centrifuged again 
and left overnight at -20°C. The following day the bacterial pellet was allowed to 
thaw on ice and resuspended in buffer B (lOmM Tris-HCl pH 7.4, ImM EDTA, 
ImM  DTT, ImM PMSF) with lpg/m L of each of the protease inhibitors antipain, 
pepstatin and leupeptin. Triton-X 100 was added to 1% and the mixture was 
sonicated at full power for 5 x 15s. Following sonication 25mL of buffer C (20mM 
HEPES pH 7.6, lOOmM KC1, 0.2mM EDTA, 20% Glycerol, ImM DTT, ImM 
PMSF) was added to the mixture as well as 400pi aprotinin and protease inhibitors. 
After centrifugation at 35000 rpm at 4°C the supernatant was added to lm L of pre­
swollen glutathione-Agarose beads (80mg of beads before swelling) and the 
mixture was left rotating for 2hrs at 4°C. The beads were then washed 3 x lOmin in 
buffer C. Elution was carried in lm L elution buffer (buffer C containing 50mM 
Glutathione, pH 7.5). The mix was centrifuged at 4000rpm for 2 min and the 
supernatant containing the fusion protein removed. A second elution was carried 
out to obtain higher yields. Fusion proteins in elution buffer were dialysed 
overnight in PBS at 4°C using a 10000 MWCO dialysis cassette (Pierce). Fusion 
proteins were stored at -20°C.
MBP fusion protein production
BL21 bacteria were transformed with pMAL-c2x constructs and grown on LB agar 
plates containing Ampicilin. A single colony was grown overnight at 37°C in 
lOmL LB containing 2g/L glucose andlOOpg/mL Ampicilin. This was then grown 
further in 1L of LB Amp + glucose for 2-3hrs until the culture reached an OD600 of 
0.5. Protein expression was then induced by addition of (IPTG) to a final 
concentration of 0.3mM and vigorous shaking at room temperature for 3hrs. Cells 
were harvested by centrifugation at 4200rpm for 20min. The bacterial pellet was 
resuspended in 50mL Column buffer (20mM Tris-HCl pH 7.4, 200mM NaCl, ImM 
EDTA) and kept at -2 0 °C overnight. The following day the samples were thawed 
on ice and sonicated at maximum power for 5 x 15s. Samples were centrifuged at
72
35000rpm at 4°C for 30min and the supernatant saved and diluted 1:2 in Column 
buffer. MBP fusion proteins were purified over a 4 cm amylose resin column 
(NEB). The column was washed with 30mL Column buffer prior to loading the 
supernatant. The supernatant was run through the column at a flow rate of 
approximately 2mL/min for 2-3hrs. The column was then washed with 50mL of 
column buffer and the protein eluted with Column buffer containing lOmM 
maltose. Fractions containing the highest protein concentrations were pooled, 
concentrated in an Amicon Ultra centrifugal filter (Millipore) and dialysed 
overnight in PBS.
Electrophysiology
HEK293 cells were transfected (electroporation) with equimolar mixes of the 
relevant expression constructs. 24-72 later the transfected cells were recorded in the 
whole-cell configuration of the patch-clamp technique at room-temperature 
(holding potential -50 mV). Cells were superfused continously with a 
Krebs'solution containing (in mM): NaCl 140, KC1 4.7, HEPES 10, glucose 11, 
M gCh 1.2 and CaCh 2.5 (adjusted to pH 7.4 with NaOH). Borosilicate pipettes 
(2-5 M Q) were filled with (mM) KC1 140, HEPES 10, EGTA 11, M gCh 2, CaCh 
1, M g2+-ATP 2, and additionally for Leupeptin experiments with 40 pM Leupeptin 
(adjusted to pH 7.2 with KOH). An Axopatch 200B amplifier and Digidata 1322A 
(Axon Instruments) software were used for pulse generation, data acquisition (10 
kHz), and filtering (2 kHz, 4-pole Bessel filter). Series resistance and membrane 
capacitance were partially compensated (70-80 %). GABA (5 pM) was rapidly 
applied at each time point to single cells using a modified U-tube, placed < 150  pm 
away from the cell o f interest (Bogdanov et al., 2006).
mIPSCs were recorded from hippocampal neurons, treated overnight with 400pM 
leupeptin, using whole-cell patch clamp technique in conjuction with a patch clamp 
amplifier as previously described (Jovanovic et al., 2004; Kittler et al., 2004b)
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Media and reagents
LB medium
Per litre:
10g tryptone 
5g yeast extract 
lOg NaCl 
pH 7.0
LB Agar
LB + 15g agar
SOC medium
Per lOOmL:
2g tryptone 
0.5g yeast extract 
0.05g NaCl
20mM Glucose (added after autoclaving)
DMEM
Per 500mL
DMEM (Gibco, Invitrogen)
5mL Penicillin-Streptomycin 
50mL FBS
Neuronal Attachment Media
Per 500mL
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MEM (Gibco, Invitrogen)
6.6mL Glucose 
5mL Sodium Pyruvate 
50mL Horse serum
Neuronal Maintenance Media
Per 500mL
Neurosbasal (Gibco, Invitrogen) 
lOmL B27 supplement (Gibco, Invitrogen) 
5mL Penicillin-Streptomycin 
6.6mL Glucose
HBSS
Per 500mL
50mL 10X HBSS (Gibco, Invitrogen)
5mL 1M HEPES 
445mL dH20 
10X Running Buffer 
0.25M Tris-HCl, pH 7.4 
2.5M Glycine 
1% SDS
10X Transfer Buffer
0.25M Tris-HCl, pH 7.4
1.92M Glycine
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0.37% SDS 
PBS
137mM NaCl 
2.7mM KC1 
lOmM Na2HP04 
2mM KH2PO4 
Buffer A
50mM Tris-HCl, pH 8.0 
25% sucrose 
lOmM EDTA 
Buffer B
lOmM Tris-HCl, pH 7.4 
lm M ED TA  
lm M D T T  
Buffer C
20mM HEPES, pH 7.6 
lOOmM KC1 
0.2mM EDTA 
lm M D T T  
20% Glycerol
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3. M ap p in g  th e  m o lecu la r  d e te rm in a n ts  
o f  GABAa re c e p to r  e n d o c y tic  so r tin g
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Introduction
As outlined in chapter 1, regulating the number of post-synaptic receptors at the 
cell surface has been described as an important mechanism for synaptic plasticity. 
A significant amount o f research has recently focused on understanding the 
mechanisms involved in regulating receptor trafficking with particular focus on 
receptor endocytosis and endocytic sorting.
GABAa receptors have been shown to be constitutively internalised in a clathrin 
dependent manner in both heterologous expression systems and cultured neurons 
by the association of (3 and y  subunits with the adaptor protein AP2 (Connolly et al., 
1999; Kittler et al., 2000). In agreement with these findings, blocking GABAa 
receptor endocytosis by disrupting the clathrin endocytic pathway results in an 
increase in GABAergic currents (Kittler et al., 2000). A recent study has provided a 
mechanism for regulating the endocytosis o f GABAa receptors. Kittler et al 
demonstrated how the association o f AP2 with the (3 subunit of GABAa receptors 
is regulated in a negative fashion by phosphorylation o f a conserved serine residue 
in the intracellular loop o f all (3 subunits (Kittler et al., 2004b).
In addition the binding o f HAP 1 to the intracellular loop of the |33 subunit has also 
been shown to determine the endocytic sorting fate of GABAa receptors in cultured 
cortical neurons (Kittler et al., 2004b). Furthermore, downregulation o f HAP1 
expression results in a reduction of GABAa receptor p subunit expression and a 
reduction in mIPSCs (Sheng et al., 2006). Although these results convincingly 
identify HAP1 as a regulator of GABAa receptor endocytic sorting the exact 
molecular mechanisms by which this is achieved remain unknown.
Despite the large number of GABAa receptor subunits a number o f studies have 
revealed that the majority of benzodiazepine sensitive GABAa receptor subtypes in 
the brain consist o f 2a2p  and ly2 subunit. The critical role played by the y2 subunit 
in inhibitory synaptic transmission has become more evident over a number of 
years where it has been shown that this subunit is critical for GABAa receptor
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functional expression and pharmacology. y2 knockout mice show a lethal 
phenotype and heterozygous animals show reduced number of inhibitory synapses 
and this is accompanied by seizures and heightened anxiety like behaviour (Essrich 
et al., 1998; Crestani et al., 1999). In addition the y2 subunit has been shown to be 
responsible for conferring benzodiazepine sensitivity to GABAa receptors 
(Pritchett et al., 1989). Furthermore a number of studies looking at the trafficking 
and subcellular localisation o f the y2 subunit have found this subunit to be essential 
for GABAa receptor clustering and synaptic targeting (Essrich et al., 1998; Alldred 
et al., 2005).
Despite the extensive studies on GABAa receptor endocytosis very little is known 
on the role o f the y2 subunit in regulating the endocytic sorting o f these proteins. 
Given the importance of the y2 subunit it would be interesting to know whether this 
subunit can confer specific trafficking properties in the endocytic pathway. Initial 
studies have already suggested that the y2 subunit may indeed play a role in the 
endocytic pathway although what specific targeting pathway it follows and whether 
this can be regulated has not been addressed (Connolly et al., 1999a; Kittler et al., 
2000).
In this chapter the role o f the y2 subunit in regulating GABAa receptor endocytosis 
and endocytic sorting is addressed by comparing the trafficking properties of 
recombinantly expressed a  1(33 and al(33y2L containing receptors in HEK293 
cells. The fate o f internalised GABAa receptors composed o f ocl(33 or al(33y2L 
subunit combinations is compared using antibody feeding coupled with quantitative 
high resolution immunocytochemistry and confocal microscopy. Furthermore 
chimeric GABAa receptor (3/y2 subunits are constructed and used to directly 
compare and demonstrate the targeting properties of the y2 subunit intracellular 
domain and TM4 to that of the (33 subunit. Furthermore, this system is used to 
identify specific amino acids signals within the y2 subunit that may regulate the 
endocytic membrane trafficking of heteromeric GABAa receptors.
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Results
To allow the study o f GABAa receptor endocytosis recombinant GABAa receptors, 
where the a l  or the y2L subunits contained an N-terminus 9E10 (myc) epitope 
(EQKLISEEDL), were used together with GFP-tagged endosomal markers. 
Addition o f this epitope at this extracellular position is functionally silent with 
regard to both receptor physiology and pharmacology (Connolly et al., 1996). Both 
the a l  and y2L subunits are unable to reach the cell surface when expressed alone 
and depend on co-assembly with (3 subunits while unassembled homomeric 
subunits are retained within the ER (Connolly et al., 1996; Gorrie et al., 1997; 
Bollan et al., 2003). These rules of assembly, therefore ensure that only 
multisubunit receptors are visualised at the cell surface when using an anti-9E10 
antibody under non-permeabilising conditions.
GFP-tagged endosomal markers were used in this study in order to be able to 
identify the endosomal structures in which internalised GABAa receptors were 
localised. Here, GFP-2FYVE was used as a marker for early endosomes, whereas 
GFP-Rab7 was used to visualise late endosomes/lysosomes.
GFP-2FYVE consists o f two Hrs FYVE finger domains in tandem and has been 
shown to be specifically localised to early endosomes where it colocalises with 
EEA1 and transferrin receptor staining (Gillooly et al., 2000). In contrast, no 
visible colocalisation is observed with Golgi compartment or late endosomal 
markers (Gillooly et al., 2000). Interestingly, in cells transfected with GFP-2FYVE, 
endosomes appear to be larger than early endosomes in untransfected cells and 
expression o f GFP-2FYVE has been shown to trap internalised EGF receptors in 
these endosomes thereby inhibiting EGF receptor transport (but not bulk 
endosomal membrane transport) to late endosomal compartments (Petiot et al., 
2003). Therefore, GFP-2FYVE may also act as a reporter for late endosomal 
targeting o f specific cargo.
Rab7 is a small GTPase that has been shown to be necessary for lysosomal 
biogenesis by its ability to cycle between late endosomes and lysosomes (Chavrier
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et al., 1990; Feng et al., 1995; Gruenberg and Stenmark, 2004). GFP-Rab7 has 
been used as a tool for following receptor trafficking (Scott et al., 2004) as well as 
the study o f late endosomal and lysosomal biogenesis (Bucci et al., 2000; Rink et 
al., 2005).
Internalised ap receptors show reduced levels o f  colocalisation with 
GFP-2FYVE compared to apy receptors
HEK293 cells were co-transfected with GFP-2FYVE and either 9E10ocl(33 or 
a lp 3 9E10y2L. Cell surface receptors were labelled under non-permeabilising 
conditions in live cells with monoclonal anti-9E10 antibody at 4°C and allowed to 
internalised for 30min as described previously (Connolly et al., 1999a,b; Kittler et 
al., 2000). Following this, any remaining surface bound antibody was removed in 
an acid (pH4) wash, whereas 9E10 labeled internalised receptors were protected 
from this stripping procedure. Cells were then fixed, and internalised 9E10 labeled 
receptors were detected using a Texas-Red conjugated anti-mouse secondary 
antibody. Cells were examined using confocal microscopy as described in the 
materials and methods section. Colocalisation levels o f internalised receptors were 
then quantified using MetaMorph® software and expressed as a correlation factor 
or as the percentage o f internalised receptor signal overlapping the signal from 
GFP-2FYVE (see materials and methods).
Both 9E10a lp 3  and a lp 3 9E10y2L containing receptors were found to internalise 
within 30 min as shown by the punctate red staining remaining after surface 
receptors were stripped using acidic conditions (Fig. 3.1 A-B). Quantitative 
analysis revealed that 32.1% ± 3 o f internalised 9EIOa lp 3  containing receptors are 
found in GFP-2FYVE positive endosomes. This low level of colocalisation was 
also demonstrated by a correlation factor of -0.43 ± 0.04 between P3 and 
GFP-2FYVE (Fig. 3.1 C-D). In contrast, 65.1% ± 5 o f internalised receptors 
containing a l,P 3 , and 9E10y2L subunits were found in GFP-2FYVE positive 
endosomes (Fig. 3.1 C). This highly significant (P<0.01) increase in colocalisation
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Figure 3.1: The endocytosis of a ip 3  and a1p3y2 receptors in HEK293 cells 
expressing GFP-2FYVE. Antibody feeding experiments were carried out in 
HEK293 cells co-expressing a1p3 (A) or a1p3y2L (B) and the  early endosom al 
marker GFP-2FYVE. (C) Quantitative analysis shows 32.1% ± 3 of internalised a1 P3 
and 65.1% ± 5 of a1p3y2L receptors in GFP-2FYVE positive endosom es. This 
significant (P<0.01) enhancem ent in the colocalisation with GFP-2FYVE endosom es 
conferred by the presence of the y2L subunit was observed as a positive shift in the  
correlation factor (D).(** P<0.01/T-test;n=5 (ap) n=8 (apy))
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compared to a  1(33 containing receptors was also confirmed by an increase in the 
correlation factor (-0.12 ± 0.07; Fig. 3.1 D).
The above results confirm that GABAa receptors can undergo constitutive 
endocytosis in the absence of the y2 subunit (Connolly et al., 1999). However, this 
subunit confers an enhanced colocalisation with the early endosomal marker 
GFP-2FYVE on internalised GABAa receptors. Given the ability o f GFP-2FYVE 
to accumulate receptors destined to late endosomes in GFP positive endosomes, the 
above results indicate that GABAa receptors containing the y2L subunit may be 
destined for sorting to a late endosomal/lysosomal pathway. Together, these results 
suggest that the y2 subunit may specifically regulate the endocytic fate o f GABAa 
receptors.
Internalised al(33y2 receptors are localised in late endosomes
To address whether internalised GABAa receptors comprised of 9E10al[33 or al(33 
and 9E10y2L subunits were destined for lysosomal degradation antibody feeding 
experiments were carried out in HEK293 cells expressing GFP-Rab7.
Similarly to the results obtained with GFP-2FYVE, internalised al|33 containing 
receptors showed low levels o f colocalisation (43.3% ± 4; correlation factor -0.35 ± 
0.05) with the late endosomal/lysosomal marker GFP-Rab7 (Fig. 3.2). In contrast, 
there was a significant (P<0.01) increase in the percentage o f internalised al(33y2L 
containing receptors found in GFP-Rab7 positive endosomes (67.7 ± 3) as well as a 
significant increase in the correlation factor (-0.11 ± 0.04) compared to results 
obtained with a  1(33 containing receptors (Fig. 3.2). Together these results suggest 
that the y2L  subunit confers a specific lysosomal targeting pathway on internalised 
receptors.
The above results revealed a critical role of the y2 subunit in targeting internalised 
GABAa receptors to late endosomes under basal conditions in HEK293 cells. In 
keeping with these observations, a role for the y2 subunit in modulating GABAa
GFP-Rab7
5 jam
B
a ip 3  a l  p3y2L a ip 3  aip3y2L
Figure 3.2: The endocytosis of a ip 3  and a1p3y2 receptors in HEK293 cells 
expressing GFP-Rab7. Antibody feeding experiments were carried out in HEK293 
cells co-expressing a1p3 (A) or aip3y2L (B) and the late endosom al marker 
GFP-Rab7. (C, D) Quantitative analysis shows 43.3% ± 4 of internalised a1p3 in 
GFP-Rab7 positive endosom es and a correlation factor of -0.35 ± 0.05. In contrast, 
internalised aip3y2L receptors and GFP-Rab7 have a correlation factor o f -0.11 ± 
0.04, w here 67.73% of internalised receptors are overlapping GFP-Rab7 
endosom es. (** P<0.01,T-test;n=16 (ap),n=26 (aPy))
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receptor endocytosis has previously been suggested (Connolly et al., 1999 ). This 
study demonstrated the ability o f alp3y2L  containing receptors to constitutively 
internalise and recycle back to the plasma membrane. However, this study did not 
provide any insights on the proportion of receptors that were recycled or whether 
GABAa receptors could be targeted for lysosomal degradation. The above results 
demonstrate that a significant proportion o f internalised GABAa receptors are 
targeted for lysosomal degradation. Furthermore, they establish a distinct role for 
the y2 subunit in conferring the lysosomal targeting o f GABAa receptors. However, 
it is not clear what the molecular determinants for this sorting decision may be.
Creating a chimeric system to identify the molecular determinants o f  
endocytic sorting
The large intracellular loop of G A B A a receptor subunits is the site for a number of 
post-translational modifications as well as the binding site for various associated 
proteins that play a role in the trafficking o f G A B A a receptors (Kittler and Moss,
2003). In addition to the intracellular loop, the TM4 of the y2 subunit has also been 
shown to play an important role in receptor trafficking (Alldred et al., 2005). Given 
the importance o f these subunit domains in receptor trafficking, it is possible that 
these domains contain the molecular determinants important for the specific y2 
subunit dependent endocytic sorting of G A B A a receptors. Expression of the 
G A B A a receptor (33 subunit in heterologous expression systems results in the 
formation o f homomeric chloride permeable channels at the cell surface in a 
manner dependent o f its N-terminus (Taylor et al., 1999). Therefore, a p3-y2 
chimera consisting o f a p3 backbone (N-terminus and TM1-3) with an N-terminal 
9E10 tag and the intracellular loop o f the y2 subunit as well as its TM4 was created 
(Fig. 3.3). This p3-y2 chimera allowed for a direct comparison between p3 and y2 
subunit dependent endocytic trafficking using a monomeric system and to test 
whether the intracellular loop and TM4 o f the y2 subunit were important in the 
endocytic sorting o f G A B A a receptors.
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9E10
P3
C1
N-Term-TM1-3
N-Term-TM1-3
VNY1FFGRGPQRQKKLAEKTAKAKNDRSKSE1NRVDAHGNILLAPMDVHNEMNEVAGSVGD 
FDNSGIQYRKQSMPKEGHGRYMGDRSIPHKKTHLRRRSSQLKIKIPDLTDVNAIDR TM4
318 412
TGHYFVSNRKPSKDKDKKKKNPLLRMFSFKAPTIDIRPRSATIQMNNAT
HLQERDEEYGYECLDGKDCASFFCCFEDCRTGAWRHGRIHIRIAKMDS |-----1 TM4
Figure 3.3: Schematic diagram of chimera 1 (C1).C1 consists of a GABAa receptor 
p3 subunit backbone (N-terminus and TM1-3) containing an N-terminal 9E10 tag, 
and the  intracellular loop and TM4 of the GABAa receptor y2 subunit.
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Figure 3.4: Expression of (33 and Cl in both HEK293 cells and cultured 
hippocampal neurons. Antibody labeling experiments were carried out in HEK293 
cells (A) and cutured hippocampal neurons (B) expressing p3 or Cl. Cell surface 
receptors were labelled with anti-9E10 antibody and allowed to internalise for 60 min. 
Remaining surface receptors were labelled with FITC conjugated anti mouse antibody. 
Internalised receptors were labelled with Texas Red conjugated antibody.
To test if  the {33/72 chimera (termed chimera 1 (C l)) was able to reach the cell 
surface and in addition to undergo constitutive endocytosis in a manner similar to 
heteromeric GABAa receptors, a modified version o f the antibody feeding 
experiment, described above, was carried out. In HEK293 cells or cultured 
hippocampal neurons transfected with (33 or C l, surface expressing receptors were 
labeled with anti 9E10 antibody and then allowed to internalise at 37°C for 30min. 
Surface receptors were labeled using a FITC conjugated secondary antibody 
whereas a Texas-Red conjugated secondary antibody was used to label internalised 
receptors after permeabilisation o f the cells. These antibody feeding experiments 
demonstrated that C l was able to reach the cell surface and undergo constitutive 
endocytosis in both HEK293 cells and hippocampal neurons (Fig. 3.4).
Chimera 1 colocalizes with GFP-2FYVE
Similar to the experiments described above, antibody feeding experiments were 
carried out in HEK293 cells co-expressing GFP-2FYVE and Chimera 1 (C l) or (33. 
The (33 subunit was found to constitutively internalize and similar to a  1(33 
containing receptors 41.3% ± 4 of internalised (33 was found in GFP-2FYVE 
positive endosomes (Correlation factor -0.34 ± 0.04; Fig. 3.6). In contrast, a 
substantially higher percentage of internalised C l was found overlapping 
GFP-2FYVE positive endosomes (69.6% ± 2). This highly significant (PO .O l) 
increase was confirmed by an increase in the correlation factor (0.09 ± 0.04; Fig. 
3.5).
Chimera 1 is targeted to late endosomes
Analogous to the results obtained with GFP-2FYVE, antibody feeding experiments 
in HEK293 cells expressing GFP-Rab7 and Cl or (33 revealed a significant 
enhancement in the colocalisation levels of internalised C l (60.2% ± 2) compared 
to results obtained with internalised (33 subunit (29.9% ± 4; Fig. 3.6). Together, 
these results indicate that the intracellular loop and/or the TM4 of the y2 subunit 
contains a molecular signal to confer the lysosomal targeting o f GABAa receptors.
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Figure 3.5: The endocytosis of (33 and C1 in HEK293 cells expressing 
GFP-2FYVE. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing p3 (A) or Cl (B) and the early endosomal marker GFP-2FYVE. (C, D) 
Quantitative analysis shows 41.3% ± 4 of internalised p3 colocalised with 
GFP-2FYVE positive endosom es and a exhibits a correlation factor of -0.3389. In 
contrast, 69.6% ± 2 of internalised C1 is found in GFP-2FYVE positive endosom es 
and this is reflected by a significant increase (+ 0.43) in the  correlation factor 
com pared to p3. (** P<0.01 ,T-test; n=29 (p3), n=34 (Cl))
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Figure 3.6:The endocytosis of (33 and Cl in HEK293 cells expressing GFP-Rab7.
Antibody labelling experim ents were carried out in HEK293 cells co-expressing (33 
(A) or Cl (B) and the late endosom al marker GFP-Rab7. (C, D) Quantitative analysis 
shows 29.9% ± 4 of internalised 03 colocalised with GFP-Rab7 positive endosom es 
and the two channels exhibit a correlation factor o f -0.45 ± 0.03. In contrast, 60.2% 
± 2 of internalised C1 is found in GFP-2FYVE positive endosom es and this is 
reflected by a significant increase (+ 0.31) in the correlation factor com pared to  03. 
(** P<0.01,T-test;n=12 (03),n=27 (Cl))
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Furthermore, these results establish a single subunit chimeric system as an 
appropriate method for identifying the molecular determinants o f the endocytic 
sorting o f y2 subunit containing GABAa receptors.
Chimera 1 co-localises with GFP-2FYVE when co-expressed in 
hippocampal neurons.
To examine the relevance o f these recombinant experiments the targeting of (33 and 
C l was investigated in cultured hippocampal neurons. Antibody feeding 
experiments were carried out in hippocampal cells co-expressing GFP-2FYVE and 
C l or (33. Antibody bound [33 and C l were allowed to internalise for 30min at 37° 
C. Antibody bound surface receptors were detected using Cy-5 conjugated anti 
mouse antibody. Cells were then permeabilised and internalised receptors were 
detected using a Texas-Red conjugated anti mouse antibody. Internalised (33 was 
found along the dendrites and in the cell body (Fig. 3.7 A). C l was also found 
along dendrites but was highly concentrated in large structures inside the cell body 
(Fig. 3.7 B). Upon closer examination of internalised receptors with the early 
endosomal marker GFP-2FYVE high levels o f internalised C l were found 
overlapping GFP-2FYVE, whereas internalised (33 was not found in GFP positive 
endosomes (Fig. 3.7 C-D). These results suggest that (33 and C l may follow in 
neurons a similar endocytic pathway as a  1 (33 and al(33y2L receptors expressed in 
HEK293 cells.
A tyrosine m otif is not necessary fo r GABAa receptor lysosomal 
targeting
The above experiments with (33 and Cl demonstrate that the intracellular loop and 
TM4 of the y2 subunit is sufficient to determine the endocytic sorting o f GABAa 
receptors. A number o f molecular signals have been shown to play role in the 
endocytic sorting of membrane proteins, the most predominant o f them being the 
tyrosine m otif Y X X 0, where 0  represents any bulky hydrophobic amino acid (see 
intro; Bonifacino and Traub, 2003). Analysis o f the protein sequence of the y2
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Figure 3.7: Internalisation of (33 and Cl in hippocampal neurons expressing 
GFP-2FYVE. Antibody labeling experiments were carried out in m ature 
hippocampal neurons transfected with GFP-2FYVE and (33 or Cl. Cell surface 
receptors were labelled with anti 9E10 antibody and allowed to internalise for 60 
min. Remaining surface receptors were labelled with Cy5 conjugated anti m ouse 
antibody. Internalised receptors were labelled with Texas Red conjugated antibody. 
Internalised (33 is found along dendrites and in small aggregates in the cell body (A) 
where it does not colocalise with GFP-2FYVE (C). Internalised C1 is found in large 
aggregates concentrated in the  cell body (B) where it is highly colocalised with 
GFP-2FYVE (D).
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intracellular loop revealed the presence of a classical tyrosine based internalization 
and endocytic sorting signal which is absent in the intracellular loops of a  and p 
subunits. In order to address whether this m otif could play a role in the endocytic 
sorting o f GABAa receptors, a mutated version o f C l was used together with the 
early endosomal marker GFP-2FYVE.
Y367 in C l was mutated using site directed mutagenesis to an alanine residue, a 
mutation that has been previously shown to abolish tyrosine based signal function 
in other receptors (Williams and Fukuda, 1990; Haucke and de Camilli, 1999; Li et 
al., 2000). In HEK293 cells transfected with C1Y367A, surface expressing receptors 
were labeled with anti 9E10 antibody and then allowed to internalise at 37°C for 
30min. Surface receptors were labeled using a FITC conjugated secondary 
antibody whereas a Texas-Red conjugated secondary antibody was used to label 
internalised receptors after permeabilisation o f the cells. These antibody feeding 
experiments demonstrated that C1Y367A was able to undergo constitutive 
endocytosis suggesting that this tyrosine m otif is not necessary for the 
internalisation o f the y2 subunit (Fig. 3.8).
Similar antibody feeding experiments were carried out to investigate the 
accumulation of C1Y367A in GFP-2FYVE positive endosomes. Quantitative analysis 
revealed that 73.9 ± 4% o f internalised C1Y367A is found in GFP-2FYVE positive 
endosomes expressed in HEK293 cells (Fig. 3.9). This high degree of 
colocalisation was confirmed by the positive correlation factor (0.11 ± 0.06). These 
results were highly significant (P<0.01) compared to those obtained with the p3 
subunit, but did not show a significant change compared to C l. These results 
suggest that Y367 does not play a significant role in determining the endocytic 
sorting fate o f y2 containing GABAa receptors under basal conditions at least in 
HEK293 cells.
Chimeras 2-5 do not accumulate in GFP-2FYVE endosomes
The above results suggest that an alternative late endosomal/lysosomal targeting 
signal must exist within the intracellular loop or TM4 of the y2 subunit. In order to
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A HYFVSNRKPSKDKDKKKKNPLLRMFSFKAPTIDIRPRSATIQMNNATH C 
LQERDEEYGYECLDGKDCASFFCCFEDCRTGAWRHGRIHIRIAKMDS
Y367A
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Figure 3.8: Expression of C lY367A in HEK293 cells. (A) Sequence of the intracellular 
loop of th e  y2S subunit. A classic tyrosine (YXX0) motif is highlighted in red. (B) 
Schematic diagram of C1Y367A. (C) C1Y367A was able to  reach the cell surface (green) 
and undergo constitutive endocytosis (red) as dem onstrated by antibody feeding 
experiments.
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Figure 3.9: The endocytosis of C1Y367A in HEK293 cells expressing 
GFP-2FYVE. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing p3 (A), Cl (B), or C1Y267A (C) and the  early endosomal marker 
GFP-2FYVE. (D) Quantitative analysis shows a significant difference in the  
percentage of internalised C1Y267A (73.9 ± 4)colocalised with GFP-2FYVE com pared 
to  p3 (41.3 ± 4) but not C1 (73.83 ± 3.9). (D) This difference in th e  colocalisation 
levels betw een p3 and C1Y367A is further confirmed by a significant increase in 
correlation factor with GFP-2FYVE. (** P<0.01, T-test; n=29, 34, 22 for p3, C l, and 
C i y267a respectively)
P 3 TM4N-Term-TM1-3
iGPQRQKKLAEKTAKAKNDRSKSEINRVDAHGNILLAPMDVHNEMNEVAGSVGD
DNSGIQYRKQSMPKEGHGRYMGDRSIPHKKTHLRRRSSQLKIKIPDLTDVNAIDR
C1
318 412
TM4N-Term-TM1-3 TGHYFVSNRKPSKDKDKKKKNAPTIDIRPRSATIQMNNATHLQERDEEYGYECLDGKDCASFFCCFEDCRTGAWRHGRIH1RIAKMDS
C2
346 412
TM4N-Term-TM1-3 VNYIFFGRGPQRQKKLAEKTAKAKNDRS
TGAPTIDIRPRSAT1QMNNATHLQERDEEYGYECL
DGKDCASFFCCFEDCRTGAWRHGRIHIRIAKMDS
C3
365 412
N-Term-TM1-3 VNYIFFGRGPQRQKKLAEKTAKAKN TGHLQERDEEYGYECLDGKDCASFF DRSKSEINRVDAHGNILLAPMDTG CCFEDCRTGAWRHGRIHIRIAKMDS TM4
C4
384 412
N-Term-TM1-3 VNYIFFGRGPQRQKKLAEKTAKAKNDRSKSEINR TGASFFCCFEDCRTGA VDAHGNILLAPMDVHNEMNEVAGSVGDTRNSA WRHGRIHIRIAKMDS TM4
C5
406 412
N-Term-TM1-3 VNYIFFGRGPQRQKKLAEKTAKAKNDRSKSEiNRVDAHGNILLAP TGRIA MDVHNEMNEVAGSVGDTRNSAISFDNSGIQYRKQSMPKEGHGR KMDS TM4
Figure 3.10: Schematic diagram of p3/y2 chimeras. The large intracellular loop 
and TM4 of the GABAa receptor p3 subunit were substituted fully or partly with tha t 
oftheGABAA receptor y2 subunit
96
Figure 3.11: Expression of p3 and chimeras 1-5 in HEK293 cells. Antibody 
labelling experiments were carried out in HEK293 cells expressing 9E10p3 or 
chimeras 1-5. Surface expression was detected in unpermeabilised cells using FITC 
conjugated anti mouse antibody. Internalised receptors were labelled after triton 
permeabilisation using Texas Red conjugated anti mouse antibody.
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Figure 3.12: Expression of p3 and chimeras 1-5 in hippocampal neurons.
Antibody feeding experiments were carried out in m ature hippocampal neurons. 
Cell surface receptors were labelled with 9E10 anti myc antibody and allowed to 
internalise for 60 min. Remaining surface receptors were labelled with FITC 
conjugated anti mouse antibody. Internalised receptors were labelled with Texas 
Red conjugated antibody.
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identify the possible molecular determinants o f endocytic sorting o f GABAa 
receptors four new chimeras were created. Chimeras 2-5 (C2-5) consist of amino 
acid substitutions where the N-terminal amino acids o f the 72 subunit intracellular 
loop are replaced with those o f the (33 subunit (Fig. 3.10).
To test the ability of all the chimeras to access the cell surface and undergo 
constitutive endocytosis, antibody feeding experiments were carried out in both 
transfected HEK293 and cultured hippocampal neurons as shown above. Similar to 
the (33 subunit and C l, C2-5 were able to reach the cell surface and internalise in a 
constitutive manner in both HEK293 cells (Fig. 3.11) and cultured hippocampal 
neurons (Fig. 3.12).
In order to assess the endocytic pathway that C2-5 followed antibody feeding 
experiments were carried out in HEK293 co-expressing GFP-2FYVE and (33 or 
C l -5. After allowing surface labeled chimeras to undergo constitutive endocytosis 
for 30min, internalised receptors were labeled with a Texas-Red conjugated 
secondary antibody and imaged using confocal microscopy (Fig. 3.13). 
Quantitative analysis o f the degree of colocalisation between the different chimeras 
and GFP-2FYVE revealed that unlike C l, all other chimeras created resulted in 
significantly (PO .O l) lower levels of colocalisation with GFP-2FYVE positive 
endosomes (Fig. 3.13 B-C). 37.7% ± 8 of C2, 38.2% ± 5 o f C3, 44.3% ± 4 o f C4 
and 26.3% ± 4 o f C5 were found in GFP-2FYVE positive endosomes. These levels 
o f colocalisation were furthermore confirmed by significantly lower correlation 
factors compared to C 1. However, the levels of colocalisation obtained with C2-5 
were not significant compared to those obtained with internalised (33 subunits.
A 20 amino acid stretch is required for the lysosomal 
targeting o f GABAa receptors
C l consists o f a (33 backbone and the intracellular loop of the 72 subunit as well as 
TM4. In contrast C2 differs from Cl in that the first 20 amino acids of the 
intracellular loop o f the 72 subunit have been substituted with those of (33 (Fig.
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3.10). This 20 amino acid substitution was enough to reduce the accumulation of 
C2 in GFP-2FYVE endosomes. Given the functional consequences o f GFP-2FYVE 
expression and the results obtained with (33 and C l or a  1(33 and al(33y2L 
receptors, this observation indicated that these 20 amino acids may be responsible 
for the lysosomal targeting o f y2 subunit containing GABAa receptors. In order to 
confirm that C2 was not targeted for lysosomal degradation, antibody feeding 
experiments were carried out in HEK293 cells expressing (33, C l, or C2 and the 
late endosomal/lysosomal marker GFP-Rab7 (Fig. 3.14). Quantitative analysis 
showed that 30.2% ± 4 of internalised C2 was found in GFP-Rab7 positive 
endosomes. This was confirmed with a low correlation factor of -0.50 ± 0.04. 
These results showed a highly significant (P<0.01) reduction in the overlap with 
late endosomes o f internalised C2 compared to those obtained with C l but not (33 
(Fig. 3.14).
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Figure 3.13: The endocytosis of (33 and C l-5 in HEK293 cells expressing 
GFP-2FYVE. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing (33 or C1-5 (red) and the early endosomal marker GFP-2FYVE (A). 
Quantitative analysis shows a low percentage of internalised (33 and C2-5 
colocalised with GFP-2FYVE positive endosom es (C) and a low correlation factor (D) 
com pared to C l. (** P<0.01, T-test; n=29, 34, 10, 16, 10, 13 (33, Cl, C2, C3, C4, C5 
respectively)
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Figure 3.14: The endocytosis of (33, Cl and C2 in HEK293 cells expressing 
GFP-Rab7. Antibody feeding experiments were carried out in HEK293 cells 
co-expressing (33 (A), Cl (B) or C2 (C) and the  late endosomal marker GFP-Rab7. 
Quantitative analysis shows a low percentage of internalised p3 and C2 colocalised 
with GFP-Rab7 positive endosom es (D) and a low correlation factor (E). In contrast, 
a high percentage of internalised C1 is found in GFP-Rab7 positive endosom es (D) 
and this is reflected by a significant increase in the correlation factor com pared to  
P3 (E).(** P<0.01 ,T-test;n=12,27,15 for p3,Cl,C2 respectively)
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Discussion
The endocytosis of GABAa receptors has been an active area o f research for the 
past decade. Multiple studies have shown GABAa receptors to internalise in a 
clathrin and dynamin dependent manner in both heterologous expression systems 
and cultured neurons (Kittler et al., 1999, 2000; van Rijnsoever et al., 2005; 
Herring et al., 2003). Importantly, this mechanism has been shown to play a role in 
regulating inhibitory synaptic strength.
The molecular mechanisms underlying the endocytosis of GABAa receptors are 
begininng to be understood. Interestingly the majority o f data obtained on GABAa 
receptor endocytosis involves the (3 subunits. Although both (3 and y subunits have 
been shown to bind the clathrin adaptor protein AP2, a binding site has only been 
identified on the (3 subunit (Kittler et al., 2005). Interestingly this site overlaps a 
conserved phosphoryolation site in all [3 subunits and the interaction with AP2 has 
been shown to be negatively regulated by phosphorylation (Kittler et al., 2005). In 
addition, the regulation o f the endocytic sorting o f GABAa receptors has been 
recently shown to depend on the expression o f HAP1, a protein that has been 
shown to regulate GABAa receptor recycling by its interaction with the (3 subunit.
The y2 subunit o f GABAa receptors has been shown to be o f critical importance 
for multiple aspects o f GABAa receptor functional expression in addition to both 
receptor physiological and pharmacological properties. Production of GABA gated 
channels is achieved upon expression of a  and (3 subunits, however, the co­
expression o f the y2 subunit is necessary to confer benzodiazepine sensitivity to 
these channels and increases their single channel conductance (Pritchett et al.,
1989). Furthermore it has also been proposed that the y2 subunit is necessary for 
the post-synaptic targeting and clustering o f GABAa receptors (Essrich et al., 1998; 
Alldred et al., 2004).
Despite the extensive studies on GABAa receptor endocytosis very little is known 
on the role that the y2 subunit plays as a determinant of this process. Initial studies
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have already suggested that the y2 subunit may play a role in the endocytic 
pathway (Connolly et al., 1999; Kittler et al., 2000). However, whether this subunit 
directly regulates the rate of receptor endocytosis or the trafficking o f GABAa 
receptors within the endocytic pathway remains to be established.
y2 containing GABAa receptors have been previously reported to recycle back to 
the plasma membrane upon internalisation (Connolly et al., 1999). Furthermore, 
internalised y2 containing GABAa receptors have been observed associated with 
the postsynaptic density where they overlap with gephyrin (van Rijnsoever et al.,
2004). In the present study, however, a significant proportion o f y2 containing 
GABAa receptors were shown to be destined for lysosomal degradation. In 
contrast, the majority of internalised GABAa receptors lacking the y2 subunit were 
not found in late endosomes and are most probably recycled back to the plasma 
membrane. These result suggest that the y2 subunit contains an amino acid motif 
capable o f conferring late endosomal/lysosomal targeting on to GABAa receptors.
In order to further investigate the molecular signals that may determine this 
lysosomal targeting o f y2 containing G A B A a receptors a chimeric system was 
created. The control subunit ((33) was shown to follow a similar endocytic sorting 
fate as those G A B A a receptors consisting of a l  and (33 subunits alone. In contrast, 
a chimera where the (33 subunit intracellular domain and TM4 has been exchanged 
for that of the y2 subunit (C l) followed a late endosomal/lysosomal targeting 
pathway much like al(33y2 containing receptors. These results were observed in 
both HEK293 cells and cultured hippocampal neurons, establishing (33 and C l as 
adequate representatives of a  1(33 and al(33y2 containing receptors respectively.
The intracellular loop of the y2 subunit contains a Y X X 0 sequence motif. Y X X 0 
is a tyrosine based signal that has been implicated in the internalisation o f various 
membrane proteins, including the NR2B subunit o f NMD A receptors, by its ability 
to bind AP2 (Roche et al., 2001; Bonifacino and Traub, 2003). In addition, Y X X 0
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signals have also been implicated in further trafficking events such as lysosomal 
targeting from endosomes (Bonifacino and Traub, 2003; Williams and Fukuda,
1990). The possible role o f this tyrosine based sorting signal found within the y2 
subunit intracellular loop was investigated using a mutated version o f C l. 
Surprisingly, C1Y367A mutant was not only found to internalise, but internalised 
C i Y367A was founci to accumulate in GFP-2FYVE positive endosomes. The degree 
of colocalisation o f C1Y367A with GFP-2FYVE was significantly different to the 
levels obtained with internalised (33, but not to those obtained with internalised C l. 
Given the ability o f GFP-2FYVE to accumulate in early endosomes internalised 
receptor cargo destined for late endosomes (Petiot et al., 2003), these results 
suggest that Y367 does not play a role in the late endosomal/lysosomal targeting of 
GABAa receptors under basal conditions in F1EK293 cells.
A new set of chimeras was created in order to identify the region within the y2 
intracellular loop responsible for the late endosomal/lysosomal targeting of y2 
containing GABAa receptors. Antibody feeding experiments in HEK cells 
overexpressing the chimeras and GFP-2FYVE and quantitative confocal 
microscopy revealed that only C l was able to behave like al(33y2L containing 
receptors and show a significant proportion o f internalised receptors accumulated 
in GFP-2FYVE positive endosomes. These results were further confirmed using 
the late endosomal/lysosomal marker GFP-Rab7.
C2 showed a significant reduction in the levels o f internalised receptor found in 
late endosomes compared to the results obtained with C l. Interestingly C l and C2 
differ in their sequence by 20 amino acids in the N-terminus of the intracellular 
loop. These results suggested that the first 20 amino acids o f the y2 subunit 
intracellular loop contained a motif required for late endosomal/lysosomal 
targeting.
The degree o f late endosomal/lysosomal targeting achieved with y2 containing 
GABAa receptors in HEK293 cells is unlikely to occur in neurons. Previous
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studies have revealed that the majority of internalised y2 containing GABAa 
receptors are found in the postsynaptic density where the presence of late 
endosomes is unlikely (van Rijnsoever et al., 2004). In addition, quantitative 
biotinylation experiments in neurons have reported that only a small proportion of 
all (33 containing GABAa receptors are degraded over time (Kittler et al., 2004b). 
The previously reported studies on GABAa receptor internalisation and the results 
obtained in this study therefore suggest the possibility that strict regulatory 
mechanisms may exist in neurons to specifically determine the y2 subunit 
dependent endosomal sorting o f internalised GABAa receptors. It would therefore 
be interesting to elucidate any regulatory signals within the 20 amino acid stretch 
responsible for the degradation o f y2 containing GABAa receptors.
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Introduction
In the previous section the sorting fate o f internalised <xlp3 and aip3y2L  
containing GABAa receptors was investigated in HEK293 cells. GABAa receptors 
composed of a l ,  |33, and y2L subunits were found to constitutively internalise with 
significant proportion being targeted to late endosomes. In constrast, receptors 
composed o f a l  and |33 subunits were also found to internalise in a constitutive 
manner, but the vast majority of internalised receptors were not targeted to late 
endosomes. These results suggest that the y2 subunit is likely to play a specific role 
in regulating the late endosomal/lysosomal targeting o f internalised GABAa 
receptors. Further analysis using p3/y2 chimeras and quantitative confocal 
microscopy, allowed for the identification of a 20 amino acid region within the 
intracellular loop o f the GABAa receptor y2 subunit adjacent to TM3, responsible 
for the late endocytic targeting o f GABAa receptors. Previous findings on GABAa 
receptor internalisation kinetics suggests that the endocytic sorting fate of GABAa 
receptors may be tightly regulated (Kittler et al., 2004b). However, no molecular 
determinants for the regulation of GABAa receptor sorting have been identified.
The endocytic sorting fate of internalised transmembrane receptors can be, in part, 
determined by specific amino acid motifs within the intracellular tails o f these 
proteins. Tyrosine based signals have been identified as key internalisation motifs 
by their ability to bind the clathrin adaptor protein AP2 as well as important for the 
targeting to late endosomes from the early/sorting endosome (Bonifacino and 
Traub, 2003). However, the results presented in chapter 3 suggest that at least under 
basal conditions in HEK293 cells a tyrosine motif present in the intracellular loop 
o f the y2 subunit does not appear to participate in the targeting o f GABAa receptors 
to late endosomal/lysosomal structures.
Protein ubiquitination, a process involved in the degradation o f proteins in the 
proteasome, has been recently implicated in the sorting o f cargo within the 
endocytic pathway in both yeast and mammalian cells. Ubiquitin has been 
suggested as a signal for endocytosis for a number o f mammalian receptors
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including the EGF receptor (Joazeiro et al., 1999; Levkowitz et al., 1999; 
Waterman et al., 2002), the epithelial sodium channel (Rotin et al., 2000), E- 
cadherin (Fujita et al., 2002) and potentially glycine receptors (Buttner et al., 
2001). However, the exact mechanisms by which ubiquitination mediates receptor 
internalisation are not understood (DiAntonio and Hicke, 2004). Interestingly, 
ubiquitin has also been suggested as a signal for endocytic sorting into the 
lysosomal pathway. The EGF receptor (Levkowitz et al., 1998), interleukin-2 
receptor (Rocca et al., 2001), CXCR4 receptor (Marchese and Benovic, 2001), (32 
adrenergic receptor (Shenoy et al., 2001), growth hormone receptor (VanKerkhof 
and Strous, 2001) and the LDL receptor related protein (Melman et al., 2002) are 
all sorted into MVBs and the lysosomal pathway in a manner that is dependent of 
ubiquitination. Interestingly, whereas polyubiquitination appears to play a role 
protein degradation at the level of the proteasome, monoubiquitination is required 
for endocytosis and endocytic sorting (Hicke, 2001).
The GABAa receptor (33 subunit has been recently shown to be a target for 
ubiquitination (Saliba et al., 2005). Ubiquitination o f the (33 subunit is important 
for regulating proteasomal degradation of GABA receptors and hence membrane 
insertion. Conversely, ubiquitination of this subunit was not found to be involved in 
the endocytic pathway. However, the possible ubiquitination o f other subunits, 
including the y2 subunit, has not yet been investigated.
GABAa receptor phosphorylation has been implicated in various mechanisms of 
receptor modulation including altering channel kinetics, open time, rate of 
desensitization, sensitivity to pharmacological agents as well as channel receptor 
stability (Brandon et al., 2002; Kittler and Moss, 2003, Kittler et al., 2004b). The 
large intracellular loop o f GABAa receptor subunits has been shown to be the 
target for various protein kinases including PKC, PKA, PKG, CamKII, and Src 
kinase both in vitro and in vivo (Brandon et al., 2002; Kittler and Moss, 2003). In 
particular, the y2 subunit has been shown to be phosphorylated in vitro on residues 
S327 and S343 by PKC (Kellenberger et al., 1992; Krishek et al., 1994) and Y365
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and Y367 by Src kinase (Moss et al., 1995). Importantly, the phosphorylation of 
these residues in heterologous expression systems have produced varied and 
contradicting results ranging from an enhancement in the response to GABA to a 
downregulation o f GABAa receptor function. While these results may reflect a 
specific role for individual kinase isoforms in regulating GABAa receptor 
membrane trafficking (Song and Messing, 2005), it should be noted that the 
majority o f these functional studies are performed at room temperature (18-24°C), 
conditions in which endocytosis and intracellular membrane transport events are 
severely compromised.
Having established a role for the y2 subunit in the endocytic sorting o f GABAa 
receptors and identified a 20 amino acid m otif responsible for this targeting, this 
chapter investigates the possible molecular determinants within these 20 amino 
acids in the endocytosis o f GABAa receptors.
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Results
The ~{2 subunit intracellular loop
The large intracellular loop between TM3 and TM4 of GABAa receptor subunits is 
the site for various protein interactions as well as the site for a number o f post- 
translational modifications including phosphorylation, palmitoylation and 
ubiquitination (Brandon et al., 2002; Kittler et al., 2003; Rathenberg et a l , 2003; 
Saliba et al., 2005). In the previous chapter, a 20 amino acid region within the y2 
subunit intracellular loop was identified to contain the molecular information for 
the enhanced late endosomal/lysosomal targeting y2 subunit containing GABAa 
receptors in HEK293 cells under basal conditions. The aim of the following work 
was to attempt a better mechanistic understanding o f the role of this region in the 
late endosomal/lysosomal targeting of GABAa receptors.
Analysis o f the residues present in this 20 amino acid region within the y2 subunit, 
highlights two interesting observations: Firstly, this region is heavily rich in lysine 
residues (Fig. 4.1 B (red)); secondly, this region also contains residue S327 a 
known target for phosphorylation (Fig. 4.1 B (blue)). This suggested that 
ubiquitination and phosphorylation within this region may be important for 
GABAa receptor sorting. In order to investigate the possible role of these residues 
in the late endosomal/lysosomal targeting o f GABAa receptors, antibody labeling 
experiments were carried out in HEK293 cells expressing mutant versions C 1 and 
heteromeric receptors.
A stretch of lysines regulates GABAa receptor sorting
In order to investigate the possible role o f a stretch o f lysine residues in the 
intracellular loop of the 72 subunit in receptor endocytic sorting, site directed 
mutagenesis was carried out in C l. All 7 lysines (K325, 328, 330, 332, 333, 334 
and 335) present in the first 20 amino acid region of the intracellular loop were 
replaced with arginine, which is a conservative substitution; and the resulting 
construct was termed C1K7R.
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Figure 4.1: The intracellular loop of the y2 subunit. (A) Schematic diagram of the y2 
subunit. (B) Amino acid sequence of the intracellular loop of the y2 subunit. 20 
N-terminal amino acids of the intracellular loop are highllighted in light blue. 
Putative ubiquitination targets are highlighted in red. S327, a known 
phosphorylation site, is highlighted in blue.
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Antibody labeling experiments were carried out in HEK293 cells co-expressing the 
late endosomal/lysosomal marker GFP-Rab7 and (33, C l, or C1K7R. Labeled surface 
receptors were allowed to internalise at 37°C for 60min. Remaining surface 
receptors were stripped in an acid wash, and internalised receptors were detected 
using a Texas-Red conjugated secondary antibody. Confocal analysis revealed that 
similar to C l and (33, C1K7R was able to undergo constitutive endocytosis as 
observed by the red punctate intracellular staining (Fig. 4.2).
However, quantitative analysis showed that, in contrast to internalised C l (60.2% ± 
4), 36.0% ± 5 o f internalised C1K7R was found in GFP-Rab7 positive endosomes. 
The correlation factor between the GFP expression and internalised C1K7R was 
-0.37 ± 0.05 (Fig. 4.2). These levels of colocalisation were significantly (P<0.001) 
lower than those obtained with C l but not compared to those obtained with the (33 
subunit (Fig. 4.2).
In order to investigate whether this mutation may play a role in the endocytic 
sorting o f fully assembled heteromeric GABAa receptors, the same 7 lysines in the 
intracellular loop o f the y2L subunit were mutated to arginines by site directed 
mutagenesis. Antibody labeling experiments were carried out in HEK293 cells co­
expressing GFP-Rab7 and 9E10cxl (33; al(339E1072L or; a lp 3 9E10y2LK7R subunit 
combinations.
Quantitative colocalisation measurements on confocal microscopy images revealed 
that internalised al(33y2L containing receptors showed high levels of colocalisation 
(67.7% ± 3; correlation factor -0.1 ± 0.04) with the late endosomal/lysosomal 
marker GFP-Rab7 (Fig. 4.3). In contrast, there was a significant (P<0.01) decrease 
in the percentage of internalised alp3y2LK7R containing receptors found in GFP- 
Rab7 positive endosomes (32.9 ±7) as well as a significant decrease in the 
correlation factor (-0.4 ± 0.1) compared to results obtained with alp3y2L  
containing receptors (Fig. 4.3). Similar to the results obtained with the chimeric 
system, the degree o f colocalisation between internalised alp3T2LK7R and GFP-
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Figure 4.2: The endocytosis of Cl and C1K7R in HEK293 cells expressing 
GFP-Rab7. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing C1 (A),C1K7R (B) or P3 (C) and the late endosomal marker GFP-Rab 7.(D, 
E) Quantitative analysis shows 60.15 % ± 2 of internalised Cl colocalised with 
GFP-Rab7 positive endosom es and the two channels exhibit a correlation factor of 
-0.14 ± 0.03. In contrast, 36.0% ± 5 of internalised C1K7R is found in GFP-Rab 7 positive 
endosom es and this is reflected by a significant decrease (- 0.22) in the  correlation 
factor com pared to  Cl. However, the results obtained with C1K7R were not 
siginificantly different to  those obtained with the p3 subunit. (** P<0.01 ,T-test; n=27, 
15,12 for C1, C1K7R and p3 respectively.)
114
A alp3y2L GFP-Rab7
/
10|im
B
C
al p3y2 al p3y2K7R a1 p3 a1 p3y2 al P3y2K7R al p3
Figure 4.3: The endocytosis of aip3Y2LK7R in HEK293 cells expressing 
GFP-Rab7. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing a 1p372L (A), a1p3T2LK7R (B) or a lp 3  (C) and the  late endosom al 
marker GFP-Rab 7. (D, E) Quantitative analysis shows 67.7 % ± 3 of internalised 
a1p3Y2L colocalised with GFP-Rab7 positive endosom es and the  two channels 
exhibit a correlation factor of -0.11 ± 0.04. In contrast, 32.9% ± 7 of internalised 
alp3T2LK7R is found in GFP-Rab 7 positive endosom es and this is reflected by a 
significant decrease (- 0.34) in the correlation factor com pared to  a i p 372L. 
However, the results obtained with oc1p3Y2LK7R were not siginificantly different to 
those obtained with the a ip 3  subunit. (** P<0.01,T-test; n=26, 7 ,16  fo a 1p372L, 
a1 P3y2LK7R and a l  p3 respectively.)
Rab7 were not significantly different to those obtained with internalised ocl|33 
containing receptors. Together these results suggest that these 7 lysine residues 
within the intracellular loop o f the y2L subunit are responsible for the late 
endosomal/lysosomal targeting o f internalised a(3y containing GABAa receptors.
The y2 subunit is ubiquitinated
The modification o f lysines by the polypeptide ubiquitin has been described as a 
signal for degradation in the proteasome and the lysosome (Hicke, 1999; Aguilar 
and Wendland, 2003). The revelation that a lysine rich stretch in the intracellular 
loop o f the y2 subunit is responsible for the late endosomal/lysosomal targeting of 
y2 containing GABAa receptors suggested that this subunit may be a target for 
ubiquitination. GABAa receptors have recently been shown to be a substrate for 
ubiquitination on their (33 subunit, although this ubiquitination has been shown to 
be o f importance only within the secretory pathway (Saliba et al., 2005).
In order to investigate the ubiquitination o f the intracellular loop o f the y2 subunit, 
an immunoprecipitation approach was used. Given that the GABAa receptor (33 
subunit can be ubiquitinated, the ubiquitination o f the y2 subunit would be better 
assessed in the absence o f the (33 subunit. However, expression of the y2L subunit 
in heterologous expression systems results in its accumulation in the ER and its 
inability to access the cell surface. Therefore, in order to investigate whether the 
intracellular loop o f the y2 subunit can be ubiquitinated, C l was preferentially used 
as this construct is able to reach the cell surface alone due to its (33 N-terminal 
backbone (Fig. 3.3; Fig. 3.4).
COS cells expressing HA tagged ubiquitin (HA-Ub) and Cl or C1K7R were scraped 
in lysis buffer and sonicated. Membranes were solubilised by addition of SDS to a 
final concentration o f 0.2% and heated to 60°C. Any remaining insoluble 
membranes were solubilised by the addition of triton to a final concentration o f 1% 
and further sonication. Remaining insoluble cellular and nuclear debris was
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removed by centrifugation. 10% of the supernatant was used for protein expression 
analysis whereas the remaining 90% was used for immunoprecipitating C l or 
C1K7R with anti-myc antibody. Precipitates were then resolved using SDS-PAGE 
and analysed by western blotting. Importantly, the use o f HA-Ub allows the 
detection o f covalent modification by ubiquitin using antibodies to HA as 
previously described (Fujita et al., 2002).
Immunoblotting for the presence o f HA-Ub in the immunoprecipitated C l samples 
revealed a high molecular weight smear characteristic of ubiquitinated proteins 
(Fig. 4.4) suggesting that C l is in fact a substrate for ubiquitination. Interestingly, 
the precipitation of C1K7R revelaed a highly significant (PO .O l) decrease in the 
levels o f ubiquitin as determined by densitometry. These results suggest that these 
7 lysines in the intracellular loop of the y2 subunit are found ubiquitinated in 
HEK293 cells.
S327 can also regulate the endocytic sorting of GABAa 
receptors
The results presented above demonstrate a role for the y2 subunit in the late 
endosomal/lysosomal targeting of GABAa receptors. Furthermore a lysine stretch 
is shown to be ubiquitinated and be responsible for the late endosomal/lysosomal 
targeting o f GABAa receptors. In addition to the lysine stretch described above, 
another putative signal for the membrane sorting o f y2 subunit containing GABAa 
receptors is S327.
Given the location of S327 within the endocytic sorting signal o f the y2 
intracellular loop and its possible functional modulation o f GABAa receptor 
expression, it is possible that S327 may also play a role in the endocytic sorting of 
y2 containing GABAa receptors. Below, a mutant version of C l (C1S327A) is used in 
antibody labeling experiments to investigate the possible role o f this residue in the 
late endosomal/lysosomal targeting of y2 subunit containing GABAa receptors.
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Chimera
Figure 4.4: Ubiquitination of C l . Lysates of COS cells expressing HA-Ub alone, or 
co-expressed with C1 or C1K7R were immunoprecipitated with anti-9E10 antibody 
and im m unoblotted against HA. HA levels were quantified by densitom etry and 
normalised to  total expression of the chimeras with levels in control (C l) assigned a 
value of 100%. (** P<0.01 ,T-test; n=3)
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Antibody labeling experiments were carried out in HEK293 cells co-expressing the 
late endosomal/lysosomal marker GFP-Rab7 and 9E10(33, C l, or C1S327A. Labeled 
surface receptors were allowed to internalise at 37°C for 60min. Remaining surface 
receptors were stripped in an acid wash, and internalised receptors were detected 
using a Texas-Red conjugated secondary antibody. Similar to the results obtained 
with C1K7R, confocal analysis revealed that similar to C l and (33, C1S327A was able 
to undergo constitutive endocytosis as observed by the red punctate intracellular 
staining (Fig. 4.5).
Quantitative analysis revealed that 36.6% ± 5 o f internalised C1S327A was found 
overlapping GFP-Rab7 positive endosomes. These levels o f colocalisation were 
significantly (P<0.01) lower to those obtained with C l, which displayed 60.2% ± 2 
of internalised C l in GFP-Rab7 positive endosomes. The correlation factor 
between GFP-Rab7 expression and internalised C1S327A was o f -0.45 ± 0.06, which 
was significantly (P<0.01) lower than that obtained with C l (Fig. 4.5). In contrast, 
the colocalisation levels obtained with C1S327A were not significantly different to 
those obtained with internalised (33 subunit (Fig. 4.5).
In order to investigate whether this mutation could also play a role in the endocytic 
sorting o f fully assembled heteromeric GABAa receptors, S327 in the intracellular 
loop o f the y2L subunit was mutated to an alanine residue by site directed 
mutagenesis. Antibody labeling experiments were carried out in HEK293 cells co­
expressing GFP-Rab7 and 9E10al(33; al(339E10y2L or; al(339E10y2LS327A subunit 
combinations.
Quantitative colocalisation measurements on confocal microscopy images revealed 
that internalised al(33y2L containing receptors showed high levels o f colocalisation 
(67.7% ± 3; correlation factor -0.11 ± 0.04) with the late endosomal/lysosomal 
marker GFP-Rab7 (Fig. 4.6). In contrast, there was a significant (P<0.01) decrease 
in the percentage o f internalised cc1(33y2LS327A containing receptors found in GFP- 
Rab7 positive endosomes (43.6 ± 4) as well as a significant decrease in the
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correlation factor (-0.37 ± 0.04) compared to results obtained with al|33y2L 
containing receptors (Fig. 4.6). Similar to the results obtained with the chimeric 
system, the degree of colocalisation between internalised a l  (33y2LS327A and GFP- 
Rab? were not significantly different to those obtained with internalised a  1(33 
containing receptors. Together these results suggest that S327 is required for the 
late endosomal/lysosomal targeting of internalised a(3y containing GABAa 
receptors.
S327 is necessary for the ubiquitination of GABAa receptors
The results presented above suggest that the late endosomal/lysosomal targeting of 
y2 containing GABAa receptors is dependent on a lysine stretch within the 
intracellular loop of the y2 subunit. In addition this lysine stretch is a substrate for 
ubiquitination, a known signal for endocytic membrane sorting. Furthermore, the 
presence o f S327, a substrate for PKC dependent phosphorylation, is also required 
for the late endosomal/lysosomal targeting of y2 containing GABAa receptors. 
However, whether these two signals act in concert or independently o f each other is 
unclear.
The ubiquitination of lysines occurs in three enzyme mediated steps: activation, 
conjugation and ligation. Substrate recognition is carried out by the ligase enzyme 
type E3 (see introduction, Fig. 1.3). How E3 ligases recognize their targets varies 
can vary among different proteins. However, there are reports for a number of E3 
ligases where substrate recognition occurs by binding phosphorylated (Yaron et al., 
1998; Skowyra et al., 1997; Feldman et al., 1997) or dephosphorylated (Honda and 
Yasuda, 1999) residues. Given the role of S327 in the late endosomal/lysosomal 
targeting o f y2 containing GABAa receptors and its previously characterised effects 
on GABAergic function, it may be possible that S327 can regulate the 
ubiquitination o f the lysine stretch in the intracellular loop o f the y2 subunit.
In order to investigate the possible role of S327 in the ubiquitination of the 
intracellular loop o f the y2 subunit COS cells expressing HA tagged ubiquitin and
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Figure 4.5: The endocytosis of Cl and C1S327A in HEK293 cells expressing 
GFP-Rab7. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing C1 (A),C1S327A (B) or p3 (C) and the late endosomal marker GFP-Rab 
7. (D, E) Quantitative analysis shows 60.2 % ± 4 of internalised Cl colocalised with 
GFP-Rab7 positive endosom es and the two channels exhibit a correlation factor of 
-0.14 ± 0.03. In contrast, 36.6% ± 5 of internalised C1S327A is found in GFP-Rab 7 
positive endosom es and this is reflected by a significant decrease (- 0.31) in the  
correlation factor compared to  C1. However, the  results obtained with C1S327A were 
not siginificantly different to those obtained with the p3 subunit. (** P<0.01,T-test; 
n=27,16,12 for C1, C1S327A and p3 respectively.)
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Figure 4.6: The endocytosis of a1 P3y2LS327A in HEK293 cells expressing 
GFP-Rab7. Antibody labelling experiments were carried out in HEK293 cells 
co-expressing a1p3Y2L (A), a1 p3Y2LS327A (B) or al(33 (C) and the  late endosom al 
marker GFP-Rab 7. (D, E) Quantitative analysis shows 67.7 % ± 4 of internalised 
(x1P3y2L colocalised with GFP-Rab7 positive endosom es and the  two channels 
exhibit a correlation factor of -0.11 ± 0.04. In contrast, 43.6% ± 4 of internalised 
alp3T2LS327A is found in GFP-Rab 7 positive endosom es and this is reflected by a 
significant decrease (- 0.26) in the correlation factor com pared to  oc1p3Y2L. 
However, the results obtained with a1 P3y2LS327A were not siginificantly different to 
those obtained with the a1 p3 subunit. (** P<0.01, T-test; n= 26 ,11,16 for a1 P3t2L, 
a1 P3t2LS327A and a lp 3  respectively.)
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C l, C1K7R or C1S327A were lysed by scraping and sonication in SDS and Triton 
buffer. Lysates were immunoprecipitated with anti-myc antibody and protein A 
sepharose. Precipitates were then resolved using SDS-PAGE and analysed by 
western blotting using monoclonal anti-HA (12CA5) antibody.
Immunoblotting for the presence o f HA-Ub in C l precipitated samples revealed a 
high molecular weight smear characteristic o f ubiquitinated proteins (Fig. 4.7). As 
shown above, the ubquitination levels were significantly reduced when 7 lysines in 
the intracellular loop were mutated. Interestingly, the precipitation of C1S327A also 
revealed a highly significant (P<0.01) decrease in the levels of ubiquitin as 
determined by densitometry. These results suggest that these 7 lysines in the 
intracellular loop o f the y2 subunit are found ubiquitinated in HEK293 cells and 
this ubiquitination is dependent on the presence of S327.
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Figure 4.7: S327 dependent ubiquitination of C l . Lysates of COS cells expressing 
HA-Ub alone, or co-expressed with C1, C1K7R or C1S327A were im m unoprecipitated 
with anti-9E10 antibody and immunoblotted against HA. HA levels were quantified 
by densitom etry and normalised to total expression of the chimeras with levels in 
control (Cl) assigned a value of 100%. (** P<0.01,T-test;n=3).
Discussion
The endocytic sorting o f GABAa receptors is, in part, determined by subunit 
composition. The work presented in this thesis, demonstrates a critical role for the 
y2 subunit in the late endosomal/lysosomal targeting o f internalised GABAa 
receptors. Furthermore, using a chimeric system, a 20 amino acid region 
responsible for the late endosomal/lysosomal targeting o f GABAa receptors was 
identified. In this chapter, site directed mutagenesis was used together with 
antibody labeling experiments and quantitative confocal microscopy in order to 
further elucidate the mechanisms responsible for the late endosomal/lysosomal 
targeting o f y2 containing GABAa receptors.
The ubiquitination of lysines is a well characterised signal for protein degradation 
in the proteasome. More recently, mono-ubiquitination or small ubiquitin chains 
have been recently identified to act as signals for both endocytosis and sorting of 
membrane proteins (Hicke et al., 2001; Di Antonio and Hicke, 2004). The 
mechanisms by which ubiquitin can act as an internalisation signal are not fully 
understood. In constrast, a number of proteins o f the endocytic sorting machinery 
have been shown to contain ubiquitin interacting motifs (UIM), and it is thought 
that the binding o f these motifs to ubiquitin facilitates the trafficking of 
ubiquitinated proteins to late endosomes and consequently lysosomal degradation 
(Dupre et al., 2001; Rocca et al., 2001).
Sequence analysis o f the intracellular loop of the y2 subunit revealed the presence 
of multiple lysine residues within the 20 amino acid region thought to contain a 
signal for late endosomal/lysosomal targeting o f GABAa receptors. All 7 lysines 
within this region were mutated by site directed mutagenesis to arginine residues in 
both C l and the y2L GABAa receptor subunit. These mutations resulted in a 
reduction in the levels o f internalised receptor found in GFP-Rab7 late endosomes 
expressed in HEK293 cells.
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In agreement with this, biochemical analysis revealed that the intracellular loop of 
the y2 subunit is a substrate for ubiquitination, and this ubiquitination is severely 
reduced when the 7 lysines within the N-terminal end of the intracellular loop are 
mutated. These results suggest that like some non-neuronal membrane proteins, 
including the EGF receptor (Levkowitz et al., 1998), interleukin-2 receptor (Rocca 
et al., 2001), CXCR4 receptor (Marchese and Benovic, 2001), p2 adrenergic 
receptor (Shenoy et al., 2001), growth hormone receptor (VanKerkhof and Strous, 
2001) and the LDL receptor related protein (Melman et al., 2002), GABAa receptor 
degradation within the endocytic pathway is dependent on the ubiquitination of 
lysine residues within the intracellular domain of the y2 subunit. Importantly, these 
lysines were not found to be necessary for the internalisation of C l or heteromeric 
apy  GABAa receptors, suggesting that ubiquitin plays an exclusive role in the 
membrane sorting but not internalisation o f GABAa receptors. Moreover, these 
results highlight an important role for ubiquitin in GABAa receptor degradation 
outside the proteasome.
In addition to a lysine stretch in the intracellular loop of the y2 subunit, the role of 
S327 in GABAa receptor post endocytic sorting was also investigated. Antibody 
labeling experiments were carried out in HEK293 cells expressing GFP-Rab7 and 
C1S327A or a lp 3 9E10y2LS327A. Interestingly, quantitative analysis of the 
colocalisation levels o f internalised receptors with GFP-Rab7 positive endosomes 
revealed that similar to the results obtained with mutation of the lysine stretch, late 
endosomal/lysosomal targeting was significantly reduced when S327 was mutated.
The ubiquitination o f proteins occurs in three steps mediated by three different 
enzymes: E l (activation), E2 (conjugation) and E3 (ligation). Substrate recognition 
is carried out by E3 type enzymes, which in some cases recognize their targets by 
binding to phosphorylated or dephosphorylated residues (for review see Pickart 
2001). S327 is a known substrate for PKC phosphorylation (Brandon et al., 2002; 
Song and Messing, 2005), and work presented here suggests that mutation of this 
site reduces the late endosomal/lysosomal targeting o f GABAa receptors in a
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similar maimer to the mutation of a lysine stretch. Therefore, a possible role for 
S327 in the ubiquitination of the intracellular loop of the GABAa receptor y2 
subunit was investigated. Interestingly, y2 subunit ubiquitination was found to be 
completely abolished by a single point mutation at S327. These results indicate that 
S327 can regulate the ubiquitination of the y2 subunit and hence the late 
endosomal/lysosomal targeting o f GABAa receptors.
The role of S327 phosphorylation, however, is not fully understood. Evidence in 
heterologous expression systems is contradictory, possibly due to the existence of 
multiple PKC isoforms (Song and Messing, 2005). Whereas phosphorylation of 
S327 by phorbol ester induced PKC activation has been shown to downregulate 
GABAa receptor function (Kellenberger et al., 1992; Krishek et al., 1994), 
phosphorylation o f the same site using the catalytically active domain of PKC 
(PKM) results in an enhancement o f GABAa receptor expression (Lin et al., 1996). 
In hippocampal neurons, evidence suggests that dephosphorylation at this site by 
calcineurin activation results in a downregulation o f GABAa receptor expression at 
the cell surface (Wang et al., 2003). In addition, activation o f PKC by phorbol 
esters results in a downregulation o f GABAa receptor cell surface expression in a 
manner that is independent of receptor phosphorylation (Connolly et al., 1999). 
Given the complications o f PKC activation in heterologous expression systems, it 
is unclear, whether in the endocytic pathway S327 mediates late endosomal/ 
lysosomal sorting in its phosphorylated or dephosphorylated state.
The above results identified ubiquitination as a molecular signal for the degradation 
in the lysosome of y2 containing GABAa receptors. Moreover, S327 was found to 
be necessary for inducing ubiquitination of the y2 subunit, raising the possibility 
that this process may be regulated by phosphorylation. Together these results 
revealed a critical role for receptor post-translational modification by both 
ubiquitination and possibly phosphorylation in the y2 subunit dependent endocytic 
sorting o f GABAa receptors.
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5. Functiona l sign ificance o f m o d u la tin g  
GABAa re c e p to r  en d o cy tic  so r tin g
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Introduction
In the previous chapters, the endocytic sorting fate o f GABAa receptors was 
investigated revealing that GABAa receptors are targeted to late endosomes/ 
lysosomes via a mechanism dependent on the y2 subunit. Using (33/y2 chimeras 
coupled with site directed mutagenesis it was evident that the late endosomal/ 
lysosomal targeting o f GABAa receptors was dependent on the ubiquitination of a 
lysine stretch within the intracellular loop of the y2 subunit. Furthermore the 
ubiqutination of these lysines was shown to be dependent on the presence of S327 
a known phosphorylation site (Kellenberger et al., 1992; Krishek et al., 1994). This 
indicated the possible existence of a mechanism to control GABAa receptor 
ubiquitination dependent upon the phosphorylation state o f S327.
Synapses are able to modify in structure and function in response to stimuli. 
Changes in the efficacy of synapses are important for modulating the input-output 
relationship of neurons, and this plasticity is thought to underlie higher cognitive 
functions such as learning and memory as well as playing a key role in during 
development (Gaiarsa et al., 2002; Kittler and Moss, 2003; Esteban, 2003; 
Collingridge et al., 2004). The efficacy of synaptic transmission can be modulated 
by presynaptic changes and postsynaptic changes. Research into receptor function 
has revealed two main mechanisms for regulating synaptic efficacy: changing 
receptor channel properties with post-translational modification, or regulating the 
number o f receptors accumulated at synapses (Kittler and Moss, 2003; Esteban, 
2003; Collingridge et al., 2004).
In keeping with this, both excitatory and inhbitory receptors have been shown to be 
highly mobile, capable o f altering their number at synapses in response to various 
forms o f stimuli (Kittler et al., 2003; Collingridge et al., 2004). Three distinct 
mechanisms have been shown to play critical roles in changing the number of 
receptors at synaptic sites thereby regulating synaptic efficacy.
A number of studies have described the ability of AMPA, glycine and GABAa 
receptors to dynamically move in and out of synaptic sites by lateral diffusion
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accross the neuronal membrane. Studies on the lateral mobility of receptors 
including AMPA, glycine, and GABAa receptors have revealed that there are 
significant rates of exchange between synaptic and extrasynaptic pools of these 
ligand-gated ion channels (Choquet and Triller, 2003; Dahan et al., 2003; Tardin et 
al., 2003, Thomas et al., 2005, Jacob et al., 2005) and this lateral diffusion has been 
shown to be directly regulated under conditions that result in receptor 
downregulation (Tardin et al., 2003).
In addition, the regulation o f endocytosis has been established as being a potent 
mechanism for altering the number o f receptors found at the cell surface together 
with the efficacy synaptic transmission (Collingridge et al., 2004). A number of 
neuronal receptors, including, AMPA, NMDA, Kainate, Glycine and GABAa 
receptors, have been shown to undergo clathrin mediated endocytosis either 
constitutively or in response to stimuli (Collingridge et al., 2004; Kittler and Moss, 
2003). For GABAa receptors, endocytosis has been shown to occur constitutively 
in cultured neurons, and this has been shown to be inhibited by conditions that 
block clathrin mediated endocytosis. Furthermore, blockade o f GABAa receptor 
internalisation has been shown to cause an upregulation o f GABAergic function 
further confirming the role o f receptor trafficking as a mechanism for altering the 
strength o f inhibitory synapses. Importantly, GABAa receptor internalisation has 
recently been shown to be a dynamically regulated process. GABAa receptor 
endocytosis has been recently been shown to be regulated in a negative fashion by 
receptor phosphorylation and this mechanism has been shown to be of importance 
in the downregulation o f GABAa receptor function in response to D3 receptor 
activation in the nucleus accumbens (Kittler et al., 2005; Chen et al., 2006).
In addition to regulating the lateral diffusion and internalisation of synaptic 
receptors, recent evidence has implicated endocytic sorting as a method for 
dynamically altering receptor cell surface expression. For example, AMPA receptor 
recycling has recently been described as a critical mechanism for altering synaptic 
strength under physiological conditions such as LTP where there is an increase in 
the number of AMPA receptors at the cell surface, which originate from a recycling
130
pool of receptors (Park et al., 2004). The endocytic sorting o f GABAa receptors 
has also recently been highlighted as a potential mechanism for regulating synaptic 
inhibition. The (3 subunits of GABAa receptors have been shown to bind HAP1, 
and overexpression of this protein in hippocampal cells resulted in an increase in 
GABAergic currents compared to mock transfected cells. Furthermore, this 
increase was correlated by an increase in cell surface receptors as demonstrated by 
biotinylation experiments (Kittler et al., 2004b). Interestingly, internalised GABAa 
receptors have been associated with an intracellular pool close to the post-synaptic 
density, suggesting the possible existence o f a reserve pool for dynamically 
increasing the number of receptors at the cell surface (vin Rijnsoever et al., 2005).
Having established the molecular determinants for GABAa receptor endocytic 
sorting this chapter focuses on analysing the possible functional consequences of 
regulating this process with particular attention to changes in the cell surface 
expression levels of GABAa receptors and their accumulation at post-synaptic 
sites.
131
Results
It is evident from the data presented in the preceding chapters that the late 
endosomal/lysosomal targeting of GABAa receptors is largely determined by the 
presence of the y2 subunit. Leupeptin is a generic lysosomal protease inhibitor that 
has previously been used to block lysosomal degradation o f internalised neuronal 
receptors (Ehlers, 2000; Fairfax et al., 2004; Ju et al., 2004; Kittler et al., 2004b). 
Therefore, to address if modifying the lysosomal degradation of GABAa receptors 
can alter their accumulation on the plasma membrane, the effects of leupeptin on 
GABAa receptor function were assessed using electrophysiological, biochemical 
and immuncytochemical approaches.
Leupeptin treatment enhances the functional expression of 
recombinant GABAa receptors in HEK293 cells
The effects of leupeptin on GABAa receptor function were assessed in transfected 
HEK293 cells expressing receptors o f distinct subunit combinations. These 
experiments used patch clamp recordings in the whole cell mode to measure the 
magnitude o f GABA induced currents ( I g a b a )  over time in the presence of non­
saturating concentrations o f agonist (Wooltorton et al., 1997; Connolly et al., 
1999a).
For HEK293 cells expressing GABAa receptors composed of al(33 subunits, I g a b a  
induced by the rapid application o f a non-saturating concentration of agonist (5|iM 
GABA, Woolworton et al., 1997, Connolly et al., 1999a), were well maintained 
over a time course o f 40min at 32-33°C (Fig. 5.1). The introduction of leupeptin 
via intracellular dialysis had little effect on I g a b a  of receptors composed of a  1(33 
subunits over the same recording period. Cells expressing GABAa receptors 
composed o f al(33y2L subunits showed similar well maintained currents under 
control conditions over a 40min time period. However, in contrast to cells 
expressing receptors composed of al(33 subunits, leupeptin produced a significant 
time dependent increase in the magnitude of I g a b a  for cells expressing al(33y2L
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subunits. After 30min leupeptin caused a 102.3% ± 21  increase in I g a b a  compared 
to that observed after 1 min for alp3y2L containing GABAa receptors (Fig. 5.1). 
Together these results suggest that blocking lysosomal degradation specifically 
modulates the functional expression of GABAa receptors composed of aip3y2L  
subunits, which is consistent with the cell biological experiments presented in 
chapter 3 which illustrate a critical role for the y2 subunit in regulating the delivery 
of GABAa receptors to late endosomal/lysosomal structures. Moreover, given that 
both GABAa receptors composed of a l  [33 or alp3y2L  subunits can undergo 
constitutive endocytosis (Fig. 3.1) these results suggest that leupeptin treatment can 
alter GABAergic function without affecting internalisation. Most likely, the 
blockade o f receptor degradation in the lysosome causes an accumulation of 
receptors along the endocytic pathway resulting in a reversal of the sorting decision 
at the level o f the early endosome (Fig. 5.2)
Studies in chapter 4 also identified specific amino acid motifs within the y2 subunit 
that regulate GABAa receptor delivery to late endosomes. Therefore, the effects of 
leupeptin on the function of wild typre receptors composed o f alp3y2L were 
compared to those composed of alp3y2L K7R, and al(33y2LS327A subunit 
combinations. Interestingly, leupeptin treatment resulted in a small albeit 
significant (P<0.05) increase in evoked GABAergic currents from HEK293 cells 
expressing receptors composed of al(33y2LK7R or al(33y2LS327Asubunits (Fig. 5.3). 
However, this increase was significantly lower than that obtained with cells 
expressing al(33y2L subunits, suggesting that mutation of the lysine stretch or 
S327 causes a reduction in the downregulation of GABAa receptors in the 
lysosome.
The results presented above, highlight the importance o f endocytic sorting in 
regulating the number o f receptors at the cell surface. Moreover the data using the 
f2L mutants (y2LK7R or y2LS327A) and leupeptin correlates with the findings that
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Figure 5.1: Analysis of GABA evoked currents in HEK293 cells expressing a l  p3 
or a l p3y2L in the presence or absence of leupeptin. (A) HEK293 cells expressing 
a l and p3 subunits were able to produce stable currents when activated with 
GABA (5jiM). In the  presence of leupeptin (40pM perfused through the  patch 
pipette) there was no significant change in the normalised current com pared to  the 
control. (B) Evoked GABAergic currents in HEK293 cells expressing a1, p3, and y2L 
subunits were significantly increased in the presence of leupeptin over tim e 
showing a 102.3% ± 21 increase in am plitude after 30min.(* P<0.05;T-test)
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Figure 5.2: Effect of leupeptin on GABAa receptor endocytosis.The inhibition of 
GABAa receptor degradation can change th e  sorting decision in the early 
endosom e and increase the levels of receptor recycling (red).
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Figure 5.3: Analysis of GABA evoked currents in HEK293 cells expressing 
a1p3y2L a l  p3y2LK7R or aip3y2LS327A in the presence or absence of leupeptin.
(A) Evoked GABAergic currents in HEK293 cells expressing a l , p3, and y2L subunits 
(black squares) were significantly increased in the  presence of leupeptin over tim e 
showing a 102.3% ± 21 increase in am plitude after 30min. In contrast, the 
normalised current at t=30min was significantly lower in leupeptin trea ted  HEK293 
cells expressing a l  p3y2LK7R (grey triangles) or (B) a l  p3y2LS327A (grey open squares). 
(* P<0.05,T-test)
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these sites within the intracellular loop are required for late endosomal/ lysosomal 
targeting o f y2 containing GABAa receptors.
Leupeptin modulates the efficacy o f synaptic inhibition in 
cultured hippocampal neurons
To examine whether blocking lysosomal degradation regulates the accumulation of 
GABAa receptors on the plasma membrane o f neurons, the effects o f leupeptin on 
the properties o f mIPSCs were examined. For these experiments hippocampal 
neurons were treated overnight with 400pM  leupeptin and then subjected to whole­
cell patch clamp recordings as described previously (Kittler et al., 2001; 2004b). 
The cumulative average o f mIPSC amplitudes in leupeptin-treated neurons was 
found to show a rightward shift towards higher higher amplitudes compared to 
control neurons and the average mIPSC amplitude was found to be increased nearly 
two-fold by leupeptin (Fig. 5.4). Importantly leupeptin did not affect channel 
kinetics, suggesting that the enhancement o f GABAergic function upon leupeptin 
treatment is a result o f altered GABAa receptor trafficking (Fig. 5.4).
Leupeptin enhances GABAa receptor cell surface 
expression levels in cortical neurons
In order to address whether the potentiation o f GABAergic currents after leupeptin 
treatment arose from an increase in the number o f GABAa receptors found at the 
cell surface, biotinylations were carried out in 15DIV cultured cortical neurons 
treated overnight with 400p(M leupeptin. Surface proteins were labeled with biotin 
under non-permeabilising conditions. After lysis in RIPA buffer, biotinylated 
proteins were precipitated with neutravidin beads. Precipitates were resolved by 
SDS electrophoresis and immunoblotted against the GABAa receptor p3 subunit. 
Although cortical neurons express a range o f GABAa receptor a , P and y subunits, 
the p3 subunit is expressed at significantly higher levels than the other p subunits, 
therefore blotting for this subunit should reliably detect most subtypes expressed in 
these cells (Kittler et al., 2004b). Biotinylated GABAa receptors were detected
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Figure 5.4: Analysis of mIPSCs in hippocampal neurons with leupeptin 
treatment. Whole-cell patch clamp recordings (A) and mIPSC histograms (C) from 
control neurons and neurons treated with leupeptin (B and D). The cumulative 
average of mIPSC am plitudes in leupeptin-treated neurons (filled symbols) is 
shifted to  higher am plitudes com pared to control neurons (open symbols) (E) and 
the average mIPSC am plitude is increased nearly two-fold by leupeptin (F). While 
leupeptin does not affect the time constant of decay (H), th e  mIPSC rise tim e 
(10-90%) is slower in leupeptin-treated neurons (G).(* P<0.05,T-test).
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Figure 5.5: Leupeptin treatment results in an increase in GABAa receptors 
expressed at the cell surface. (A) Control untreated (-) cortical neurones, or 
neurones treated overnight with 400|iM leupeptin (+) were biotinylated. Cells were 
then  lysed and cell surface biotinylated receptor populations were purified with 
neutravidin immobilised on beads, separated by SDS-PAGE followed by 
quantitative im m unoblotting with a rabbit polyclonal antibody to the GABAa 
receptor (33 subunit. (B) Leupeptin trea tm ent resulted in an 82.4% ± 30 increase in 
the levels of GABAa receptor expressed at the  cell surface of cultured cortical 
neurons. (* P<0.05,T-test; n=5)
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using [125JI coupled secondary antibody, and levels were quantified with a 
phosphorimager. Bands for the (33 subunit were normalised to total protein as 
determined by a BCA protein assay and control levels o f biotinylated (33 were 
assigned 100%. Interestingly, leupeptin treatment resulted in a signficant (82.4% ± 
30, P<0.05) increase in the cell surface expression o f the (33 subunit (Fig. 5.5). 
These results indicate that the increase in GABAergic function caused by leupeptin 
treatment is due to an increase in the cell surface expression o f GABAa receptors.
Measuring the effects o f leupeptin on the number and size 
of GABAa receptor clusters in hippocampal neurons
The results presented above suggest that leupeptin treatment can alter the endocytic 
sorting fate o f GABAa receptors destined for lysosomal degradation. In cells 
treated with leupeptin, GABAa receptors targeted for degradation will continue to 
internalise but will accumulate along the endocytic pathway and eventually be 
targeted for recycling causing an increase o f receptor numbers at the cell surface 
(Fig. 5.2). Importantly, this increase in GABAa receptor numbers resulted in an 
enhancement in the efficacy o f synaptic inhibition as demonstrated by an increase 
in the amplitude o f mIPSCs suggesting an increase in receptor number at inhibitory 
sites. To provide further evidence for an increase in receptor number at inhibitory 
synapses in response to leupeptin treatment, quantitative immunofluorescence 
techniques were utilised to measure the number o f GABAa receptor clusters in 
control neurons and those treated with leupeptin.
Leupeptin treatment results in an increase in GABAa receptor cluster 
number in both distal and proximal dendrites
12-16DIV hippocamapal neurons treated overnight with 400pM  leupeptin were 
fixed in 4% PFA. Cell surface GABAa receptor clusters were identified by staining 
for the y2 subunit under non-permeabilising conditions. After permeabilisation, 
anti-VIAAT was used for synaptic identification and MAP2 for neuronal and 
dendritic identification.
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Detailed analysis of cluster size and number was carried out in the distal and 
proximal sections o f neuronal dendrites in cells treated with leupeptin overnight. 
The cluster size (in pm 2) and number, independent o f synaptic colocalisation, was 
recorded for each 25 pm  section o f neuronal process. Analysis o f the total area 
occupied by clusters in leupeptin treated cells revealed a 43.65%± 17.66 increase in 
the distal dendrites (Fig. 5.6) and a 36.81%± 9.81 increase in the proximal 
dendrites (Fig. 5.7) when compared to control numbers. The number o f clusters 
were found to significantly increase by 46.1% ± 17 in distal dendrites (Fig. 5.6) and 
45.7% ± 14 in proximal dendrites (Fig. 5.7). Interestingly, the size distribution of 
clusters revealed that this increase affected all clusters, as there was no change in 
the distibution curves (Figs. 5.6 & 5.7).
These results strongly suggest that leupeptin treatment results in the formation o f 
new clusters.
Leupeptin treatment results in an increase in GABAa receptor cluster 
size in the AIS
The axon initial segment (AIS) is a major site for GABAergic innervation (Christie 
and De Bias, 2003). In addition, altered GABAa receptor accumulation at this 
cellular specialisation has been strongly implicated in the pathology of 
schizophrenia (Volk et al., 2002). In order to investigate the possible effects of 
modulating receptor endocytic sorting on GABAa receptor accumulation at 
subcellular specialisations, high resolution image analysis o f GABAa receptor 
clusters was carried out in the AIS after leupeptin treatment
Similar to the results obtained in the dendrites, leupeptin treatment caused a 45.6% 
± 15 increase in the total area occupied by clusters compared to clusters in control 
cells. Intriguingly, the determinant for this increase differed from that obtained in 
the dendritic analysis. Whereas in both distal and proximal dendrites there was a 
significant increase in the total number o f clusters, the AIS cluster number was not 
significantly increased. Instead, there was a significant increase in the size o f the 
GABAa receptor clusters as observed by a rightward shift in the size distribution
141
trace (Fig. 5.7). Interestingly, these results indicate that perhaps there are structural 
restrictions (quite possibly related to the network o f cytoskeletal proteins that allow 
membrane protein anchoring in the AIS (Winckler et al., 1999)) within the AIS that 
prevent a regulation o f receptor cluster number.
Leupeptin does not alter the ratio o f synaptic/non-synaptic 
y2 containing GABAa receptor clusters
High resolution images o f distal and proximal dendrites were taken and analysed 
using M etamorph imaging software. The number o f y2 subunit clusters present in a 
25pm  length o f dendrite was recorded. Clusters found overlapping or opposing 
VIAAT clusters were considered synaptic, whereas all other clusters were 
considered non-synaptic.
The ratio o f non-synaptic to synaptic y2 containing GABAa receptor clusters was 
calculated for both cells treated with leupeptin and those untreated. Results 
revealed that 90.7 %± 4 o f GABAa receptor clusters are synaptic in untreated cells 
(Fig. 5.9). Similarly, in cells treated overnight with leupeptin 91.2%± 3 o f clusters 
were found to be synaptic (Fig. 5.9). These results were not significantly different 
from each other suggesting that leupeptin increases the number o f GABAa receptor 
clusters at the cell surface without affecting their ability to form synaptic 
connections.
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Figure 5.6: Distribution analysis of cluster size and number in the distal 
dendrites. Cell surface of labeling GABAa receptors was carried out in 12-16DIV 
cultured hippocampal neurons treated overnight with 400jiM leupeptin. (A) GABAa 
receptor clusters were identified using a guinea pig antibody to  the N-terminus of 
the  y2 subunit (red). Presynaptic inhibitory terminals were labeled with anti-VIAAT 
(green) and neuronal dendrites were stained for using anti-MAP2 (blue). High 
resolution confocal images were taken of the  distal dendrites (35pm away from the  
cell body). (B) GABAa receptor clusters were identified by an increase in intensity 
around a central point (arrow heads).The size and num ber of clusters was recorded 
for each dendrite and results were normalised to  the control cells. Leupeptin 
treatm ent caused a significant increase in the  total area occupied by clusters (C) and 
the  num ber of clusters (D). The relative size distribution of clusters shows no 
significant change betw een both sets of data. (* P<0.05,T-test;n=9)
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Figure 5.7: Distribution analysis of cluster size and number in the proximal 
dendrites. Cell surface labeling of GABAa receptors was carried out in 12-16DIV 
cultured hippocam pal neurons treated  overnight with 400|iM leupeptin. (A) GABAa 
receptor clusters were identified using a guinea pig antibody to  the N-terminus of 
the  y2 subunit (red). Presynaptic inhibitory terminals were labeled with anti-VIAAT 
(green) and neuronal dendrites were stained for using anti-MAP2 (blue). High 
resolution confocal images were taken of the  proximal dendrites. (B) GABAa receptor 
clusters were identified by an increase in intensity around a central point (arrow 
heads).The size and num ber of clusters was recorded for each dendrite and results 
were normalised to the control cells. Leupeptin treatm ent caused a significant 
increase in the total area occupied by clusters (C) and in the num ber of clusters (D). 
The relative size distribution of clusters is equal for both control and leupeptin 
treated clusters. (* P<0.05,T-test; n=9)
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Figure 5.8: Distribution analysis of cluster size and number in the AIS. Cell 
surface labeling of GABAa receptors was carried out in 12-16DIV cultured 
hippocampal neurons trea ted  overnight with 400jiM leupeptin. (A) GABAa receptor 
clusters were identified using a guinea pig antibody to the N-terminus of the  y2 
subunit (red). Presynaptic inhibitory terminals were labeled with anti-VIAAT (green) 
and neuronal dendrites were stained for using anti-MAP2 (blue). High resolution 
confocal images were taken of the AIS (defined by MAP2 negative staining). (B) 
GABAa receptor clusters were identified by an increase in intensity around a central 
point (arrow heads).The size and num ber of clusters was recorded for each AIS and 
results were normalised to  the  control cells. Leupeptin trea tm ent caused a 
significant increase in the total area occupied by clusters (C) but not in the  num ber 
of clusters (D). The relative size distribution of clusters shows a rightward shift 
indicative of an increase in th e  num ber of larger clusters. (* P<0.05,T-test; n=9)
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Figure 5.9: Leupeptin does not affect the ability of clusters ot form synaptic 
connections. The percentage of clusters colocalising or opposing presynaptic 
inhibitory terminals was calculated in control cells and cells treated  overnight with 
400juM leupeptin. 90.7% ± 4 and 91.2% ± 3 of clusters were found to be synaptic in 
control and leupeptin treated  cells respectively (n=9).
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Discussion
In this study GABAa receptors are shown to be internalised to two endocytic 
sorting fates. The sorting decision is largely regulated by subunit composition 
where the y2 subunit plays a critical role in allowing for late endosomal/lysosomal 
targeting. Using a chimeric system and site directed mutagenesis together with 
antibody labeling experiments and quantitative confocal microscopy a lysine rich 
stretch, and a known phosphorylation site were identified as key regulators o f late 
endosomal/lysosomal targeting.
This lysine rich stretch was found to be a target for ubiquitination, suggesting that 
ubiquitination at this site was a determinant of endocytic sorting. Furthermore, 
mutation o f S327 resulted in decreased levels o f internalised receptor found in late 
endosomes and reduced ubiquitination levels. Together, these results suggest that 
ubiquitination o f the y2 subunit is required for late endosomal/lysosomal targeting 
and this ubiquitination can be regulated by S327 quite possibly by its 
phosphorylation state.
In this chapter the possible functional consequences o f endocytic sorting were 
investigated. Blocking the internalisation o f GABAa receptors has previously been 
shown to result in an increase in the number o f cell surface receptors as shown by 
electrophysiological recordings and cell surface biotinylations (Kittler et al., 2000; 
vin Rijnsoever et al., 2005). In addition, overexpression o f HAP1 a modulator o f 
endocytic sorting o f GABAa receptors by its interaction with the p subunits, can 
also cause an increase in cell surface receptor number (Kittler et al., 2004b). 
GABAa receptor degradation in the lysosome has been previously shown to be 
blocked by the protease inhibitor leupeptin (Kittler et al., 2004b). Here, leupeptin 
was used to block the degradation of GABAa receptors targeted to the late 
endosomes/lysosomes and change the sorting fate o f internalised receptors. The 
functional consequences o f changing this sorting decision was then investigated on 
inhibitory currents, surface receptor number as well as GABAa receptor cluster 
size and number.
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Electrophysiological recordings o f HEK293 cells expressing recombinant GABAa 
receptors consisting o f a ip 3  or a lp3y2L  revealed that whereas a lp 3  expressing 
cells were able to produce stable currents that were unaffected by leupeptin 
addition, cells expressing a lp3y2L  subunits showed a time dependent increase in 
the whole cell current upon acute leupeptin treatment. This approach confirmed a 
y2 subunit dependence on the leupeptin effect suggesting that leupeptin can cause 
an enhancement o f GABAa receptor functional expression, independent o f receptor 
internalisation.
Importantly, HEK293 cells expressing GABAa receptors containing mutant forms 
o f the y2 subunit (y2K7R or y2S327A) did not show such an extensive increase in the 
whole cell current when compared to cells expressing wild-type al(33y2L 
containing receptors confirming that these mutations cause a reduction in the late 
endosomal/lysosomal targeting o f GABAa receptors.
Given that the y2L subunit is present in the majority o f inhibitory synapses in the 
brain, the effect o f leupeptin was also investigated in neuronal preparations. 
Cultured hippocampal neurons were treated overnight with leupeptin and mIPSCs 
were recorded. Similar to the results above, leupeptin caused an increase in the 
amplitude o f mIPSCs without affecting channel kinetics. Furthermore, cell surface 
biotinylations on cortical neurons demonstrated that enhanced GABAergic function 
in response to leupeptin was a result o f an increase in receptor number at the cell 
surface.
To examine where in the neurons these changes were occuring a detailed 
immunofluorescent study was carried out. The size and number o f y2 containing 
cell surface clusters was investigated in 13-16DIV hippocampal neurons and 
compared to those treated with leupeptin overnight. Leupeptin treatment resulted in 
a significant increase in the area occupied by clusters in all parts o f the neuron 
examined, results that correlated with the previous findings o f an increase in 
GABAa receptor numbers and an enhancement in GABAergic function. However,
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whether this change was due to an increase in synaptic number or size varied in the 
different neuronal regions. In both the proximal and distal dendrites, leupeptin 
caused an increase in the number o f clusters without affecting the size distribution. 
Importantly, the majority o f clusters were found to be synaptic independent of 
leupeptin treatment suggesting that the new formation o f clusters due to leupeptin 
treatment did not affect their ability to form synaptic connections.
The AIS is the site for action potential initiation (Matus, 2001). GABAergic 
innervation at this site is therefore o f great importance in determining the decision 
on action potential propagation (Somogyi et al., 1983; Christie and de Bias, 2003). 
Furthermore, altered GABAa receptor expression in the AIS has been shown in 
schizophrenic patients further highlighting the importance o f inhibition at this site 
(Blum and Mann, 2002; Benes and Berretta, 2001; Fritschy and Brunig, 2003). In 
cultured hippocampal cells treated overnight with leupeptin, there was and increase 
in the area o f the neuron occupied by synaptic GABAa receptors. In the AIS, 
however, this change was achieved solely by a change in the size o f GABAergic 
clusters. Importantly, an increase in synapse size in the AIS could result in a 
substantial influx o f chloride concentrated in a relatively small area resulting in a 
large inhibitory response.
The data presented here therefore highlights the importance o f regulating endocytic 
sorting in inhibitory synaptic transmission. In particular, it identifies a method by 
which only synaptic GABAa receptors can be dynamically regulated to enhance 
GABAergic function by allowing the formation o f new synaptic connections, as 
well as an enlargement o f existing ones.
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6. Final D iscussion
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Summary
Recent evidence suggests that GABAa receptor trafficking is a dynamically 
regulated process (Kittler et al., 2001; Kittler and Moss, 2003; Collingridge et al., 
2004, Kittler et al., 2005; Chen et al., 2006). This thesis describes studies carried 
out to gain further insight into the mechanisms that underlie control of the 
endocytic trafficking o f synaptic GABAa receptors. To this end, molecular, 
biochemical and cell biological methodologies were used to analyse receptor 
trafficking in heterologous expression systems and cultured neurons.
The role o f GABAa receptor subunit composition was investigated in HEK293 
cells coexpressing recombinant GABAa receptor subunits and GFP-tagged 
endosomal markers. Receptors composed o f oclp3 or a lp3y2L  were found to 
constitutively internalise as previously shown (Connolly et al., 1999a,b; Kittler et 
al., 2000). However, the levels o f colocalisation with the early endosomal marker 
GFP-2FYVE or the late endosomal/lysosomal marker GFP-Rab 7 were 
significantly different when comparing internalised a lp 3  and alp3y2L . Whereas a 
small proportion o f internalised a lp 3  receptors were found to be targeted to late 
endosomes for subsequent degradation in the lysosome, a significanlty larger 
proportion o f a lp3y2L  receptors were found to be destined for lysosomal 
degradation in HEK293 cells. Although the levels o f internalised receptors targeted 
for late endosomes in HEK293 cells overexpressing GABAa receptors are unlikely 
to occur in neurons, these results suggest a critical role for subunit composition in 
the targeting o f GABAa receptors along the endocytic pathway as well as 
suggesting the possible existence o f a regulatory mechanism acting on the y2 
subunit that can specfically alter the degradation o f synaptic GABAa receptors.
Using a p3/y2 chimera consisting of a p3 N-terminal backbone and the intracellular 
loop and TM4 o f the y2 subunit, it was evident that the y2 subunit intracellular loop 
and TM4 were necessary and sufficient for this enhanced targeting to late 
endosomes in both HEK293 cells and cultured hippocampal neurons. A number of 
chimeras, consisting o f amino acid replacements in the intracellular loop o f the y2
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subunit with those o f the (33 subunit, were created in order to map the possible 
molecular determinants within the y2 intracellular loop or TM4 o f the late 
endosomal/lysosomal targeting o f 72 subunit containing GABAa receptors. 
Interestingly, chimeras which lacked the fisrt 20 amino acids o f the 72 intracellular 
loop, were unable to reach late endosomal/lysosomal structures to the same level as 
the chimera which had the whole intracellular loop and TM4 of the 72 subunit. 
These results strongly suggested that the late endosomal/lysosomal targeting of 72 
containing GABAa receptors was achieved by a molecular signal in the first 20 
amino acids o f the 72 intracellular loop.
The 20 amino acid region, within the 72 subunit intracellular loop, identified to be 
important in the late endosomal/lysosomal targeting o f GABAa receptors contains 
many lysine residues which can be a target for covalent modification by the small 
polypeptide ubiquitin. The ubiquitination o f proteins has been shown to be a key 
mechanism in regulating protein degradation in the proteasome as well as the 
lysosome. Importantly, a stretch o f lysine residues within the intracellular loop of 
the GABAa receptor 72 subunit was shown to be a target for ubiquitination. 
Furthermore, mutagenesis experiments revealed that these lysines were found to be 
necesasary for determining the late endosomal/lysosomal targeting o f GABAa 
receptors. Importantly, this site was not necessary for receptor internalisation, 
suggesting that ubiquitination within this sorting signal might occur post- 
internalisation at the level o f the early endosome. These findings are the first report 
to sugest that ubiquitination o f GABAa receptors is important for the degradation 
o f receptors outside the proteasome, within the endosomal pathway.
Phosphorylation o f GABAa receptors has long been suggested as an important 
mechanism for regulating GABAergic function. Diverse studies on GABAa 
receptor phosphorylation have implicated this process in altering channel kinetics, 
open time, rate of desensitization and sensitivity to pharmacological agents 
(Brandon et al., 2002; Kittler et al., 2003; Song and Messing, 2005). Recently, 
GABAa recptor phosphorylation has also been shown to play a role in controlling
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receptor cell surface stability. The binding o f AP2 to a novel binding site within the 
(3 subunits o f the GABAa receptor was shown to be regulated by the 
phosphorylation state o f a conserved serine residue in all GABAa receptor (3 
subunits (Kittler et al., 2005). Here, S327, a residue within the late endosomal/ 
lysosomal sorting signal in the intracellular loop o f the y2 subunit was shown to 
play a key role in determining the endocytic sorting o f internalised GABAa 
receptors by regulating the ubiquitination o f the y2 subunit.
How S327 regulates the ubiquitination o f GABAa receptors remains unclear. 
However, it is most likely that the phosphorylation state of this residues plays a 
major role. The ubiquitination of proteins requires 3 different enzymes (El-3) 
which act at different stages o f the ubiquitin pathway. Substrate recognition is 
carried out by E3 enzymes which bind their target protein and allow the ligation of 
the ubiquitin peptide to specific lysine residues. Due to their nature, E3 ligases are 
the most abundant o f ubiquitin enzymes. Substrate recognition has been 
investigated for a number o f E3 ligases, and although this varies between ligases, 
the phosphorylation state o f residues among the target protein has been shown to be 
a recurrent mechanism for regulating substrate recognition. For example there are a 
number o f E3 ligases that recognise their substrates where substrate recognition 
occurs by binding phosphorylated (Yaron et al., 1998; Skowyra et al., 1997; 
Feldman et al., 1997) or dephosphorylated (Honda and Yasuda, 1999) residues.
Intriguingly both phosphorylation and dephosphorylation o f S327 on the y2 subunit 
have been previously shown to cause a downregulation of GABAa receptors. In 
hippocampal neurons, evidence suggests that dephosphorylation at this site by 
NMDA receptor dependent activation o f calcineurin results in a downregulation of 
GABAa receptor expression at the cell surface (Wang et al., 2003). Furthermore, 
the use o f a constitutively active form of PKC (PKM) results in an enhancement of 
GABAergic function in transfected mouse fibroblasts in a manner that is partly 
dependent on phosphorylation at S327 (Lin et al., 1996). In contrast, the use of 
phorbol esters to activate PKC caused a time dependent downregulation of
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GABAergic currents in cultured sympathetic neurons and heterologous expression 
systems. Interestingly, this effect was shown to be slightly reduced in heterologous 
expression systems when S327 was mutated (Kellenberger et al., 1992; Krishek et 
al., 1994). It has been speculated that this discrepancy in the results arises from the 
existence o f multiple PKC isoforms that may produce different responses 
depending on their site o f action (Song and Messing, 2005).
In this thesis, the effects o f blocking receptor degradation at later stages of the 
endocytic pathway were investigated using leupeptin, a drug known to inhibit 
GABAa receptor degradation in the lysosome. Leupeptin treatment caused an 
enhancement o f GABAergic function in a manner independent o f receptor 
internalisation in both heterologous expression systems and cultured hippocampal 
neurons. Furthermore, biochemical analysis revealed that enhancement was due to 
an increase in cell surface receptor number. An increase in synaptic receptor 
number and synaptic inhibition can be achieved in 2 ways: an increase in the size 
o f synapses, or an increase in the number o f synaptic connections. Interestingly, 
immunocytochemical analysis o f GABAergic synapses in cultured neurons 
revealed that leupeptin could affect both synapse size and number, although an 
increase in synapse size was achieved solely in the AIS, whereas in the dendrites 
the synapse size did not change, but there was an overall increase in the number of 
synapses. The reasons for this are unknown, although they suggest that perhaps in 
the AIS there are structural restrictions that do not allow for the formation o f new 
synaptic connections.
GABAa receptor trafficking and synaptic plasticity
Activity dependent synaptic plasticity is thought to be important for certain forms 
o f learning and memory, neuronal development and pathological states o f neuronal 
excitability (Gaiarsa et al., 2002, Gaiarsa and Ben-Ari, 2006). Synaptic plasticity 
describes the ability o f synapses to modify in structure and function in response to 
stimuli. The most characterised forms of plasticity, long-term potentiation (LTP) 
and long-term depression (LTD), describe the ability o f a synapse to undergo long 
term changes in strength after repeated stimuli and is thought to be the basis for
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learning and memory. In addition to LTP and LTD, another form of plasticity has 
been recently characterised. Whereas LTP and LTD describe the ability of 
indivudual synapses to change in response to stimuli, synaptic scaling allows for 
the regulation o f the total synaptic strength o f a neuron in response to activity by 
altering all synapses (Turrigiano et al., 1998; Turrigiano and Nelson, 2000).
Although synaptic plasticity is best characterised in glutamatergic synapses, these 
forms o f plasticity have also been observed in inhibitory synapses. LTP and LTD of 
inhbitory synapses has been reported in various brain regions including: 
hippocampus (Caillard et al 1999a, Caillard et al 1999b, Stelzer et al 1987), cortex 
(Komatsu & Iwakiri 1993; Komatsu, 1996; Holmgren & Zilberter 2001) and 
cerebellum (Kano et al 1996, Kano et al 1992). In addition, synaptic scaling of 
inhibitory synapses has also been observed in cultured visual cortical pyramidal 
neurons (Kilman et al., 2002) and cultured hippocampal neurons (Stellwagen et al., 
2005; Swanwick et al., 2006) and has been suggested to be a mechanism important 
in development and certain epilepsies (Kilman et al., 2002).
Changes in synaptic transmission can be achieved by modulating the efficacy of the 
postsynaptic response to transmitter release. This can be achieved by modifying 
receptor channel properties with post-translational modifications. Alternatively, 
under saturating levels o f neurotransmitter, increasing or decreasing the number of 
receptors in the post-synaptic membrane would be expected to have a significant 
effect on synaptic transmission. Because of this, a number o f studies have focused, 
over the past decade, in further understanding the regulation o f receptor trafficking, 
with particular interest in the endocytosis of receptors as a mechanism for altering 
the strength o f synapses.
GABAa receptors have been shown to undergo constitutive clathrin mediated 
endocytosis, and this has been shown to be a highly regulated process mediated by 
various associated proteins and post-translational modifications (reviewed in 
Kittler et al., 2002; Kittler and Moss, 2003; Arancibia-Carcamo and Moss, 2006). 
The internalisation o f GABAa receptors has been recently shown to be regulated
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by the phosphorylation state of the p subunit (Kittler et al., 2005), a mechanisms 
that has been shown to be important in the downregulation o f GABAergic function 
upon D3 receptor activation in the nucleus accumbens (Chen et al., 2006). In 
addition, GABAa receptor endocytic sorting has been shown be regulated, in part, 
by the association o f the GABAa receptor P subunit with HAP1 (Kittler et al., 
2004b). Consistent with the suggested role o f endocytosis in regulating synaptic 
strength, blockade o f endocytosis results in an upregulation of GABAergic currents 
in cultured hippocampal neurons (Kittler et al., 2000, 2005). In addition, 
overexpression o f HAP 1 causes an increase in the expression o f GABAa receptors 
at the cell surface in cultured cortical neurons and an increase in the amplitude of 
GABAergic currents in cultured hippocampal neurons (Kittler et al., 2004b). 
Furthermore this is confirmed by results from HAP1 knockout mice that show 
reduced levels o f GABAa receptor surface expression in the hypothalamus (Sheng 
et al., 2006). In contrast, little is known regarding the subunit dependence of 
endocytic sorting or the regulatory mechanisms.
The results presented in this thesis provide further evidence to support the idea that 
the regulation o f postsynaptic GABAa receptor cycling could be an effective means 
o f regulating inhibitory synaptic transmission. Furthermore, it demonstrates the 
importance o f GABAa receptor subunit composition and describes a previously 
uncharacterised mechanism by which only synaptic receptors are differentially 
regulated along the endosomal pathway. In addition, whereas regulation of 
endocytosis can result in dynamically regulating individual synapses, these results 
suggest that the regulatory step may be occuring further down the endocytic 
pathway probably at the level o f the early endosome. Endosomes have been shown 
to be found along dendrites close to post-synaptic sites. However it is likely that 
multiple synapses share the same endocytic organelles as has been previously 
demonstrated for excitatory spines (Cooney et al., 2002). This suggests, that 
regulation o f endocytic sorting can also regulate multiple synapses at the same time 
as observed for example in synaptic scaling (Turrigiano et al., 1998; Turrigiano and 
Nelson, 2000, Kilman et al., 2002).
156
Recycling
ENDOSOME
Phosphorylation?
Ubiquitination djbj
RECEPTOR
DOWNREGULATION
Degradation
Figure 6.1: Proposed model for the regulation of GABAa receptor endocytic 
sorting. GABAa receptors undergo constitutive clathrin m ediated endocytosis. 
Receptors are though t to  move out of the synapse before entering clathrin coated 
pits. Upon internalization GABAa receptors are transported to  sorting endosom es 
where they can be sorted for either recycling or degradation. Under conditions in 
which GABAa receptor function needs to  be dow nregulated, phosphorylation or 
dephosphorylation of S327 in the  y2 subunit leads to  ubiquitination of this subunit 
which results in the  late endosomal targeting of GABAa receptors and subsequent 
degradation in the  lysosome.
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Proposed model for the regulation of synaptic 
GABAa receptor endocytic sorting
The results of this thesis propose a previously undescribed model for the regulation 
of inhibitory synaptic strength. Upon internalisation, synaptic GABAa receptors 
reach the early/sorting endosome were they can be sorted for degradation or 
recycled to the surface plasma membrane. Under basal conditions, the majority of 
receptors are unmodified and recycled back to the plasma membrane. However, 
under conditions were receptor downregulation is necesary, the phosphorylation or 
dephosphorylation of S327 in the intracellular loop of the y2 subunit results in the 
ubiquitination o f a stretch of lysines witin the y2 subunit. This results in an 
enhancement in the late endosomal targeting and subsequent degradation of the 
GABAa receptors (Fig. 6.1).
Future directions
The results described in this thesis demonstrate a role for subunit composition in 
the endocytic sorting of GABAa receptors. Furthermore, they describe a 
mechanism by which the endocytic sorting of y2 subunit containing receptors can 
be regulated and highlight the importance of this sorting in altering the number and 
size of inhibitory synapses. However, further questions need to be answered in 
order to fully understand this regulatory mechanism.
The importance of a serine residue (S327) within the intracellular loop of the y2 
subunit in regulating GABAa receptor ubiquitination and degradation raises the 
possibility of regulation by phosphorylation. S327 is a known PKC substrate 
although contradictory findings mean that the functional effects of phosphorylation 
at this site are not yet fully understood. In order to further elucidate the signalling 
pathways upstream from this S327 mediated ubiquitination of GABAa receptors it 
will be necessary to assess whether ubiquitination is regulated in a positive or 
negative manner by phosphorylation.
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In addition, it would be interesting to identify the machinery involved in the 
ubiquitination and trafficking of GABAa receptors. In particular the identification 
o f the E3 ligase involved in this process might provide important information on 
the physiological conditions in which GABAa receptor downregulation by this 
mechanism is important.
Finally, it would be interesting to analyse the effects on GABAa receptor 
ubiquitination o f already known physiological conditions that cause a 
downregulation in GABAergic function. For example, NMD A receptor dependent 
activation o f calcineurin has been shown to dephosphorylate GABAa receptors at 
S327 causing a reduction o f GABAa receptors at the cell surface (Stellwagen et al., 
2005). The link to S327 makes the model described above an attractive mechanism 
for explaining this process.
In addition, it is possible that the mechanism proposed, based on the results in this 
thesis, may play a role in the synaptic scaling o f GABAergic function (Turrigiano 
and Nelson, 2000; Kilman et al., 2002; Stellwagen et al., 2005). The identification 
o f the subcellular localisation at which the endocytic sorting o f GABAa receptors 
occurs will be important to provide further information as to whether this 
mechanism could be important for synaptic scaling. Furthermore, the synaptic 
downscaling o f GABAa receptors has been recently observed in response to TNF- 
a  (Stellwagen et al., 2005). It would therefore be interesting to see whether TNF-a 
application or NMDA receptor activation can cause a change in the ubiquitination 
o f GABAa receptors and whether this downregulation can be blocked by leupeptin 
treatment or by mutation o f the stretch o f lysines or S327.
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